US20040073301A1 - Less-invasive devices and methods for cardiac valve surgery - Google Patents
Less-invasive devices and methods for cardiac valve surgery Download PDFInfo
- Publication number
- US20040073301A1 US20040073301A1 US10/662,727 US66272703A US2004073301A1 US 20040073301 A1 US20040073301 A1 US 20040073301A1 US 66272703 A US66272703 A US 66272703A US 2004073301 A1 US2004073301 A1 US 2004073301A1
- Authority
- US
- United States
- Prior art keywords
- valve
- chest
- patient
- access port
- heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
- A61B17/0218—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
- A61B17/0293—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors with ring member to support retractor elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06061—Holders for needles or sutures, e.g. racks, stands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/122—Clamps or clips, e.g. for the umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/50—Supports for surgical instruments, e.g. articulated arms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0467—Instruments for cutting sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00039—Electric or electromagnetic phenomena other than conductivity, e.g. capacity, inductivity, Hall effect
- A61B2017/00044—Sensing electrocardiography, i.e. ECG
- A61B2017/00048—Spectral analysis
- A61B2017/00053—Mapping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00278—Transorgan operations, e.g. transgastric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00902—Material properties transparent or translucent
- A61B2017/00907—Material properties transparent or translucent for light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00946—Material properties malleable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
- A61B2017/0237—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for heart surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
- A61B2017/0237—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for heart surgery
- A61B2017/0243—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for heart surgery for immobilizing local areas of the heart, e.g. while it beats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
- A61B2017/047—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery having at least one proximally pointing needle located at the distal end of the instrument, e.g. for suturing trocar puncture wounds starting from inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
- A61B2017/0472—Multiple-needled, e.g. double-needled, instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
- A61B2017/0474—Knot pushers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0469—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
- A61B2017/0475—Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery using sutures having a slip knot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B2017/0496—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
- A61B2017/2912—Handles transmission of forces to actuating rod or piston
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
- A61B2017/2927—Details of heads or jaws the angular position of the head being adjustable with respect to the shaft
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
- A61B2017/2932—Transmission of forces to jaw members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2926—Details of heads or jaws
- A61B2017/2932—Transmission of forces to jaw members
- A61B2017/2943—Toothed members, e.g. rack and pinion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/30—Surgical pincettes without pivotal connections
- A61B2017/306—Surgical pincettes without pivotal connections holding by means of suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/30—Surgical pincettes without pivotal connections
- A61B2017/306—Surgical pincettes without pivotal connections holding by means of suction
- A61B2017/308—Surgical pincettes without pivotal connections holding by means of suction with suction cups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
- A61B2017/3405—Needle locating or guiding means using mechanical guide means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B2017/348—Means for supporting the trocar against the body or retaining the trocar inside the body
- A61B2017/3492—Means for supporting the trocar against the body or retaining the trocar inside the body against the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
- A61B2018/00232—Balloons having an irregular shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
- A61B2018/0025—Multiple balloons
- A61B2018/00261—Multiple balloons arranged in a line
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00291—Anchoring means for temporary attachment of a device to tissue using suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00363—Epicardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00982—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/061—Measuring instruments not otherwise provided for for measuring dimensions, e.g. length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/306—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2496—Devices for determining the dimensions of the prosthetic valve to be implanted, e.g. templates, sizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
- A61F2007/101—Cooling bags, e.g. ice-bags for cooling organs in the body before or during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3623—Means for actively controlling temperature of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M2025/028—Holding devices, e.g. on the body having a mainly rigid support structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
- A61M2039/027—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body having a particular valve, seal or septum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
- A61M2039/0279—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for introducing medical instruments into the body, e.g. endoscope, surgical tools
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
- A61M2202/047—Liquids non-physiological cardioplegic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3344—Measuring or controlling pressure at the body treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3355—Controlling downstream pump pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/366—General characteristics of the apparatus related to heating or cooling by liquid heat exchangers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
Definitions
- the present invention relates generally to surgical instruments, and more specifically, to surgical instruments for less-invasive surgery of the heart and great vessels, especially instruments for repair and replacement of heart valves.
- the present invention is directed to devices and techniques for the surgical treatment of heart valve disease, and particularly aortic valve disease.
- the aortic valve separates the left ventricle of the heart from the aorta, which carries oxygenated blood to the arterial system. Normally, when the left ventricle contracts during systole, the aortic valve opens to allow blood to flow into the aorta. During diastole, when the left ventricle returns to its uncontracted state, the aortic valve closes to prevent blood from flowing from the aorta back into the heart.
- aortic valve disease the aortic valve is compromised due to calcification of the valve leaflets, congenital deformation of the valve, or other conditions such that the valve does not completely open or close normally.
- the valve restricts blood flow out of the heart during systole, or the valve allows blood flow back into the heart during diastole. If the condition becomes sufficiently severe, surgical treatment is frequently required.
- aortic valves Various surgical techniques have been used to repair aortic valves.
- a large opening is formed in the chest—known as a sternotomy or thoracotomy—the patient's heart is arrested while circulation is supported by a cardiopulmonary bypass system, an incision is formed in the aorta, and instruments are then used to decalcify the valve, to separate valve leaflets which are fused together, or to constrict the annulus of an enlarged valve.
- Less-invasive approaches to valve repair have also been proposed.
- Balloon valvuloplasty involves the use of a balloon catheter threaded from a peripheral artery into the aorta, and expansion of a balloon within the calcified aortic valve to separate the valve leaflets while the heart remains beating.
- aortic valve repair techniques have not had long-lasting success in preventing recurrence of the disease, and eventual replacement of the valve is frequently required.
- aortic valve replacement The most widely-accepted surgical technique for the treatment of severe aortic valve disease is aortic valve replacement.
- aortic valve replacement surgery the diseased aortic valve is replaced with a prosthetic valve, homograft, allograft, or other type of replacement valve.
- Conventional aortic valve replacement techniques require a sternotomy or thoracotomy to be formed so as to provide access into and visualization of the chest cavity.
- the patient is placed on cardiopulmonary bypass, and the heart is stopped using an aortic cross-clamp to block blood flow through the aorta while a cardioplegic fluid is injected into the aorta upstream of the cross-xclamp or into the coronary sinus on the venous side of the heart.
- An incision is then made in the ascending aorta near the aortic valve, and the native valve leaflets are removed using surgical scissors inserted through the aortic incision. Specialized instruments may also be used to debride the valve annulus. A replacement valve is then sutured in place at the native valve position.
- aortic valve replacement is frequently effective in treating aortic valve disease and can add ten or more years to the life of a patient having the disease, the procedure also suffers from significant drawbacks surrounding the invasiveness and trauma of the surgery.
- the large thoracotomy required by the procedure is highly invasive, produces a great deal of pain, heightens the risk of infection and other complications, increases costs. and lengthens hospital stay considerably.
- the devices and techniques should obviate the need for a sternotomy and minimize the size of any necessary thoracic incisions to eliminate the pain, trauma, risks, costs, and lengthy recovery time associated with conventional aortic valve surgery.
- the devices and techniques should facilitate replacement of a diseased aortic valve with the same types of replacement valves which currently enjoy wide acceptance for aortic valve replacement, including mechanical valves, bioprosthetic valves, homografts, allografts, and others.
- the invention provides devices and methods for performing heart valve surgery which eliminate the need for a median sternotomy or other type of thoracotomy.
- the devices and methods are particularly advantageous in that they facilitate surgical repair or replacement of a heart valve in a manner analogous to the widely-accepted surgical techniques used in open-chest valve repair or replacement, yet without the invasiveness, pain, risks, and recovery time of conventional techniques.
- the devices and methods facilitate replacement of a diseased heart valve using various types of commercially-available replacement valves with proven safety and effectiveness.
- the devices and methods of the invention are perhaps most useful for the repair and replacement of the aortic valve, but may be used for the surgical treatment of any of the valves of the heart, as well as in other surgical procedures within the heart and great vessels of the thorax.
- a method for accessing an internal chamber of a patient's heart through a vessel in fluid communication with the chamber.
- the method includes visualizing the vessel through a percutaneous access port between two adjacent ribs.
- An instrument is positioned into an inner lumen of the vessel through a penetration in a wall of the vessel.
- the proximal end of the instrument extends out of the patient's chest through a percutaneous access port between the ribs, and the proximal end of the instrument is then manipulated to position the distal end of the instrument through the vessel and into the internal chamber of the heart. With the instrument within the internal chamber. various types of inspection, diagnostic and interventional procedures may then be performed.
- All manipulations of the instrument are performed with the surgeon's hands outside of the patient's chest, and none of the ribs or the sternum are cut or removed during each step.
- none of the ribs or the sternum are significantly retracted from their natural undeflected positions during the procedure.
- Visualization is accomplished either by looking directly into the chest through an access port between the ribs, by introducing a thoracoscope through such an access port and viewing a video image of the vessel and heart on a monitor, or by using other available less-invasive visualization devices.
- the vessel is the aorta
- the chamber is the left ventricle of the heart
- the distal end of the instrument is positioned into the aorta, through the aortic valve, and into the left ventricle.
- the instrument may then be used to perform a procedure in the heart or on the aortic valve itself.
- the instrument could be used for repairing a diseased aortic valve, and may comprise a debridement device for removing calcium from the valve annulus or leaflets, a scissors for incising the leaflet commissures to separate the leaflets, a cutting device for resecting the valve leaflets, or a needle driver for applying a suture to the valve annulus to reduce the diameter of the valve.
- the instrument is used in the replacement of a diseased aortic valve.
- the instrument may be a scissors, rongeur, knife or other cutting instrument for removing the native valve leaflets, or a needle driver or other device for applying sutures to the native valve annulus which are used to secure a replacement valve at the aortic valve position.
- the instrument could alternatively comprise a valve sizing device for measuring the size of the native valve annulus, or a valve delivery instrument for positioning a replacement valve at the aortic valve position.
- the instrument extends from the left ventricle out of the chest through a percutaneous access port between two ribs, and is manipulated entirely from outside of the chest.
- the instrument may comprise any of a variety of devices for performing diagnostic or interventional procedures within the heart, such as an angioscope or other endoscopic visualization device, an electrophysiological mapping or ablation device. or a laser for transmyocardial revascularization.
- the instrument could be used to repair or replace other valves of the heart.
- the mitral valve could be repaired or replaced by positioning the instrument through the aorta and left ventricle to the mitral position (and through the mitral valve into the left atrium if necessary).
- an instrument could be positioned through the superior vena cava or the inferior vena cava into the right atrium to perform a procedure on the right side of the heart, including repair or replacement of the tricuspid valve between the right atrium and right ventricle, or repair or replacement of the pulmonary valve between the right ventricle and the pulmonary artery.
- Various other procedures may also be performed according to the method of the invention, including pulmonary thrombectomy, the Cox “maze” procedure for treatment of atrial fibrillation, and repair of congenital defects such as atrial and ventricular septal defects or patent ductus arteriosus.
- the patient is placed on cardiopulmonary bypass and the heart is arrested.
- general anesthesia is administered.
- an arterial cannula is placed into a peripheral artery, usually a femoral artery, and a venous cannula is placed in a peripheral vein, usually a femoral vein.
- the arterial and venous cannulae are connected to a cardiopulmonary bypass pump and oxygenator, allowing deoxygenated blood to be withdrawn from the venous system through the venous cannula, oxygenated, and then pumped back into the patient's arterial system through the arterial cannula.
- the heart may then be arrested in any of several ways.
- an aortic catheter is introduced into a peripheral artery selected from among the femoral, brachial or subclavian arteries.
- the aortic catheter is advanced transluminally into the ascending aorta, and an expandable member such as a balloon is expanded in the ascending aorta to block blood flow through the aorta
- a cardioplegic fluid is then delivered into the ascending aorta upstream of the expandable member so as to perfuse the myocardium via the coronary arteries.
- a thoracoscopic aortic occlusion device may be used to arrest the heart.
- the thoracoscopic aortic occlusion device may be an external clamp positionable through a percutaneous access port between two ribs and around the exterior of the aorta, the clamp being movable between an open position and a closed position in which it clamps the aorta to occlude the aortic lumen.
- a cardioplegic fluid is then delivered into the aorta upstream of the clamp, either through a cannula penetrating the aortic wall and extending out of the chest through an intercostal access port, or through an endovascular catheter extending into the ascending aorta from a peripheral artery.
- the thoracoscopic aortic occlusion device may alternatively comprise a shaft having an expandable member such as a balloon mounted to its distal end which is configured to be introduced into the aorta through a small incision or puncture in the aortic wall.
- the expandable member may be expanded within the aorta to occlude the aortic lumen, and a cardioplegic fluid then delivered upstream of the clamp through either a thoracoscopic cannula or endovascular catheter.
- an endovascular catheter is introduced transluminally into the coronary sinus, which drains into the right atrium of the heart, from a peripheral vein such as the femoral, subclavian or internal jugular vein.
- the endovascular catheter preferably has a balloon or other occluding member on its distal end for occluding the coronary sinus during delivery of cardioplegic fluid.
- the occluding member is expanded while cardioplegic fluid is delivered, then contracted to allow fluid to drain into the right side of the heart from the capillary beds feeding the myocardium.
- a valve prosthesis is positioned through a percutaneous access port between two adjacent ribs and through an incision in a wall of the aorta using a first instrument.
- the valve prosthesis is then attached at the aortic valve position between the left ventricle and the aorta using at least a second instrument. All instruments used in the procedure are manipulated only from outside of the chest, and neither the ribs nor the sternum are cut or removed during the procedure.
- Visualization of the vessel and heart is accomplished, as described above, by direct vision through an access port, or using a thoracoscope or other minimally-invasive visualization device.
- the first instrument comprises a delivery handle which is coupled to the valve prosthesis, or to a holder on which the valve prosthesis is mounted.
- the delivery handle is configured to allow the valve prosthesis to be introduced into the chest through the percutaneous access port and has a length selected to reach the aortic valve position from outside of the chest.
- the valve prosthesis is introduced from the first, second, third, or fourth intercostal space on the anterior side of the chest, and the delivery handle is at least about 20 cm in length.
- valve prosthesis is movably coupled to the delivery handle such that it may be positioned through the access port between the ribs in a first orientation, then re-oriented within the chest relative to the delivery handle into a second orientation suitable for attachment at the aortic valve position.
- the delivery handle has an actuator on its proximal end to allow the valve prosthesis to be reoriented by moving the actuator outside of the patient's chest
- the valve prosthesis is preferably coupled to the delivery handle in such a way that it may be positioned through an intercostal space without removing or retracting the ribs significantly.
- the valve prosthesis is mounted such that an axis extending axially through the middle of the sewing ring of the valve prosthesis is approximately perpendicular to the longitudinal axis of the delivery handle. In this way, the profile of the valve prosthesis and delivery handle in a plane perpendicular to the longitudinal axis of the delivery handle is minimized.
- the profile of the valve and handle will be large enough that some minor retraction of the adjacent ribs may be required to allow the valve to be introduced into the chest without risking damage to the valve.
- the percutaneous access port through which the valve prosthesis is positioned may comprise a puncture or incision through the chest wall between the ribs which does not involve cutting or removing the ribs or the sternum adjacent to the incision.
- no significant retraction or displacement of the ribs or sternum will be necessary.
- the tissue adjacent to the access port will need to be retracted or separated to provide an opening into the chest which will not interfere with introduction of the valve prosthesis and through which the surgeon may view the chest cavity.
- the invention provides a retraction device particularly well-suited for aortic valve replacement.
- the retraction device comprises a cannula having a distal end suitable for placement between the ribs into the chest. a proximal end, and a passage therebetween configured to allow the valve prosthesis to be easily passed through it.
- the passage in the cannula has a cross-sectional height which is substantially greater than its cross-sectional width, preferably at least about 1.5 times the cross-sectional width. In this way, the cross-sectional height may be large enough to accommodate the outer diameter of the valve prosthesis in the passage, while the cross-sectional width is small enough to fit between the ribs without significant retraction (yet being large enough to accommodate the height of the valve prosthesis when mounted to the delivery handle).
- the retraction device of the invention may be adjustable in width to provide a slightly larger passage into the chest while the valve is introduced, deflecting the ribs adjacent to the access port as needed. Once the replacement valve is within the chest cavity, the retraction device may be returned to a smaller width in which the ribs are in their natural, undeflected positions for the remainder of the procedure.
- the retraction device of the invention may further include a suture organizer mounted to it for arranging the sutures used to secure the valve prosthesis in the aortic valve position.
- the suture organizer is mounted to the proximal end of the cannula through which the valve prosthesis is positioned, whereby a plurality of sutures may be drawn out of the chest cavity through the passage in the cannula and placed in spaced-apart locations on the suture organizer.
- the suture organizer may comprise, for example, a ring having a plurality of radial slots arranged about its perimeter each of which is configured to receive and retain a suture thread.
- the native valve leaflets are excised from the native annulus and any calcium or other debris on the annulus is removed before a replacement valve is implanted.
- thoracoscopic scissors and forceps may be introduced through a percutaneous access port and used to cut the leaflets from the annulus.
- Specialized thoracoscopic debridement devices such as rongeurs having an inner lumen through which suction may be applied, are then used to cut away calcific deposits and other undesirable matter from the surface of the valve annulus.
- a filter or trap may be placed through the aortic valve into the left ventricle to catch any debris which may be released.
- the native valve annulus must be measured to ascertain the appropriate size of the valve prosthesis to be used. This is accomplished by utilizing a specialized valve sizing device which may be introduced through a percutaneous access port and positioned adjacent to or advanced through the native annulus.
- the sizing device preferably includes an elongated handle with a sizing disk of a known size at its distal end which may be compared to or positioned within the native annulus.
- the sizing disk may be adjustable in diameter to measure a range of sizes, may include markings for visual identification of the size of the annulus, or may be interchangeable with larger and smaller sizing disks to allow multiple sizes to be tried until the proper one is found.
- the sizing disk is mounted to the distal end of the handle in such a way as to be positionable into the chest without retracting or removing ribs, and is preferably pivotably attached to the handle so as to be movable into a low profile orientation for introduction, or is collapsible for introduction and then expandable for sizing the valve annulus.
- a variety of different replacement valves may be implanted using the devices and methods of the invention, including mechanical prostheses, bioprostheses, homografts and allografts.
- the invention facilitates the use of many of the clinically-proven replacement valves currently used in open-chest valve replacement without modification of these valves and without the need for removal or significant retraction of the ribs.
- the replacement valve may be secured at the native valve position in various ways, but is preferably secured using sutures.
- the sutures are applied to the aortic valve annulus using elongated thoracoscopic needle drivers or other known types of thoracoscopic suture placement devices positioned through a percutaneous access port.
- a plurality of sutures are applied to the annulus, drawn out of the chest cavity, and then applied to the sewing ring of the valve prosthesis outside of the chest.
- the valve prosthesis is then slid along the sutures through the access port and placed against the native valve annulus using the delivery handle or other appropriate thoracoscopic instrument.
- a knot is formed in each suture outside of the chest, and the knot is pushed along the suture through the access port and against the sewing ring of the valve prosthesis using a thoracoscopic knot pusher. The free ends of the suture are then trimmed using thoracoscopic scissors.
- thoracoscopic needle drivers may be positioned through an access port and used to drive a needle alternately between the native annulus and the sewing ring of the replacement valve. The suture is then tied off and trimmed using thoracoscopic instruments.
- the aortic incision must be closed.
- Thoracoscopic needle drivers are introduced through a percutaneous access port and used to drive a suture back and forth across the incision from end to end in a running stitch. The suture is then tied off and trimmed.
- the patient's heart is restarted by removing the aortic occlusion device, whether an external clamp, endovascular aortic occlusion catheter, or other means, from the ascending aorta. If placed through a puncture in a wall of the aorta, the puncture is closed with a purse- string suture or running stitch using thoracoscopic needle drivers. Warm oxygenated blood delivered to the arterial system by the arterial cannula is thereby allowed to flow into the ascending aorta and to perfuse the myocardium via the coronary arteries. Normal heartbeat will ordinarily resume spontaneously. If not, electrical defibrillation may be administered.
- any retractors, trocars, or other devices in the percutaneous access ports are removed, and chest incisions are closed with sutures or adhesive strips.
- the patient is gradually weaned from cardiopulmonary bypass, all arterial and venous cannulae are removed, and arterial and venous punctures are closed. The patient is then recovered from anesthesia.
- FIG. 1 is an anterior view of a patient's chest schematically illustrating an endovascular system for inducing cardioplegic arrest and establishing cardiopulmonary bypass according to the invention.
- FIG. 2 is a close-up view of a patient's heart and aorta showing the placement of an endoaortic catheter in the system of FIG. 1.
- FIG. 3 is an anterior view of a patient's chest schematically illustrating a first embodiment of a thoracoscopic system for inducing cardioplegic arrest and establishing cardiopulmonary bypass according to the invention.
- FIG. 3A is an anterior view of a patient's chest schematically illustrating a technique of gaining access to the aorta according to the invention.
- FIG. 4 is a close-up view of a patient's heart and aorta illustrating the placement of a thoracoscopic balloon cannula in the system of FIG. 3.
- FIG. 5 is an anterior view of a patient's chest schematically illustrating a second embodiment of a thoracoscopic system for inducing cardioplegic arrest and establishing cardiopulmonary bypass according to the invention.
- FIG. 6 is a close-up view of a patient's heart and aorta illustrating the placement of a thoracoscopic clamp in the system of FIG. 5.
- FIG. 7 is an anterior view of a patient's chest schematically illustrating a third embodiment of a thoracoscopic system for inducing cardioplegic arrest and establishing cardiopulmonary bypass according to the invention.
- FIG. 8 is a close-up view of a patient's heart and aorta illustrating the placement of a detachable thoracoscopic clamp and applicator in the system of FIG. 7.
- FIG. 9 is an anterior view of a patient's chest schematically illustrating the formation of an aortotomy in the ascending aorta according to the invention.
- FIG. 10 is a close-up view of a patient's heart and aorta illustrating the formation of an aortotomy in the ascending aorta according to the invention.
- FIG. 11 is an anterior view of a patient's chest schematically illustrating retraction of the aortotomy according to the invention.
- FIG. 12 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the placement of sutures for retraction of the aortotomy according to the invention.
- FIG. 13 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the removal of the aortic valve leaflets according to the invention.
- FIG. 14 is a close-up partial cross-section of the left ventricle of the heart and the aorta showing a catcher placed in the left ventricle to catch pieces of valve leaflet and debris removed from the native valve annulus according to the invention.
- FIG. 15 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the removal of calcific and fibrous material from the native valve annulus according to the invention.
- FIG. 16 is a transverse cross-sectional view of a portion of the patient's chest and heart illustrating the use of a valve sizing device for sizing the native valve annulus according to the invention.
- FIG. 17 is a transverse cross-sectional view of a portion of the patient's chest and heart illustrating the placement of sutures in the native valve annulus according to the invention.
- FIG. 18 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the placement of sutures in the native valve annulus according to the invention.
- FIG. 19 right lateral elevational view of the patient's chest illustrating the placement of sutures through a prosthetic valve according to the invention.
- FIG. 20 is a transverse cross-sectional view of a portion of the patient's chest and heart illustrating the positioning of a prosthetic valve into the chest through an access port according to the invention.
- FIG. 21 is a right lateral elevational view of the patient's chest with a portion of the chest cut-away illustrating the placement of the prosthetic valve at the native valve position in the heart.
- FIG. 22 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the tying and trimming of sutures to secure a prosthetic valve in the heart according to the invention.
- FIG. 23 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the closure of the aortotomy according to the invention.
- FIG. 24 is a perspective view of an alternative embodiment of a delivery handle according to the invention holding an element schematically representing a valve sizing disk or prosthetic valve.
- FIG. 25 is a perspective view of the delivery handle of FIG. 24 illustrating the element pivoted into an orientation suitable for positioning through an intercostal access port.
- FIG. 26 is a side cross-sectional view of the delivery handle of FIGS. 24 and 25.
- FIG. 27 is a perspective view of an additional embodiment of an access port through which a prosthetic valve may be positioned into the chest according to the invention.
- FIG. 28 is a perspective view of the access port of FIG. 27 showing deployment of a retention element for retaining the access port in the chest wall.
- FIG. 29 is a perspective assembly view of the access port of FIGS. 27 - 28 .
- FIG. 30 is a perspective view of an obturator for use in conjunction with the access port of FIGS. 27 - 29 .
- FIGS. 31 A- 31 B are side cross-sectional views of the obturator of FIG. 30 illustrating the actuation a means for retracting the retention means of the access port of FIGS. 27 - 29 .
- FIG. 32 is a perspective view of the delivery handle of FIGS. 24 - 26 including an alternative embodiment of a valve holder according to the invention.
- FIG. 33A is a side assembly view of a distal portion of the delivery handle and valve holder of FIG. 32.
- FIG. 33B is an end view of the valve holder of FIG. 32.
- FIG. 34 is a perspective view of a bileaflet mechanical heart valve useful in conjunction with the devices and methods of the invention.
- FIG. 35 is a perspective view of a further embodiment of a valve holder according to the invention holding the bileaflet mechanical heart valve of FIG. 34.
- FIGS. 36 A- 36 C are side, bottom, and proximal end views, respectively of the valve holder of FIG. 35.
- FIG. 37 is a perspective view of an access port and illumination device constructed in accordance with the principles of the invention.
- FIGS. 38 - 40 are cross-sections taken along the lines 38 - 38 , 39 - 39 and 40 - 40 , respectively, of FIG. 37.
- FIG. 41 is a transverse cross-section of an alternative embodiment of an access port and illumination device according to the invention.
- FIG. 42A is a front view of an alternative embodiment of an access port having a channel through which an illumination or visualization device may be inserted.
- FIG. 42B is a transverse cross-section taken along line 42 B- 42 B of FIG. 42A.
- the types of interventions which can be performed include not only aortic valve repair and replacement, but catheter interventions in the coronaries such as angioplasty, atherectomy, stent placement or endoarterectomy, electrophysiological interventions within the heart such as mapping and ablation, transmyocardial revascularization using a laser placed within the heart, repair of septal defects and patent ductus arteriosus using patch placement or other defect closure devices placed in the right or left chambers of the heart, repair or replacement of the mitral, tricuspid or pulmonary valve including placement of annuloplasty rings and prosthetic valves, reattachment of chordae tendonae, commissurotomy, and quadrangular resection, incision of the atrial or ventricular wall for the performance of a Cox maze procedure in the treatment of atrial fibrillation, and other procedures.
- catheter interventions in the coronaries such as angioplasty, atherectomy, stent placement or endoarterectomy
- electrophysiological interventions within the heart such as mapping and ablation, transmyocardi
- the patient is first prepared for aortic valve surgery by putting the patient under general anesthesia, establishing cardiopulmonary bypass (CPB) and inducing cardioplegic arrest.
- CPB cardiopulmonary bypass
- General anesthesia is induced in a conventional manner.
- a preferred technique for accomplishing CPB and cardioplegic arrest which does not require a sternotomy, thoracotomy, or other opening in the patient's chest is illustrated in FIG. 1. Additional aspects of the systems and methods for inducing cardioplegic arrest described here may be found in patent application Ser. Nos. 08/1282,192, filed Jul. 28, 1994, now U.S. Pat. Nos. 5,584,803 and 08/486,216, filed Jun. 7, 1995, now U.S. Pat. No. 5,766,151, the complete disclosures of which are hereby incorporated herein by reference.
- a cardiopulmonary bypass system 20 includes a venous cannula 22 which is placed in a femoral vein 24 in the groin area or in another peripheral vein such as an internal jugular vein or subclavian vein, located in the neck. While illustrated in a shorter configuration, the venous cannula may be long enough to extend from the femoral vein into the inferior vena cava, into the right atrium of the heart or through the right atrium into the superior vena cava.
- the system also includes an arterial return cannula 26 placed in a femoral artery 28 or in another peripheral artery such as the subclavian or brachial artery in the neck or armpit.
- the arterial return cannula 26 is generally long enough so that it extends sufficiently into the femoral artery to avoid backing out of the artery but as short as possible to reduce damage to blood delivered through the arterial return cannula.
- Both venous cannula 22 and arterial return cannula 26 are configured to be placed into the femoral vein and femoral artery, respectively, either by surgical cut-down, or by a percutaneous technique such as the Seldinger technique.
- Venous cannula 22 and arterial return cannula 26 are connected to a CPB pump and oxygenator 30 of well-known construction.
- CPB pump and oxygenator 30 oxygenates the deoxygenated blood withdrawn from the patient's venous system through venous cannula 22 , and pumps the oxygenated blood back into the patient's arterial system via arterial return cannula 26 . In this way, circulation and re-oxygenation of the patient's blood may be maintained while the heart is temporarily arrested.
- Cardioplegic arrest may be induced using any of several techniques.
- One preferred technique is illustrated in FIGS. 1 and 2.
- an endoaortic catheter 32 is introduced by surgical cut-down or by a percutaneous technique into a peripheral artery, which may be the femoral artery 34 as illustrated, or a brachial or subclavian artery.
- Endoaortic catheter 32 is configured to be advanced transluminally, usually over a guidewire (not shown), from femoral artery 34 into the aorta until its distal end 36 is positioned in the ascending aorta 38 between the coronary ostia (not shown) just downstream of the aortic valve and the brachiocephalic artery 40 .
- Endoaortic catheter 32 has an expandable member 42 mounted near its distal end 36 which, as shown in FIG. 2, is configured to expand into sealing engagement with the inner wall of the ascending aorta 38 to block blood flow through the aorta without occluding either brachiocephalic artery 40 or the coronary ostia.
- expandable member 42 is an elastomeric balloon in communication with an inflation lumen 43 extending through endoaortic catheter 32 to a delivery device such as syringe 46 for delivering an inflation fluid such as saline or radio-opaque contrast solution to expand expandable member 42 until completely occluding the aorta.
- the elastomeric balloon preferably is short in the axial direction, being disc-shaped (a short cylinder), donut-shaped (toroidal), ellipsoidal, or other shortened shape to minimize the amount of the ascending aorta which is occupied by the balloon so that the surgeon has the maximum room to work upstream of the balloon.
- expandable member 42 has an axial length between its proximal and distal ends of about 1-40 mm, preferably about 1-20 mm, and an expanded outer diameter in the radial direction of about 10 to 60 mm, preferably about 30-40 mm.
- arterial return cannula 26 includes an additional hemostatic port (not shown) at its proximal end that allows endoaortic catheter 32 to be slidably positioned through the blood return lumen of the arterial return cannula.
- Arterial return cannulae having such a configuration are disclosed in copending application Ser. No. 08/282,192, filed Jul. 28, 1994, now U.S. Pat. No. 5,584,803, which is incorporated herein by reference.
- a cardioplegic fluid is delivered from a cardioplegic fluid supply 48 through a delivery lumen 44 in endoaortic catheter 32 and a port 51 at its distal end 36 into the ascending aorta distal to expandable member 42 so that the cardioplegic fluid flows into the coronary arteries to perfuse the myocardium.
- the cardioplegic fluid preferably includes a cardioplegic agent such as potassium chloride mixed with blood and cooled to a low temperature, e.g. 5-20° C. Upon perfusion of the myocardium with cardioplegic fluid, heart contractions will quickly cease.
- Circulation of oxygenated blood to organs and tissues other than the heart is maintained by cardiopulmonary bypass system 20 .
- Expandable member 42 prevents the oxygenated blood delivered by arterial return cannula 26 from reaching the coronary arteries, which would allow the blood to perfuse the myocardium and revive the heart.
- Endoaortic catheter 32 preferably also includes a pressure port 53 near its distal end 36 in communication with a pressure lumen extending to the proximal end of the catheter where it may be connected to a pressure measurement device 50 , allowing pressures in the ascending aorta distal to expandable member 42 to be monitored during the procedure.
- a coronary sinus catheter 52 is placed into a peripheral vein 54 , preferably the internal jugular vein or subclavian vein in the neck, and advanced through the superior vena cava into the right atrium, where it is maneuvered into the coronary sinus (not illustrated).
- Coronary sinus catheter 52 has a balloon or other expandable member 58 near its distal end 60 which may be expanded by means of a syringe 62 to occlude the coronary sinus during fluid delivery.
- a delivery lumen extends through the coronary sinus catheter 52 to a port at its distal end 60 to allow delivery of a cardioplegic fluid, which will usually be similar to that described above used in antegrade delivery.
- Coronary sinus catheter 52 may also include a pressure port near distal end 60 and a pressure lumen extending to its proximal end for monitoring pressure distal to expandable member 58 .
- Other aspects of coronary sinus catheters and retrograde cardioplegia techniques useful in connection with the present invention are disclosed in copending application Ser. No. 08/372,741, filed Jan. 12, 1995, now U.S. Pat. No. 5,558,644, which is hereby incorporated herein by reference.
- cardioplegic fluid is preferably delivered in periodic infusions at, for example, 600 ml volumes delivered in about 120 to 180 seconds at 15 minute intervals.
- expandable member 58 of coronary sinus catheter 52 is preferably deflated to allow fluid to drain from the coronary sinus.
- devices are introduced thoracoscopically through access ports between the ribs to occlude the ascending aorta and, optionally, to deliver cardioplegic fluid into the ascending aorta upstream of the occluded area.
- the pericardium is first opened to expose the ascending aorta.
- several access ports 71 such as trocar sleeves or other tubular cannulae, are placed in intercostal spaces I between ribs R.
- a thoracoscope 73 of conventional construction and having a video camera 75 mounted to its proximal end may be placed through one of access ports 71 for visualizing the procedure, or the surgeon may look directly into the chest through one of access ports 71 .
- Thoracoscopic scissors 77 and graspers 79 are introduced through access ports 71 and used to create an incision 81 approximately 4-10 cm in length in the anterior side of the pericardium 83 overlying the aorta 85 so that the ascending aorta 87 and upper anterior side of the heart 89 are exposed.
- Thoracoscopic scissors 77 and graspers 79 may have any of various well-known constructions, including those described in copending application Ser. No. 08/194,946, filed Feb. 14, 1994, now U.S. Pat. No. 5,501,698, which is hereby incorporated herein by reference.
- an expandable member 64 such as an elastomeric balloon is positioned in the ascending aorta 66 through a penetration in a wall of the aorta. Expandable member 64 will be shaped and dimensioned to allow complete occlusion of ascending aorta 66 without blocking blood flow into the brachiocephalic artery 78 or the coronary ostia.
- expandable member 64 will be as short as possible in the axial direction (along the central axis of the aortic lumen) to minimize its space requirements in the ascending aorta, preferably having a short cylindrical, discoid, ellipsoid, donut or toroidal shape with an axial length of about 1-40 mm, preferably about 1-20 mm.
- Expandable member 64 is attached to a distal end 68 of a shaft 70 , which may be a rigid or flexible biocompatible metal or polymer. Shaft 70 extends through the penetration in the aortic wall and out of the chest through an access port 72 between the ribs R.
- Shaft 72 is at least about 6 cm, preferably about 10-20 cm, in length so that its proximal end 76 is outside of the chest when expandable member 64 is in the ascending aorta 66 between the brachiocephalic artery 78 and the coronary ostia (not shown).
- Access port 72 is illustrated as a tubular cannula Or trocar sleeve, but may alternatively comprise a wound retractor with rigid blades or flexible adhesive strips for retracting tissue to create a small opening between the ribs. Instruments may alternatively be positioned directly through a puncture or incision between the ribs without a retractor, cannula or trocar, but usually some means of retracting tissue is desirable to prevent tissue damage and to facilitate introduction and manipulation of instruments. In some cases, it may be necessary to cut or remove one or more of the costal cartilages that connect the ribs to the sternum, to allow a slightly greater degree of rib retraction.
- the access ports will be configured to facilitate introduction of surgical instruments, visualization devices, valve prostheses, and other devices used in the various procedures of the invention without removing the ribs R or sternum S, and preferably without retracting or cutting the ribs R significantly.
- the access ports will have a transverse profile suitable for positioning within an intercostal space I between two adjacent ribs R, which typically has a width (the distance between adjacent ribs R) of about 10-25 mm in normal adult patients, without cutting or removing the ribs, and without retracting the ribs more than about 1-2 cm from their natural, undeflected positions.
- the access ports may be circular in cross-section with an outer diameter of less than about 12 mm so as to be easily positionable within an intercostal space I.
- the access ports may have a cross-sectional shape other than circular and may have a slightly larger transverse dimension to accommodate specialized instruments or prostheses, as described below.
- shaft 70 includes a delivery lumen 80 extending from a first connector 82 at proximal end 76 to a delivery port 84 at distal end 68 , through which cardioplegic fluid may be delivered into ascending aorta 66 .
- expandable member 64 is a balloon
- shaft 70 also has an inflation lumen 86 extending from a second connector 88 to the interior of expandable member 64 , through which an inflation fluid such as saline or contrast solution may be delivered into the balloon.
- shaft 70 may optionally include an arterial return lumen 90 extending from a third connector 92 at proximal end 76 to an arterial return port 94 at distal end 68 , through which oxygenated blood may be delivered into the aorta downstream of expandable member 64 .
- Third connector 92 may be connected with tubing to the outlet of cardiopulmonary bypass system 20 , allowing arterial return lumen 90 to be used in place of or as a supplement to the use of separate arterial return cannula 26 of FIG. 1.
- Shaft 70 may also include a pressure lumen (not shown) extending from proximal end 76 to a pressure port (not shown) at distal end 68 to allow pressure monitoring in ascending aorta 66 upstream of expandable member 64 .
- Shaft 70 is dimensioned so as to pass easily through access port 72 between ribs R, while having sufficient cross-section that lumens 80 , 86 and 90 are large enough to perform their respective functions.
- shaft 70 will have an outer diameter of less than about 12 mm, preferably less than about 10 mm.
- Delivery lumen 80 must be large enough in cross-section to allow cardioplegic fluid to be delivered at a sufficient flow rate to induce and maintain cardioplegic arrest, preferably allowing cooled cardioplegic fluid containing blood, usually having a viscosity of about 1-4 centipoise, to be delivered at a flow rate of at least about 200 ml/min at a pressure no more than about 300 mmHg.
- delivery lumen 80 has a cross-sectional area of about 0.5-8 mm 2 , preferably about 0.5-2.0 mm 2 .
- Arterial return lumen 90 is preferably large enough to allow blood to be delivered at flow rates adequate to maintain full cardiopulmonary bypass with the heart arrested (preferably without the use a separate arterial return cannula), having a cross-sectional area of about 12-75 mm 2 , and preferably about 25-50 mm 2 .
- inflation lumen 86 must be large enough to allow saline or other inflation fluid to be delivered at flow rates sufficient to inflate expandable member 64 in less than about 30 seconds, preferably less than about 10 seconds, having a cross-sectional area of about 0.1-5 mm 2 , preferably about 1-3 mm.
- FIGS. 5 - 6 A second embodiment of a thoracoscopic technique for inducing cardioplegic arrest is illustrated in FIGS. 5 - 6 .
- an external clamp 98 is placed around the ascending aorta 100 to occlude the aortic lumen 102 just upstream of the brachiocephalic artery 104 .
- Clamp 98 is attached to a distal end 106 of a shaft 108 which is long enough to extend out of the chest through an access port 110 between ribs R, having a length of at least about 10 cm, preferably 20-30 cm.
- An actuator 112 is attached to proximal end 114 of shaft 108 to allow clamp 98 to be opened and closed from outside of the chest.
- Actuator 112 includes a pair of movable handles 116 with finger loops 118 , and a locking mechanism 120 which may comprise a pair of overlapping fingers 122 with transverse teeth (not shown) which interlock with one another.
- Clamp 98 includes a first jaw 124 fixed to shaft 108 , and a second jaw 126 fixed to an inner shaft (not shown) extending through the interior of shaft 108 and rotatable relative to shaft 108 .
- One of handles 116 is fixed to the proximal end of shaft 108 , while a second of handles 116 is fixed to a proximal end of the inner shaft, so that by pivoting handles 116 relative to one another, the inner shaft rotates relative to shaft 108 , opening or closing jaws 124 , 126 .
- Other aspects of thoracoscopic clamping devices suitable for use in the method of the invention are described in U.S. Pat. No. 5,425,705, which is incorporated herein by reference.
- a delivery cannula 130 may be positioned through an inner lumen of shaft 108 so that a needle 132 at the distal end of the delivery cannula extends distally of distal end 106 of shaft 108 , generally parallel to and spaced apart from jaws 124 .
- Jaws 124 may be curved or angled away from shaft 108 so that the portions of the jaws that extend around the aorta are offset from needle 132 to allow needle 132 to be placed through shaft 108 and penetrate the aortic wall upstream from jaws 124 .
- Delivery cannula 130 has an inner lumen extending from its distal end to its proximal end which may be connected to a cardioplegic fluid source.
- a connector 134 is provided near the proximal end of delivery cannula 130 which connects to a connector on the proximal end of shaft 108 to fix the delivery cannula in position relative to clamp 98 .
- delivery cannula 130 may be positioned through shaft 108 to penetrate the aortic wall with needle 132 , allowing cardioplegic fluid to be delivered upstream of clamp 98 .
- the inner lumen of delivery cannula 130 will be configured to facilitate delivering cardioplegic fluid containing blood at a rate of at least about 200 ml/min and a pressure of no more than about 300 mmHg, having a cross-sectional area of at least about 0.5 mm 2 , and preferably 0.5-2.0 mm 2 .
- Delivery cannula 130 may alternatively be independent of clamp 98 and shaft 108 , and placed through a separate access port rather than being placed through shaft 108 .
- an endovascular delivery catheter may be placed through a peripheral artery such as a femoral artery until its distal end is in the ascending aortic lumen 102 upstream of the brachiocephalic artery 104 .
- Clamp 98 may then be actuated to close on the aorta around the endovascular delivery catheter, which may be reinforced in its distal extremity to prevent collapsing.
- cardioplegic fluid may be delivered upstream of the external clamp 98 without requiring a puncture through the aortic wall.
- Such an endovascular delivery catheter may also include a pressure port and pressure lumen for monitoring pressure in the ascending aorta during the procedure.
- an external clamp 136 is placed around the ascending aorta 138 by a thoracoscopic clamp applier 140 , closed on aorta 138 to block blood flow through the aortic lumen. then released from clamp applier 140 , which may then be removed from the chest.
- Clamp 136 comprises a pair of movable jaws 142 , 144 pivotably connected to each other by a pin 152 .
- Jaws 142 , 144 have proximal extremities 154 , 156 proximal to pin 152 to which a locking mechanism 148 is mounted, which may comprise a pair of deflectable overlapping fingers 150 having transverse teeth 152 which interlock with one another to maintain clamp 136 in a closed position.
- a pair of detents 158 are disposed at the proximal ends of jaws 142 , 144 and are adapted to receive the distal tips 160 of clamp applier jaws 162 .
- Clamp 136 is configured to be positionable through an access port 146 or incision between ribs R.
- Access port 146 has a transverse cross-sectional width to fit between the ribs without requiring significant deflection or removal of the ribs, but may have a longer transverse cross-sectional dimension parallel to the ribs to allow clamp 136 to be positioned through the access port when held by clamp applier 140 .
- Clamp applier 140 has, as shown in FIG. 7, an actuator 164 at its proximal end which comprises one or more movable leaves 166 pivotably mounted to a shaft 168 .
- Leaves 166 are linked to clamp applier jaws 162 by a linkage 170 , best seen in FIG. 8, which may be a rod or wire slidably disposed in a lumen 171 within shaft 168 , linked to a scissors mechanism 172 coupled to jaws 162 .
- a linkage 170 may be a rod or wire slidably disposed in a lumen 171 within shaft 168 , linked to a scissors mechanism 172 coupled to jaws 162 .
- moving leaves 166 toward shaft 168 causes jaws 162 to move between an open position for releasing clamp 136 to a closed position for grasping and closing clamp 136 .
- Clamp 136 is preferably biased into an open configuration by a torsion spring (not shown) around pin 152 or a compression spring (not shown) between proximal extremities 154 , 156 of jaws 142 , 144 . In this way, once locking mechanism 148 is released by deflecting fingers 150 away from each other, clamp 136 will be urged open as clamp applier jaws 162 are opened.
- Other aspects and alternative configurations of clamp 136 and clamp applier 140 are disclosed in commonly-assigned copending application Ser. No. 08/567,996, filed Dec. 4, 1995, now U.S. Pat. No. 5,618,307, which is hereby incorporated herein by reference.
- cardioplegic fluid may be delivered into the ascending aorta by means of a delivery cannula 176 placed into the chest through an access port 178 and having a needle 180 at its distal end for penetrating the aortic wall.
- a purse-string suture 182 will be placed in the aortic wall surrounding needle 180 using thoracoscopic needle drivers positioned through an intercostal access port. The purse-string suture 182 is cinched up around delivery cannula 176 to maintain hemostasis around the cannula.
- an endovascular delivery catheter (not illustrated) may be used which extends into the ascending aortic lumen transluminally from a peripheral artery such as the femoral, brachial, or subclavian artery.
- Clamp 136 is clamped around the aorta after the endovascular delivery catheter has been positioned so that the inner wall of the aorta seals against the outer wall of the delivery catheter.
- the delivery catheter may be reinforced in its distal extremity to resist collapsing under the force of clamp 136 .
- the delivery catheter may alternatively have an expandable member such as a balloon near its distal end which may be expended in the ascending aorta like endoaortic catheter 32 of FIGS. 1 - 2 .
- Clamp 136 may then be applied to the ascending aorta directly around the expandable member to achieve complete occlusion without excessive crushing or collapsing of the aortal Clamp 136 may also be placed distally or proximally of the expandable member, or a clamp may be placed in either side, to prevent migration of the expandable member as well as blocking blood flow.
- retrograde delivery of cardioplegic fluid via the coronary sinus by means of an endovascular catheter introduced through a peripheral vein may be used instead of or in combination with antegrade delivery through a thoracoscopic or endovascular delivery catheter placed in the aorta.
- cardioplegic arrest it may be appropriate not to induce cardioplegic arrest, but instead to place the heart in a state of fibrillation. While this is usually not desirable because it is generally thought to provide inadequate protection of the myocardium, it may be induced using the devices and methods of the present invention.
- the patient is placed on cardiopulmonary bypass as described above (without occluding the ascending aorta so as to arrest the heart), and the oxygenated blood returned to the arterial system is cooled to a sufficiently low temperature to induce fibrillation.
- An endovascular or thoracoscopic catheter may be placed in the ascending aorta as described above, and, without occluding the ascending aorta, drugs or blood may be delivered to the coronary arteries, and fluids may be removed to vent the heart and aorta.
- one of the above-described aortic occlusion devices may be used to periodically induce fibrillation during the procedure by occluding the aorta temporarily without delivering the cardioplegic fluids that induce cardioplegic arrest, with intermittent periods of no occlusion so as to avoid ischemia.
- FIGS. 9 - 10 Once cardioplegic arrest is induced, the patient is supported on cardiopulmonary bypass, and the pericardium has been opened as described above, an incision, or aortotomy, 184 is formed in the wall of ascending aorta 186 as shown in FIGS. 9 - 10 .
- at least one, and usually at least three, access ports should be placed in intercostal spaces I between ribs R on the right anterior side of the chest.
- One or two access ports 188 with outer diameter less than about 12 mm are placed in the first, second, or third intercostal space through which delivery cannula 176 and thoracoscope 73 (if utilized) are positioned.
- Another access port 190 with outer diameter less than about 12 mm is placed in the third, fourth or fifth intercostal space through which various instruments used in the procedure may be positioned.
- An additional access port 192 which is specially-configured for positioning a replacement valve through its central lumen as described more fully below, is placed in the first, second, third or fourth intercostal space, depending upon patient size and anatomy.
- access ports 188 , 190 , 192 may comprise trocar sleeves or other tubular cannulae, or simply incisions in which tissue is retracted apart to create a small opening using any of a variety of tissue retraction devices.
- access ports 188 , 190 , 192 will not require cutting or removal of ribs or the sternum, and will not require significant retraction of the ribs, preferably requiring less than about 2 cm of retraction from the ribs' natural, undeflected positions.
- a thoracoscopic light wand or a commercially-available thoracoscope or endoscope having a fiber-optic channel which emits light from the distal end of the device may be placed through an access port for illumination.
- one or more access ports may have an illumination device mounted to it, as described below in connection with FIGS. 37 - 40 .
- Aortotomy 184 is created using thoracoscopic angled scissors 194 or a knife (not shown) positioned through access port 192 , assisted by means of thoracoscopic forceps 196 positioned through access port 190 .
- Angled scissors 194 and forceps 196 may be commercially-available thoracoscopic instruments or may be constructed as described in copending applications Ser. No. 08/194,946, now U.S. Pat. No. 5,501,698, and Ser. No. 08/281,962, now abandoned, which have been incorporated herein by reference.
- Aortotomy 184 is approximately 6-8 cm in length, extending distally and slightly posteriorly along the anterior side of the aorta from a point at least about 10 mm, and preferably about 15 mm, downstream of the right coronary ostium.
- Aortotomy 184 is then retracted open as illustrated in FIGS. 11 - 12 .
- sutures 200 are placed in the aortic wall along the edges of aortotomy 184 , preferably with a suture near each end of aortotomy 184 on each side of the incision.
- Each of sutures 200 has a needle 202 attached to an end thereof which is driven through aortic wall 204 using thoracoscopic needle drivers 206 introduced through either access port 190 or access port 192 .
- Needle drivers 206 may be commercially-available thoracoscopic instruments or may be constructed as described in the aforementioned patent applications, Ser. Nos. 08/194,946, or 08/281,962, now abandoned.
- Sutures 200 preferably have a length of at least about 20 cm so that they may be withdrawn from the chest cavity by passing needles 202 through the chest wall between ribs R or by snaring the sutures with a hook introduced through an intercostal space. Sutures 200 are tensioned in opposing directions to retract aortotomy 184 open and are then secured outside the chest with hemostats 208 or other suitable clamping device of conventional construction. Alternatively, sutures 200 may be secured to tissue within the chest cavity by passing needles 202 through such tissue and tying the sutures off, or by attaching the suture ends to a clip, clamp, hook or staple which can be fastened to tissue in the chest. With aortotomy 184 retracted open, the aortic valve 210 is fully exposed and visible through the inner lumen 212 of access port 192 , as illustrated in FIG. 12.
- leaflets 214 of the native aortic valve 210 are then removed using thoracoscopic curved or angled scissors 194 or knife (not illustrated), and forceps 196 positioned through access ports 190 , 192 , respectively.
- Leaflets 214 are grasped by forceps 196 , retracted away from the valve annulus 216 , and cut closely to the inner edge of valve annulus 216 without cutting into the valve annulus or the aortic wall.
- a catcher 220 may be placed through aortic valve 210 into the left ventricle 222 and positioned so as to catch any debris released in the leaflet removal or debridement process.
- Catcher 220 may comprise a flexible, porous mesh, foam, gauze, or screen constructed as a bag or pouch with an opening 222 on a top end 224 thereof.
- Top end 224 is configured to be positioned in the left ventricle just below the aortic valve, with the sides of catcher 220 engaging the ventricular wall 226 .
- catcher 220 is collapsible into a smaller shape suitable for positioning through access port 190 or access port 192 , through aortotomy 184 , and through aortic valve 210 , and at least top end 224 is resiliently biased to return to an expanded configuration in which the outer sides of top end 224 engage ventricular wall 226 .
- a flexible and resilient metal or elastomeric ring 228 may be mounted to catcher 220 around opening 222 which may be radially collapsed during positioning, then released to allow the ring to expand outwardly to engage the ventricular wall.
- catcher 220 may be collapsed and placed in a tubular sleeve or catheter (not shown) during positioning through the aortic valve, then ejected from the sleeve within the left ventricle.
- thoracoscopic forceps or graspers positionable through an intercostal access port may be used to grasp and collapse catcher 220 and position it into the left ventricle.
- a suture or other flexible tether 230 is preferably attached to catcher 220 and extends out of the chest through an access port to allow catcher 220 to be retrieved after use.
- the aforementioned tubular sleeve may be guided over tether 230 back into the left ventricle and catcher 220 then collapsed and retracted into the sleeve to facilitate removing the device from the chest.
- Rongeurs 232 have a split-shaft construction, wherein two independent shaft members 234 , 236 are longitudinally slidable relative to one another.
- a fixed jaw 238 is disposed at the end of shaft member 234
- a movable jaw 240 is pivotably mounted to the distal end of shaft member 236 by a first pin 242 and pivotably attached to shaft member 234 by a second pin 244 .
- Fixed jaw 238 and movable jaw 240 have hollow or concave inner sides facing each other, and cutting edges 246 , 248 along the periphery of their inner sides. This construction allows cutting edges 246 , 248 to be positioned close to or against the inner surface of valve annulus 216 to excise any remaining leaflet material or calcific deposits along the valve annulus. Any material removed is collected within the concave inner sides of jaws 238 , 240 .
- rongeurs 232 include a suction lumen through which a vacuum may be applied from the proximal end of the device to evacuate tissue and debris as it is cut from valve annulus 216 .
- at least one of shaft members 234 , 236 may be provided with an inner lumen in communication with the inner sides of jaws 238 , 240 through which a vacuum may be applied to evacuate material cut by cutting edges 246 , 248 .
- an irrigation lumen may be provided in one of shaft members 234 , 236 to allow an irrigation fluid such as saline to be delivered to the inner surfaces of jaws 238 , 240 to keep the jaws clean and free of debris.
- a suction lumen is provided in one shaft member 234 and an irrigation lumen is provided in the other shaft member 236 to provide both irrigation and suction in the space between jaws 238 , 240 .
- thoracoscopic rongeurs 232 various other devices may be used for removal of calcific and fibrous material at the native valve position, including high-speed rotating cutters or grinders like those used in atherectomy and arthroscopy devices, lasers, and ultrasonic scalpels, any of which may be equipped with irrigation or suction lumens.
- valve annulus is then sized to determine the appropriate size for a replacement valve.
- a valve sizing device 250 is introduced through access port 192 into the ascending aorta 186 through aortotomy 184 .
- Sizing device 250 includes a shaft 252 having a pivoting tongue 254 at its distal end and a handle 256 at its proximal end.
- a sizing disk 258 is releasably attached to tongue 254 .
- An actuator button 260 is slidably mounted to handle 256 and is connected to tongue 254 by a linkage (not shown) such as a slidable rod extending through a passage in shaft 252 .
- sliding actuator button 260 along handle 256 pivots tongue 254 from a first orientation in which the tongue is generally parallel to shaft 252 to a second orientation in which the tongue is perpendicular to shaft 252 .
- sizing disk 258 is positionable in an orientation in which the central axis is perpendicular to the longitudinal axis of shaft 252 , providing a minimum profile to allow the sizing disk to be introduced through lumen 212 of access port 192 .
- sizing disk 258 may be re-oriented using actuator button 260 so that the sizing disk is in an appropriate orientation for sizing valve annulus 216 , usually with its axis about parallel to the longitudinal axis of shaft 252 as shown in FIG. 16.
- a button lock 262 may also be provided on actuator button 260 to allow sizing disk 258 to be releasably locked in a suitable orientation for sizing valve annulus 216 .
- Other aspects of valve sizing devices suitable for use in the method of the invention are described in copending applications Ser. No. 08/485,600 and Ser. No. 08/281,962, which have been incorporated herein by reference.
- sizing disk 258 is positioned within valve annulus 216 to allow a comparison of the outer diameter of sizing disk 258 to the inner diameter of valve annulus 216 .
- the surgeon may look directly at valve annulus 216 through lumen 212 of access port 192 or a thoracoscope may be used for video imaging of the valve annulus. If the sizing disk is either larger or smaller than the valve annulus, sizing device 250 is removed from the chest and sizing disk 258 is removed from tongue 254 and replaced with another sizing disk of a different diameter.
- the process is repeated until the surgeon has identified the appropriate size of replacement valve to be implanted. It should be understood that other techniques may be used for determining the annulus size, including endoscopic video imaging, transesophageal echocardiography, or thoracoscopic ultrasonic imaging, as well as using an adjustable valve sizer that may be placed within the valve annulus and adjusted in diameter until the appropriate size is determined.
- valve annulus When the size of the valve annulus has been determined, the appropriate replacement valve is then identified.
- a variety of replacement valves may be used in the method of the invention, including many of the more widely-accepted valves used in conventional open-chest aortic valve replacement procedures. These include mechanical valves such as the St. Jude Medical Mechanical Heart Valve (St. Jude Medical, Inc., St.
- the method of the invention may be used to replace a diseased aortic valve with an autologous graft such as the pulmonary valve from the same patient, which may be removed thoracoscopically from the patient's pulmonary artery using thoracoscopic instruments and visualization devices positioned through access ports between the ribs.
- Allografts such as an aortic valve removed from another donor patient's heart, may also be implanted using the methods of the invention. While the aortic valve replacement procedure of the invention will be described with reference to a mechanical bileaflet valve such as the St. Jude Medical Mechanical Valve, it should be understood that the methods described are equally applicable to other types of mechanical valves, as well as to bioprosthetic valves, autografts and allografts.
- a plurality of sutures 264 are placed in the native valve annulus to form mattress stitches or inverted mattress stitches.
- sutures 264 are double-armed with arcuate needles 266 on both ends, and are placed in valve annulus 216 using a specialized rotational needle driver 268 , described in detail in copending application Ser. No. 08/594,869, entitled “Endoscopic Suturing Devices and Methods”, which is hereby incorporated herein by reference.
- Rotational needle driver 268 has a shaft 270 with a rotatable carriage 272 at its distal end a handle 274 at its proximal end.
- One of needles 266 is releasably held in carriage 272 such that the needle's sharp point 274 is exposed outside of the carriage.
- Carriage 272 is rotatable about a pin 276 in shaft 270 .
- An actuator button 278 is slidably mounted to handle 274 and is coupled to carriage 272 by a linkage (not shown) such as a slidable rod within a passage in shaft 270 . In this way, sliding actuator button along handle 274 rotates carriage 272 about pin 276 .
- Carriage 272 may be configured to drive sharp point 275 of needle 266 in either a distal or proximal direction, depending upon whether it is desired to drive the needle from the ventricle toward the aorta, or from the aorta toward the ventricle.
- rotational needle driver 268 is set up to drive needle 266 from the left ventricle 222 toward aorta 186 .
- Carriage 272 holding needle 266 is positioned through access port 192 , through aortotomy 184 and through valve annulus 216 .
- Sharp point 275 of needle 266 is then positioned so as to penetrate the valve annulus a distance of about 1-5 mm from the inner edge of the annulus, as visualized by looking through access port 192 or under thoracoscopic visualization.
- actuator button 278 is moved along handle 274 to translate needle 266 through valve annulus 216 .
- the needle may be picked up with thoracoscopic needle drivers 206 positioned through access port 192 (or through a separate access port).
- a needle pick-up mechanism (not shown) is provided on needle driver 268 to allow needle 266 to be picked up without the use of a separate instrument, as described in the above-mentioned patent application Ser. No. 08/594,869, entitled “Endoscopic Suturing Devices and Methods”.
- needle 266 When needle 266 is picked up, it is drawn through valve annulus 216 and withdrawn from the chest through lumen 212 of access port 192 . A total of 10-20 sutures are placed in valve annulus 216 in this way.
- a suture organizing device is provided outside the chest to keep the sutures orderly and free of tangles.
- a suture organizer 279 is disposed on the proximal end of access port 192 itself, the suture organizer including a plurality of radial slits 280 , usually 12-24 pairs, arranged around the circumference of a rim 282 on access port 192 .
- Slits 280 are configured to frictionally engage sutures 264 placed into the slits, allowing each suture 264 to be placed in valve annulus 216 , drawn out of the chest and placed in one of slits 280 until all of the sutures have been placed.
- Other aspects of suture organizer 279 are described in copending application Ser. No. 08/485,600, which has been incorporated herein by reference.
- valve annulus 216 In the case of certain bioprosthetic valves and other types of replacement valves, techniques may be used for securing the valve to the heart which do not require a plurality of sutures to be placed in valve annulus 216 .
- some tissue valves are secured using a single continuous length of suture to make a running stitch around the sewing ring of the replacement valve.
- staples, clips or other fastening devices may be used to secure the replacement valve to the native annulus or adjacent tissue. In such cases, it may be unnecessary to place sutures or other fasteners in valve annulus 216 until after the replacement valve has been introduced into the chest and positioned at the aortic valve position.
- each suture is placed through sewing ring 286 of prosthetic valve 288 , which is held by a delivery handle 290 .
- Delivery handle 290 has an elongated shaft 291 and a handle 293 at its proximal end, and may be the same handle used in valve sizing device 250 described above in reference to FIG. 16, with sizing disk 258 removed from tongue 254 .
- Prosthetic valve 288 is releasably held on a holder 292 which includes a slot or aperture (not shown) configured to receive a tongue on delivery handle 290 similar to tongue 254 on valve sizing device 250 .
- a needle driver of conventional construction is used to grasp each of needles 266 and drive it through sewing ring 286 . After each needle is driven through the sewing ring, it is secured by means of a hemostat 294 or by placement in a suture organizer positioned on or near the patient's chest.
- Delivery handle 290 is configured to allow prosthetic valve 288 , mounted to holder 292 , to be delivered through an intercostal access port with minimal retraction of the ribs. If the annular sewing ring 286 has a central axis extending through it (generally defining the direction of blood flow through the valve), delivery handle 290 preferably holds prosthetic valve 288 in an orientation in which the central axis of sewing ring 286 is generally perpendicular to the longitudinal axis of shaft 291 , wherein the prosthetic valve, holder, and delivery handle have a minimum profile in a direction perpendicular to the longitudinal axis of shaft 291 .
- prosthetic valve 288 This will allow prosthetic valve 288 to be delivered through an intercostal space without removing or cutting the ribs or the sternum, and, in most patients, without retracting the ribs.
- Certain types of prosthetic valves, particularly tissue valves may have a larger profile. due to the height of the valve commissures.
- delivery handle 290 is adapted to hold the prosthetic valve in an orientation of minimum profile, allowing the prosthetic valve to be positioned into the chest with minimal retraction of the ribs, usually with less than about 10 mm of retraction of each rib from its natural, undetected position, and preferably less than about 5 mm from the rib's natural, undeflected position.
- the prosthetic valve is placed through inner lumen 212 of access port 192 , as illustrated in FIG. 20.
- Inner lumen 212 is specially adapted to allow prosthetic valve 288 to pass through it in an edge-first orientation.
- the prosthetic valve is positioned through lumen 212 such that the central axis of sewing ring 286 is generally perpendicular to the longitudinal axis of inner lumen 212 .
- the overall profile of access port 192 is minimized so as to require an incision in the chest wall of minimum size.
- the cross-section of inner lumen 212 in a direction perpendicular to its longitudinal axis has a cross-sectional length which is substantially greater than its cross-sectional width, with an oval, rectangular, racetrack, elliptical, or other shape suitable for passage of prosthetic valve 288 in the edge-first orientation illustrated.
- the cross-sectional length will be just larger than the outer diameter of sewing ring 286 , usually 17-35 mm, and the cross-sectional width will be just larger than the height of the valve parallel to the central axis of sewing ring 286 , ranging from about 5-25 mm for mechanical valves, to about 15-30 mm for tissue valves.
- a variety of other devices may be used to retract the chest wall tissue to allow prosthetic valve 288 to be introduced into the chest, including a soft tissue retractor designed to atraumatically retract tissue adjacent to an intercostal incision to create an opening in the chest without retracting the ribs.
- a conventional retractor with a pair of movable parallel rigid blades may be positioned in an intercostal incision parallel to the ribs, the distance between the blades being adjustable to create an opening in the intercostal space of a desired width.
- Such an adjustable retractor may be desirable where the height and outer diameter of the prosthetic valve are both larger than the distance between the ribs in the intercostal space through which the prosthetic valve is to be positioned, as may be the case with certain types of tissue valves.
- the ribs may be slightly retracted temporarily to allow the prosthetic valve to be positioned into the chest, and the retractor then re-adjusted to allow the ribs to return to their natural, undeflected positions for the remainder of the procedure, thus minimizing the trauma associated with such retraction.
- Delivery handle 290 has a length sufficient to allow prosthetic valve 288 to be positioned at the native aortic valve position in the heart with handle 293 remaining outside the chest, shaft 291 preferably having a length of at least about 15 cm.
- prosthetic valve 288 may be reoriented into an orientation suitable for securing the valve to valve annulus 216 , i.e., an orientation in which sewing ring 286 may be positioned parallel to and axially-aligned with valve annulus 216 (illustrated in FIG. 21).
- Such reorientation may be accomplished by simply removing prosthetic valve 288 from delivery handle 290 , but is preferably accomplished by pivoting prosthetic valve 288 relative to shaft 291 by sliding an actuator button 296 on handle 293 . This pivots a tongue at the distal end of shaft 291 to which holder 292 and prosthetic valve 288 are attached, in a manner like that described above with reference to valve sizing device 250 of FIG. 16 (and described in copending application Ser.
- prosthetic valve 288 is reoriented such that the central axis of sewing ring 286 is generally parallel to the longitudinal axis of shaft 291 plus or minus about 30°, although the exact angular orientation may vary according to the location of access port 192 and patient anatomy.
- Prosthetic valve 288 is positioned adjacent to the valve annulus 216 and then released from delivery handle 290 , which may then be removed from the chest, as illustrated in FIG. 21.
- Prosthetic valve 288 is preferably released by cutting a suture (not shown) on bolder 292 as frequently provided on conventional prosthetic valve holders. This allows a movable portion of holder 292 to pivot away from sewing ring 286 , releasing the prosthetic valve from the holder, as described in greater detail in copending application Ser. No. 08/281,962, which has been incorporated herein by reference.
- knots 300 are formed in each of sutures 264 outside of the chest, and a thoracoscopic knot pusher 302 is used to push knots 300 along sutures 264 through lumen 212 of access port 192 , through aortotomy 184 and against sewing ring 286 of prosthetic valve 288 .
- Knot pusher 302 preferably has an elongated shaft 303 to which is attached a head 304 with a convex curvature on its distal end 306 and a pair of axial channels 308 , 310 along its lateral sides, as described in copending application Ser. No. 08/288,674, filed Aug. 10, 1994, which is hereby incorporated herein by reference.
- each suture is threaded through channel 308 , a knot 300 is formed in the suture distally of head 304 , and the other end of the suture is positioned in channel 310 .
- knot pusher 302 is advanced toward prosthetic valve 288 , engaging knot 300 with distal end 306 and sliding the knot along suture 264 until it is against sewing ring 286 .
- Several knots are formed in each suture in this manner. The ends of sutures 264 , along with needles 266 , are then trimmed off above knots 300 , using thoracoscopic angled scissors 194 or other suitable cutting device.
- the movable leaflets 312 may be tested for proper action by inserting a probe (not shown) through an access port and exerting a gentle force against the outer edges of the leaflets.
- the probe may comprise an elongated shaft with an atraumatic tip of a soft elastomer suitable for contacting the valve leaflets, like that described in copending application Ser. No. 08/485,600, which has been incorporated herein by reference.
- the probe may include an inner lumen extending to a port at its distal end, the inner lumen being adapted for connection to a source of suction outside the chest, whereby suction may be applied to the valve leaflets to test for proper opening and closing.
- aortotomy 184 may be closed. This may be accomplished, as illustrated in FIG. 23, by suturing the opposing edges of the aortic incision together using a conventional running stitch applied by means of thoracoscopic needle drivers 206 positioned through access ports 188 , 190 or 192 .
- an endoscopic stapler may be used to apply a series of staples across aortotomy 184 .
- aortotomy 184 While aortotomy 184 is being closed, it will usually be desirable to remove any air from within the left ventricle and ascending aorta 186 upstream of aortic clamp 136 . This is accomplished by first reducing venous drainage of the heart via venous cannula 22 to allow blood to flow from the right side of the heart into the left ventricle, thereby filling the left ventricle with blood. This forces air out of the left ventricle into the ascending aorta.
- the patient will be positioned so that the superior or anterior aspect of the aortic arch is upward so that any air collects at a point where it can be suctioned out through delivery cannula 176 .
- An irrigation fluid such as saline may also be delivered through delivery cannula 176 into the ascending aorta and left ventricle to assist in displacing air to the upper part of the ascending aorta near delivery cannula 176 .
- thoracoscopic instruments may be positioned through intercostal access ports to depress and collapse the heart, forcing out any air in the left ventricle.
- Heart manipulation devices may also be positioned through an access port to lift and/or rotate the heart so that any air tends to flow through the aortic valve into the ascending aorta, where it may be suctioned out. Further, small needles may be used to aspirate air from the left ventricle and/or aorta.
- the chest cavity may be flooded with a gas such as carbon dioxide at the outset 6 f the procedure to prevent any air from entering the chest through the access ports.
- a gas delivery tube may be introduced through an intercostal access port, or a gas delivery lumen may be provided in a wall of the one of the access ports themselves through which the gas is delivered.
- the access ports may be provided with gaseous seals such as those commonly used in laparoscopic trocar sleeves which provide a gas-tight seal both when an instrument is introduced through the port, as well as when the instrument is removed.
- Aortic clamp 136 (or other aortic occlusion device) is removed from ascending aorta 186 to allow oxygenated blood delivered via arterial return cannula 26 to flow into the ascending aorta and into the coronary arteries.
- clamp applier 140 (FIGS.
- Defibrillation electrodes may be placed on the heart via intercostal access ports, or external paddles of conventional construction may be used on the surface of the chest, and an electrical charge may then be delivered to stimulate the heart.
- delivery cannula 176 When cardiac contractions have resumed, it may still be desirable to maintain suction through delivery cannula 176 so as to remove any air or other emboli which may be present in the aorta or left ventricle. When it is believed that such emboli are no longer present, delivery cannula 176 is removed from ascending aorta 186 and purse-string suture 182 (FIG. 8) is tightened securely and knotted to close the puncture in the aorta Thoracoscopic needle drivers 206 may be used for this purpose. Thoracoscopic scissors are then used to trim the ends of purse-string suture 182 .
- Chest drainage tubes may be placed temporarily through incisions used for access, or through additional incisions. All other thoracic and vascular punctures and incisions are closed, and the patient is recovered from anesthesia.
- FIGS. 24 - 26 Another exemplary embodiment of a delivery handle for positioning either a sizing disk or a replacement valve through an intercostal access port and into the native valve position is illustrated in FIGS. 24 - 26 .
- delivery handle 320 comprises a shaft 322 having a distal end 324 and a proximal end 326 .
- a sizing disk or a holder for releasably holding a replacement valve, represented schematically by cylindrical element 328 is pivotably mounted to distal end 324 by a transverse pin 330 .
- a pair of finger grips 332 are fixed to shaft 322 near proximal end 326 , and an end cap 334 is slidably received over proximal end 326 .
- a rod 336 extends through an inner lumen 338 in shaft 322 .
- Rod 336 has a proximal end 340 fixed to end cap 334 , and a distal end 342 rotatably pinned to element 328 at a point laterally offset from transverse pin 330 .
- a spring 344 is disposed within a bore 346 within end cap 334 and engages the proximal end of shaft 322 to bias end cap 334 and rod 336 in the proximal direction.
- element 328 may be pivoted relative to shaft 322 by pushing end cap 334 distally with the thumb while the fingers are placed against finger grips 332 .
- Element 328 is usually rotatable through an angle of at least about 45°, and preferably at least about 90°, relative to shaft 322 .
- delivery handle 320 is configured to position element 328 in an orientation suitable for introduction through an intercostal access port without removing, cutting, or significantly retracting the ribs.
- element 328 is preferably movable into an orientation in which the central axis AA extending axially through cylindrical element 328 is generally perpendicular +/ ⁇ 20° relative to the longitudinal axis LA of shaft 322 . In this way, the profile of delivery handle 320 together with element 328 as seen from the distal end of the device is minimized.
- Element 328 whether a sizing disk or replacement valve—may be introduced through an intercostal access port (such as access port 192 of FIGS. 7 - 24 ) in the orientation of FIG. 25 by maintaining pressure against end cap 334 . Once inside the chest, end cap 334 may be released, allowing element 328 to return to the orientation of FIG. 24, wherein the element is in a suitable orientation for alignment with the native valve annulus for either sizing the annulus or implanting the replacement valve.
- element 328 will be oriented such that central axis AA is at an angle of between ⁇ 45° and 45°, and preferably about 0°+/ ⁇ 20°, relative to the longitudinal axis LA of shaft 322 .
- FIGS. 27 - 29 illustrate an additional embodiment of an access port for retraction of tissue within an intercostal space so as to provide an open passageway through which a replacement valve may be positioned into the chest.
- Access port 350 comprises a tubular body 352 having an axial passage 354 configured to allow a replacement valve to be positioned through it without contacting the inner walls of the axial passage.
- Tubular body 352 is a metal or biocompatible polymer with sufficient rigidity to retract intercostal tissue and to retain a shape suitable for positioning a replacement valve through the axial passage into the chest.
- Axial passage 354 preferably has a cross-sectional shape suitable for introducing a replacement valve or sizing disk through it in the edge-first orientation illustrated in FIG.
- Axial passage 354 will have a cross-sectional width orthogonal to a central axis AX of less than about 30 mm, usually about 10 mm-25 mm, and preferably about 15 mm-20 mm.
- the cross-sectional length of axial passage 354 orthogonal to central axis AX will be larger than the outer diameter of the replacement valve utilized, and usually substantially larger than the cross-sectional width of the axial passage, usually being about 15 mm-50 mm, and preferably being about 25 mm-40 mm.
- Tubular body 352 has an exterior shape and dimensions suitable for positioning access port 350 in an intercostal space without cutting or removing the ribs, and preferably without significant retraction of the ribs from their natural, undeflected positions (e.g. less than about 10 mm of retraction).
- the outer surface of tubular body 352 has a shape corresponding to that of axial passage 354 with a wall thickness therebetween of about 0.25-2 mm, preferably 0.75-1.25 mm.
- the exact size and shape of tubular body 352 will be determined by the size and shape of the replacement valve to be utilized in the procedure.
- Access port 350 may further include a flange 356 on its proximal end which engages the outer surface of the patient's chest.
- a suture organizer 358 is preferably mounted to flange 356 , and includes an annular wall 360 with a plurality of radial slits 362 in spaced-apart locations around its circumference. Each slit 362 is configured to receive a suture thread and frictionally retain it as described above in connection with FIGS. 18 - 19 .
- Access port 350 additionally includes a retention mechanism 364 mounted to a distal extremity of tubular body 352 for retaining the access port in the chest wall.
- retention mechanism 364 comprises a sleeve 366 slidably mounted on tubular body 352 and coupled to flange 356 by a pair of tension springs 368 , which may be elastomeric bands or cords.
- a retention element 370 is mounted near the distal end of sleeve 366 and is collapsible for introduction through an intercostal space in the chest wall, and then expandable into a configuration in which the retention element engages the inner wall of the chest.
- retention element 370 comprises a continuous flexible band 372 which extends through two pairs of slots 374 on opposing sidewalls of sleeve 366 forming two inner loops 376 in the interior of sleeve 366 and two outer loops 378 exterior to sleeve 366 .
- Band 372 is preferably a resilient, flexible metal, plastic or elastomer which is biased into a fully expanded oval or circular ring shape.
- FIG. 29 An assembly view of access port 350 is illustrated in FIG. 29.
- Annular wall 360 has a plurality of openings 380 formed around its circumference.
- An insert assembly 382 has a support ring 383 with a plurality of elastomeric inserts 384 attached thereto and configured to fit into openings 380 .
- a lower end of each insert 384 is configured to be received in one of a plurality of slots (not shown) in flange 356 aligned with each opening 380 .
- Each insert 384 has an enlarged lower end 386 which engages the lower surface of flange 356 to retain the insert within opening 380 .
- the adjacent surfaces of inserts 384 and wall 360 within openings 380 form radial slits 362 (FIG. 27).
- Inserts 384 will preferably have sufficient compliance to deflect slightly as a suture thread is drawn into slit 362 , and sufficient resilience to maintain pressure against the thread to retain it in the slit.
- tension springs 368 which may comprise resilient elastomeric bands or cords, extending distally through a pair of appropriately aligned slots (not shown) in flange 383 .
- Sleeve 366 has a pair of ears 388 at its proximal end with axial passages through which tension springs 368 may extend.
- Each tension spring 368 has a flange or ledge 390 at its distal end which retains the tension spring in ear 388 .
- the invention provides a specialized obturator for use with access port 350 , illustrated in FIGS. 30 - 31 .
- Obturator 392 has a shaft 394 shaped to occlude axial passage 354 of access port 350 .
- a distal end 396 of shaft 394 is tapered to facilitate introduction through a puncture or incision in the chest wall.
- a handle 398 is fixed to the proximal end of shaft 394 .
- a pair of hooks 400 are movably coupled to shaft 394 near distal end 396 and form a distally-open U-shaped channel 401 configured to receive inner loops 376 of band 372 . As illustrated in FIGS.
- hooks 400 are mounted to a pair of actuators 402 pivotably mounted to handle 398 by a pin 404 such that actuators 402 move in a scissors-like manner.
- Actuators 402 each have an outwardly extending button 406 which extends through an aperture 408 in handle 398 .
- Actuators 402 are biased outwardly by a torsion or U-shaped spring 410 . In this way, pressing buttons 406 inwardly moves hooks 400 from the outward position illustrated in FIG. 31A to the inward position illustrated in FIG. 31B.
- Obturator 392 further includes a locking mechanism 412 comprising a pivotable locking button 414 mounted within an opening 416 in handle 398 .
- Locking button 414 has a foot 418 extending from a distal surface thereof.
- Each of actuators 402 has a notch 420 on a proximal surface thereof which is configured to receive foot 418 .
- a torsion spring 422 biases locking button 414 in a clockwise direction.
- actuators 402 When actuators 402 are pivoted inwardly, foot 418 slides along the proximal surfaces of actuators 402 until notches 420 are aligned. This allows foot 418 to slide into notches 420 , locking actuators 402 in the inward position, as shown in FIG. 31B.
- the locking mechanism is released by pushing on the proximal surface of locking button 414 on the side opposite that of foot 418 , pivoting locking button 414 counterclockwise to remove foot 418 from notches 420 .
- obturator 392 is positioned in axial passage 354 of access port 350 such that hooks 400 extend around inner loops 376 of band 372 to position the band in channels 401 .
- Buttons 406 are then pressed inwardly, drawing inner loops 376 inwardly and collapsing outer loops 378 against the outer surface of sleeve 366 .
- Access port 350 may then be positioned through an incision or puncture through the chest wall between two ribs.
- locking button 414 is released, allowing actuators 402 and hooks 400 to return to the outward position.
- Outer loops 378 are thereby deployed into their expanded configuration, and obturator 392 may be removed from axial passage 354 .
- Tension springs 368 pull sleeve 366 toward flange 356 on tubular body 352 , compressing the chest wall between band 372 and flange 356 .
- Access port 350 is thus firmly held in position during the procedure.
- obturator 392 is reinserted into axial passage 354 such that hooks 400 engage inner loops 376 , buttons 406 are pressed inwardly to collapse outer loops 378 , and access port 350 is withdrawn from the intercostal incision.
- FIGS. 32 - 33 a preferred embodiment of a holder for an aortic valve prosthesis according to the invention will be described.
- holder 430 is attached to the distal end of delivery handle 320 in place of element 328 , described above in connection with FIGS. 24 - 26 .
- Holder 430 is pivotable relative to shaft 322 from a first orientation of minimum profile suitable for introduction through an intercostal space, to a second orientation suitable for aligning the prosthetic valve with the native valve annulus so that it may be secured thereto.
- holder 430 is positioned such that the central axis of the prosthetic valve sewing ring is generally perpendicular to the longitudinal axis of shaft 322 , as shown in phantom in FIG. 32.
- holder 430 is preferably positioned so that the central axis of the prosthetic valve sewing ring is generally parallel to the longitudinal axis of shaft 322 .
- holder 430 A configuration of holder 430 will be described which is appropriate for use with a mechanical bileaflet aortic valve prosthesis such as the St. Jude Medical Mechanical Aortic Valve.
- holder 430 may be configured to accommodate a wide variety of prosthetic valves without departing from the scope of the invention.
- FIGS. 33 A- 33 B holder 430 is configured to hold prosthetic valve 432 from its downstream side with movable valve leaflets 434 in their closed position. In this position, valve leaflets 434 form a V-shaped space within the interior of the valve surrounded by annular valve body 436 and sewing ring 438 .
- Holder 430 therefore has a peaked or wedge-shaped distal surface 440 with angled faces 441 A, 441 B forming an angle a of between about 90° and 150°, which fits within the V-shaped space adjacent valve leaflets 434 .
- An annular rim or flange 442 is configured to abut annular sewing ring 438 of prosthetic valve 432 .
- a handle coupling 444 is attached to the proximal surface 446 of holder 430 and is configured to be attached to delivery handle 320 .
- Handle coupling 444 has a transverse channel 448 as shown in FIG. 33B configured to receive the distal end of shaft 322 .
- a pair of holes 450 , 452 extend through handle coupling 444 across channel 448 and may be aligned with holes 454 , 456 in delivery handle 320 so that pins may be inserted therethrough. In this way, by sliding rod 336 , holder 430 pivots relative to shaft 320 .
- Prosthetic valve 432 may be removably attached to holder 430 in various ways.
- sutures are placed through sewing ring 438 and through bolder 430 and tied in order to secure the prosthetic valve to the holder.
- holder 430 may include holes, loops, eyelets or the like proximal to rim 442 through which sutures may be placed.
- holder 430 may be made of a soft elastomeric material through which a suture needle may be driven to secure the suture to the holder.
- the sutures are cut with scissors or a knife.
- Certain prosthetic valves are designed to allow the valve body and valve leaflets to be rotated relative to the sewing ring of the prosthesis after the sewing ring has been secured to the heart.
- holder 430 may be used to rotate valve body 436 along with leaflets 434 by repositioning holder 430 within the V-shaped space formed by leaflets 434 and rotating handle 320 about its longitudinal axis.
- a flat 458 is provided along the two sides of holder 430 which are positioned adjacent to side supports 459 of prosthetic valve 432 , allowing torque to be transmitted to valve body 436 rather than to the fragile valve leaflets 434 .
- FIGS. 34 - 36 illustrate an alternative embodiment of a holder according to the invention.
- holder 460 is configured to hold a bi-leaflet mechanical valve from its upstream side for replacement of a diseased cardiac valve from the upstream side of the native valve, e.g., for replacement of the mitral valve via an incision in the left atrium as described in copending application Ser. No. 08/281,962 and Ser. No. 08/485,600, which have been incorporated herein by reference.
- mechanical bileaflet valve 462 has a pair of leaflets 464 movably attached to a pair of upwardly extending side supports 465 on an annular valve body 466 .
- a sewing ring 468 is attached to valve body 466 .
- Leaflets 464 are pivotable between an open position wherein the leaflets are nearly parallel, to a closed position wherein the inner edges of leaflets 464 abut one another and the curved outer edges of the leaflets abut the inner surface of annular valve body 466 .
- holder 460 is configured to be positioned on the upstream side of valve 462 with leaflets 464 in the open position.
- Holder 460 has a distal end 470 having a pair of crescent-shaped feet 472 for positioning between the outer (upstream) surface of each leaflet 464 and the inner surface of valve body 466 .
- An arcuate channel 474 extends across distal end 470 between feet 472 which accommodates side supports 465 and the inner ends of leaflets 464 .
- a rim 476 extends around the perimeter of distal end 470 which abuts sewing ring 468 and/or valve body 466 .
- Holder 460 is adapted for attachment to delivery handle 320 by a handle coupling 480 extending laterally from a proximal end of the holder.
- Handle coupling 480 has a pair of holes 482 , 484 which may be attached to delivery handle 320 as described above in connection with FIGS. 33 A- 33 B.
- Prosthetic valve 462 may be releasably attached to holder 460 in various ways.
- holder 460 is constructed of a soft elastomer which allows a suture needle to be driven through it. In this way, one or more sutures may be placed through sewing ring 468 and through holder 460 and tied to secure the valve to the holder.
- holder 460 may be a more rigid material and holes, eyelets, or loops may be mounted to the holder to which sutures may be secured. When valve 462 is to be released, the sutures are simply cut.
- access port 490 comprises a tubular cannula 492 having a distal end 494 , a proximal end 496 , and a lumen 498 through which any of the replacement valves, valve holders and valve delivery devices described above may be positioned without interference.
- lumen 498 is preferably oval-shaped, but the lumen may be any of a variety of shapes suitable for introducing a prosthetic valve into the chest with minimal retraction of the ribs.
- Cannula 492 has a wall 500 constructed of a material having sufficient rigidity to retract intercostal tissue so as to provide an opening into the chest through which a replacement valve may be positioned.
- a rim 501 is provided at proximal end 496 which is adapted to engage the outer surface of the chest.
- An obturator (not shown) removably positionable within lumen 498 may also be provided to facilitate introduction through the chest wall.
- a channel 502 extends axially through wall 500 between proximal end 496 and distal end 494 .
- a plurality of axially-extending optical fibers 504 are distributed around channel 502 so as to surround lumen 498 and are potted, bonded or other wise fixed within channel 502 such that distal ends 506 of the optical fibers are disposed near distal end 494 of the cannula and are pointing generally in the distal direction.
- Optical fibers 504 extend proximally through channel 502 , through an annular space 508 within rim 501 , and into a flexible cable 510 attached to rim 501 that has a protective, opaque jacket 511 surrounding the optical fibers.
- An optical coupling 512 is fixed to the free end of cable 510 and is configured to be coupled to a conventional fiber optic light source of the type used for fiber optic lighting in endoscopes and the like, allowing light to be transmitted from the light source through optical fibers 504 and emitted from their distal ends 506 .
- cannula 492 is positioned within a small incision between two ribs such that distal end 494 is within the chest cavity.
- Coupling 512 is connected to a light source so that light is emitted from optical fibers 504 so as to illuminate the chest cavity.
- Various surgical procedures may then be performed within the chest using instruments positioned through lumen 498 or through other access ports under the illumination provided by optical fibers 504 .
- the various steps of an aortic valve replacement procedure as described above may be performed under illumination provided by access port 490 .
- access port 490 may be positioned in alignment with the aortic valve to provide the optimum angle of illumination, while at the same time providing the optimum angle of approach to the valve for introduction of instruments, valve sizers, and the prosthetic valve itself through lumen 498 .
- the provision of optical fibers 504 on access port 490 may thereby eliminate the need for a separate light source within the body cavity for much of the procedure, reducing the number of access ports that are required.
- Optical fiber 504 may be mounted to access port 490 in various ways.
- optical fibers 504 ′ may also be mounted along one side of lumen 498 ′, in a crescent-shaped channel 516 extending through cannula 492 ′, as shown in FIG. 41.
- Multiple channels may extend along two or more sides of lumen 498 among which optical fibers 504 may be distributed.
- FIGS. 37 - 40 optical fibers 504 ′ may also be mounted along one side of lumen 498 ′, in a crescent-shaped channel 516 extending through cannula 492 ′, as shown in FIG. 41.
- Multiple channels may extend along two or more sides of lumen 498 among which optical fibers 504 may be distributed.
- an open axial channel 518 may extend through cannula 492 ′′ through which an endoscopic light wand or thoracoscope (not shown) having a light source mounted to it may be slidably inserted into the body cavity alongside lumen 498 ′′.
- the access ports of FIGS. 37 - 42 may also include any of the features of the access ports described above in connection with FIGS. 27 - 29 , including having a suture organizer mounted to the proximal end of the access port for retaining sutures in an organized manner around lumen 498 , or having a selectively deployable retention device mounted near the distal end of the access port for engaging the inner wall of the chest (or other body cavity) to maintain the access port in position.
Abstract
Systems and methods are disclosed for performing less-invasive surgical procedures within the heart. A method for less-invasive repair or replacement of a cardiac valve comprises placing an instrument through an intercostal access port and through a penetration in a wall of a vessel in communication with the heart, advancing the instrument into the heart, and using the instrument to perform a surgical intervention on a cardiac valve in the heart under visualization through an intercostal access port The surgeons hands are kept outside of the chest during each step. The surgical intervention may comprise replacing the cardiac valve with a prosthetic valve, wherein the native valve is removed using a tissue removal instrument, the native valve annulus is sized with a specialized sizing device, a prosthetic valve is introduced through an intercostal access port and through the penetration in the vessel, and the prosthetic valve is secured at the native valve position, all using instruments positioned through intercostal access ports without placing the hands inside the chest. Systems and devices for performing these procedures are also disclosed.
Description
- This application is a continuation of co-pending application Ser. No. 08/594,870, filed Jan. 31, 1996, which is a continuation-in-part of Ser. No. 08/485,600, which is a continuation-in-part of Ser. No. 08/281,962, now abandoned, which is a continuation-in-part of Ser. No. 08/163,241, now U.S. Pat. No. 5,571,215, which is a continuation-in-part of Ser. No. 08/023,778, now U.S. Pat. No. 5,452,733. This application is also a continuation-in-part of Ser. No. 08/486,941, now U.S. Pat. No. 5,799,661. The complete disclosure of each of the above-referenced applications is incorporated herein by reference for all purposes.
- The present invention relates generally to surgical instruments, and more specifically, to surgical instruments for less-invasive surgery of the heart and great vessels, especially instruments for repair and replacement of heart valves.
- The present invention is directed to devices and techniques for the surgical treatment of heart valve disease, and particularly aortic valve disease. The aortic valve separates the left ventricle of the heart from the aorta, which carries oxygenated blood to the arterial system. Normally, when the left ventricle contracts during systole, the aortic valve opens to allow blood to flow into the aorta. During diastole, when the left ventricle returns to its uncontracted state, the aortic valve closes to prevent blood from flowing from the aorta back into the heart.
- In aortic valve disease, the aortic valve is compromised due to calcification of the valve leaflets, congenital deformation of the valve, or other conditions such that the valve does not completely open or close normally. As a result, the valve restricts blood flow out of the heart during systole, or the valve allows blood flow back into the heart during diastole. If the condition becomes sufficiently severe, surgical treatment is frequently required.
- Various surgical techniques have been used to repair aortic valves. In conventional “open-chest” approaches, a large opening is formed in the chest—known as a sternotomy or thoracotomy—the patient's heart is arrested while circulation is supported by a cardiopulmonary bypass system, an incision is formed in the aorta, and instruments are then used to decalcify the valve, to separate valve leaflets which are fused together, or to constrict the annulus of an enlarged valve. Less-invasive approaches to valve repair have also been proposed. Balloon valvuloplasty, for example, involves the use of a balloon catheter threaded from a peripheral artery into the aorta, and expansion of a balloon within the calcified aortic valve to separate the valve leaflets while the heart remains beating. Unfortunately, aortic valve repair techniques have not had long-lasting success in preventing recurrence of the disease, and eventual replacement of the valve is frequently required.
- The most widely-accepted surgical technique for the treatment of severe aortic valve disease is aortic valve replacement. In aortic valve replacement surgery, the diseased aortic valve is replaced with a prosthetic valve, homograft, allograft, or other type of replacement valve. Conventional aortic valve replacement techniques require a sternotomy or thoracotomy to be formed so as to provide access into and visualization of the chest cavity. The patient is placed on cardiopulmonary bypass, and the heart is stopped using an aortic cross-clamp to block blood flow through the aorta while a cardioplegic fluid is injected into the aorta upstream of the cross-xclamp or into the coronary sinus on the venous side of the heart. An incision is then made in the ascending aorta near the aortic valve, and the native valve leaflets are removed using surgical scissors inserted through the aortic incision. Specialized instruments may also be used to debride the valve annulus. A replacement valve is then sutured in place at the native valve position.
- While aortic valve replacement is frequently effective in treating aortic valve disease and can add ten or more years to the life of a patient having the disease, the procedure also suffers from significant drawbacks surrounding the invasiveness and trauma of the surgery. The large thoracotomy required by the procedure is highly invasive, produces a great deal of pain, heightens the risk of infection and other complications, increases costs. and lengthens hospital stay considerably.
- What is needed, therefore, are devices and techniques for the surgical treatment of aortic valve disease, especially for performing aortic valve replacement, which do not suffer from the drawbacks of conventional open-chest aortic valve surgery. Most desirably, the devices and techniques should obviate the need for a sternotomy and minimize the size of any necessary thoracic incisions to eliminate the pain, trauma, risks, costs, and lengthy recovery time associated with conventional aortic valve surgery. At the same time, the devices and techniques should facilitate replacement of a diseased aortic valve with the same types of replacement valves which currently enjoy wide acceptance for aortic valve replacement, including mechanical valves, bioprosthetic valves, homografts, allografts, and others.
- The invention provides devices and methods for performing heart valve surgery which eliminate the need for a median sternotomy or other type of thoracotomy. The devices and methods are particularly advantageous in that they facilitate surgical repair or replacement of a heart valve in a manner analogous to the widely-accepted surgical techniques used in open-chest valve repair or replacement, yet without the invasiveness, pain, risks, and recovery time of conventional techniques. Advantageously, the devices and methods facilitate replacement of a diseased heart valve using various types of commercially-available replacement valves with proven safety and effectiveness. The devices and methods of the invention are perhaps most useful for the repair and replacement of the aortic valve, but may be used for the surgical treatment of any of the valves of the heart, as well as in other surgical procedures within the heart and great vessels of the thorax.
- In one aspect of the invention, a method is provided for accessing an internal chamber of a patient's heart through a vessel in fluid communication with the chamber. The method includes visualizing the vessel through a percutaneous access port between two adjacent ribs. An instrument is positioned into an inner lumen of the vessel through a penetration in a wall of the vessel. The proximal end of the instrument extends out of the patient's chest through a percutaneous access port between the ribs, and the proximal end of the instrument is then manipulated to position the distal end of the instrument through the vessel and into the internal chamber of the heart. With the instrument within the internal chamber. various types of inspection, diagnostic and interventional procedures may then be performed. All manipulations of the instrument are performed with the surgeon's hands outside of the patient's chest, and none of the ribs or the sternum are cut or removed during each step. Preferably, in fact, none of the ribs or the sternum are significantly retracted from their natural undeflected positions during the procedure. Visualization is accomplished either by looking directly into the chest through an access port between the ribs, by introducing a thoracoscope through such an access port and viewing a video image of the vessel and heart on a monitor, or by using other available less-invasive visualization devices.
- In a preferred embodiment, the vessel is the aorta, the chamber is the left ventricle of the heart, and the distal end of the instrument is positioned into the aorta, through the aortic valve, and into the left ventricle. The instrument may then be used to perform a procedure in the heart or on the aortic valve itself. For example, the instrument could be used for repairing a diseased aortic valve, and may comprise a debridement device for removing calcium from the valve annulus or leaflets, a scissors for incising the leaflet commissures to separate the leaflets, a cutting device for resecting the valve leaflets, or a needle driver for applying a suture to the valve annulus to reduce the diameter of the valve.
- In a particularly preferred embodiment, the instrument is used in the replacement of a diseased aortic valve. The instrument may be a scissors, rongeur, knife or other cutting instrument for removing the native valve leaflets, or a needle driver or other device for applying sutures to the native valve annulus which are used to secure a replacement valve at the aortic valve position. The instrument could alternatively comprise a valve sizing device for measuring the size of the native valve annulus, or a valve delivery instrument for positioning a replacement valve at the aortic valve position. In any case, the instrument extends from the left ventricle out of the chest through a percutaneous access port between two ribs, and is manipulated entirely from outside of the chest.
- As another alternative, the instrument may comprise any of a variety of devices for performing diagnostic or interventional procedures within the heart, such as an angioscope or other endoscopic visualization device, an electrophysiological mapping or ablation device. or a laser for transmyocardial revascularization. Additionally, the instrument could be used to repair or replace other valves of the heart. For example, the mitral valve could be repaired or replaced by positioning the instrument through the aorta and left ventricle to the mitral position (and through the mitral valve into the left atrium if necessary). Or, an instrument could be positioned through the superior vena cava or the inferior vena cava into the right atrium to perform a procedure on the right side of the heart, including repair or replacement of the tricuspid valve between the right atrium and right ventricle, or repair or replacement of the pulmonary valve between the right ventricle and the pulmonary artery. Various other procedures may also be performed according to the method of the invention, including pulmonary thrombectomy, the Cox “maze” procedure for treatment of atrial fibrillation, and repair of congenital defects such as atrial and ventricular septal defects or patent ductus arteriosus.
- In many of the procedures which may be performed using the methods of the invention, the patient is placed on cardiopulmonary bypass and the heart is arrested. First, general anesthesia is administered. To establish cardiopulmonary bypass, an arterial cannula is placed into a peripheral artery, usually a femoral artery, and a venous cannula is placed in a peripheral vein, usually a femoral vein. The arterial and venous cannulae are connected to a cardiopulmonary bypass pump and oxygenator, allowing deoxygenated blood to be withdrawn from the venous system through the venous cannula, oxygenated, and then pumped back into the patient's arterial system through the arterial cannula.
- The heart may then be arrested in any of several ways. In an endovascular technique, an aortic catheter is introduced into a peripheral artery selected from among the femoral, brachial or subclavian arteries. The aortic catheter is advanced transluminally into the ascending aorta, and an expandable member such as a balloon is expanded in the ascending aorta to block blood flow through the aorta A cardioplegic fluid is then delivered into the ascending aorta upstream of the expandable member so as to perfuse the myocardium via the coronary arteries. Alternatively, a thoracoscopic aortic occlusion device may be used to arrest the heart. The thoracoscopic aortic occlusion device may be an external clamp positionable through a percutaneous access port between two ribs and around the exterior of the aorta, the clamp being movable between an open position and a closed position in which it clamps the aorta to occlude the aortic lumen. A cardioplegic fluid is then delivered into the aorta upstream of the clamp, either through a cannula penetrating the aortic wall and extending out of the chest through an intercostal access port, or through an endovascular catheter extending into the ascending aorta from a peripheral artery. The thoracoscopic aortic occlusion device may alternatively comprise a shaft having an expandable member such as a balloon mounted to its distal end which is configured to be introduced into the aorta through a small incision or puncture in the aortic wall. The expandable member may be expanded within the aorta to occlude the aortic lumen, and a cardioplegic fluid then delivered upstream of the clamp through either a thoracoscopic cannula or endovascular catheter.
- In many cases, in order to maintain cardioplegic arrest, it will be desirable to deliver cardioplegic fluid to the myocardium in a retrograde manner via the coronary sinus instead of or in addition to antegrade delivery from the ascending aorta In these cases, an endovascular catheter is introduced transluminally into the coronary sinus, which drains into the right atrium of the heart, from a peripheral vein such as the femoral, subclavian or internal jugular vein. The endovascular catheter preferably has a balloon or other occluding member on its distal end for occluding the coronary sinus during delivery of cardioplegic fluid. Usually, the occluding member is expanded while cardioplegic fluid is delivered, then contracted to allow fluid to drain into the right side of the heart from the capillary beds feeding the myocardium.
- With the heart arrested and circulation of blood supported by cardiopulmonary bypass, the patient is prepared for a surgical procedure conducted in accordance with the principles of the invention. One such procedure is replacement of the aortic valve. In a method of aortic valve replacement according to the invention, a valve prosthesis is positioned through a percutaneous access port between two adjacent ribs and through an incision in a wall of the aorta using a first instrument. The valve prosthesis is then attached at the aortic valve position between the left ventricle and the aorta using at least a second instrument. All instruments used in the procedure are manipulated only from outside of the chest, and neither the ribs nor the sternum are cut or removed during the procedure. Visualization of the vessel and heart is accomplished, as described above, by direct vision through an access port, or using a thoracoscope or other minimally-invasive visualization device.
- In a preferred embodiment, the first instrument comprises a delivery handle which is coupled to the valve prosthesis, or to a holder on which the valve prosthesis is mounted. The delivery handle is configured to allow the valve prosthesis to be introduced into the chest through the percutaneous access port and has a length selected to reach the aortic valve position from outside of the chest. Usually, the valve prosthesis is introduced from the first, second, third, or fourth intercostal space on the anterior side of the chest, and the delivery handle is at least about 20 cm in length. In a specific embodiment, the valve prosthesis is movably coupled to the delivery handle such that it may be positioned through the access port between the ribs in a first orientation, then re-oriented within the chest relative to the delivery handle into a second orientation suitable for attachment at the aortic valve position. Preferably, the delivery handle has an actuator on its proximal end to allow the valve prosthesis to be reoriented by moving the actuator outside of the patient's chest
- The valve prosthesis is preferably coupled to the delivery handle in such a way that it may be positioned through an intercostal space without removing or retracting the ribs significantly. In a preferred embodiment, the valve prosthesis is mounted such that an axis extending axially through the middle of the sewing ring of the valve prosthesis is approximately perpendicular to the longitudinal axis of the delivery handle. In this way, the profile of the valve prosthesis and delivery handle in a plane perpendicular to the longitudinal axis of the delivery handle is minimized. For some types of replacement valves, however, even in this orientation, the profile of the valve and handle will be large enough that some minor retraction of the adjacent ribs may be required to allow the valve to be introduced into the chest without risking damage to the valve.
- The percutaneous access port through which the valve prosthesis is positioned may comprise a puncture or incision through the chest wall between the ribs which does not involve cutting or removing the ribs or the sternum adjacent to the incision. Preferably, no significant retraction or displacement of the ribs or sternum will be necessary. In most cases, the tissue adjacent to the access port will need to be retracted or separated to provide an opening into the chest which will not interfere with introduction of the valve prosthesis and through which the surgeon may view the chest cavity. For this purpose, the invention provides a retraction device particularly well-suited for aortic valve replacement. In a preferred embodiment, the retraction device comprises a cannula having a distal end suitable for placement between the ribs into the chest. a proximal end, and a passage therebetween configured to allow the valve prosthesis to be easily passed through it. In a preferred configuration, the passage in the cannula has a cross-sectional height which is substantially greater than its cross-sectional width, preferably at least about 1.5 times the cross-sectional width. In this way, the cross-sectional height may be large enough to accommodate the outer diameter of the valve prosthesis in the passage, while the cross-sectional width is small enough to fit between the ribs without significant retraction (yet being large enough to accommodate the height of the valve prosthesis when mounted to the delivery handle).
- If a replacement valve having a larger profile is to be used requiring some minor retraction of ribs, the retraction device of the invention may be adjustable in width to provide a slightly larger passage into the chest while the valve is introduced, deflecting the ribs adjacent to the access port as needed. Once the replacement valve is within the chest cavity, the retraction device may be returned to a smaller width in which the ribs are in their natural, undeflected positions for the remainder of the procedure.
- The retraction device of the invention may further include a suture organizer mounted to it for arranging the sutures used to secure the valve prosthesis in the aortic valve position. In a preferred embodiment, the suture organizer is mounted to the proximal end of the cannula through which the valve prosthesis is positioned, whereby a plurality of sutures may be drawn out of the chest cavity through the passage in the cannula and placed in spaced-apart locations on the suture organizer. The suture organizer may comprise, for example, a ring having a plurality of radial slots arranged about its perimeter each of which is configured to receive and retain a suture thread.
- Usually, the native valve leaflets are excised from the native annulus and any calcium or other debris on the annulus is removed before a replacement valve is implanted. To remove the valve leaflets, thoracoscopic scissors and forceps may be introduced through a percutaneous access port and used to cut the leaflets from the annulus. Specialized thoracoscopic debridement devices, such as rongeurs having an inner lumen through which suction may be applied, are then used to cut away calcific deposits and other undesirable matter from the surface of the valve annulus. During this process a filter or trap may be placed through the aortic valve into the left ventricle to catch any debris which may be released.
- In most cases, the native valve annulus must be measured to ascertain the appropriate size of the valve prosthesis to be used. This is accomplished by utilizing a specialized valve sizing device which may be introduced through a percutaneous access port and positioned adjacent to or advanced through the native annulus. The sizing device preferably includes an elongated handle with a sizing disk of a known size at its distal end which may be compared to or positioned within the native annulus. The sizing disk may be adjustable in diameter to measure a range of sizes, may include markings for visual identification of the size of the annulus, or may be interchangeable with larger and smaller sizing disks to allow multiple sizes to be tried until the proper one is found. The sizing disk is mounted to the distal end of the handle in such a way as to be positionable into the chest without retracting or removing ribs, and is preferably pivotably attached to the handle so as to be movable into a low profile orientation for introduction, or is collapsible for introduction and then expandable for sizing the valve annulus.
- A variety of different replacement valves may be implanted using the devices and methods of the invention, including mechanical prostheses, bioprostheses, homografts and allografts. Advantageously, the invention facilitates the use of many of the clinically-proven replacement valves currently used in open-chest valve replacement without modification of these valves and without the need for removal or significant retraction of the ribs.
- The replacement valve may be secured at the native valve position in various ways, but is preferably secured using sutures. The sutures are applied to the aortic valve annulus using elongated thoracoscopic needle drivers or other known types of thoracoscopic suture placement devices positioned through a percutaneous access port. Usually, a plurality of sutures are applied to the annulus, drawn out of the chest cavity, and then applied to the sewing ring of the valve prosthesis outside of the chest. The valve prosthesis is then slid along the sutures through the access port and placed against the native valve annulus using the delivery handle or other appropriate thoracoscopic instrument. A knot is formed in each suture outside of the chest, and the knot is pushed along the suture through the access port and against the sewing ring of the valve prosthesis using a thoracoscopic knot pusher. The free ends of the suture are then trimmed using thoracoscopic scissors.
- For securing bioprosthetic valves and other types of replacement valves, it may be desirable to use a single suture to form a running stitch between the sewing ring and the native valve annulus. In these cases, with the valve held in place at or near the aortic position using the delivery handle, thoracoscopic needle drivers may be positioned through an access port and used to drive a needle alternately between the native annulus and the sewing ring of the replacement valve. The suture is then tied off and trimmed using thoracoscopic instruments.
- Once the replacement valve has been secured at the aortic valve position, the aortic incision must be closed. Thoracoscopic needle drivers are introduced through a percutaneous access port and used to drive a suture back and forth across the incision from end to end in a running stitch. The suture is then tied off and trimmed.
- With the aortic incision closed, the patient's heart is restarted by removing the aortic occlusion device, whether an external clamp, endovascular aortic occlusion catheter, or other means, from the ascending aorta. If placed through a puncture in a wall of the aorta, the puncture is closed with a purse- string suture or running stitch using thoracoscopic needle drivers. Warm oxygenated blood delivered to the arterial system by the arterial cannula is thereby allowed to flow into the ascending aorta and to perfuse the myocardium via the coronary arteries. Normal heartbeat will ordinarily resume spontaneously. If not, electrical defibrillation may be administered. Once normal heartbeat has resumed, any retractors, trocars, or other devices in the percutaneous access ports are removed, and chest incisions are closed with sutures or adhesive strips. The patient is gradually weaned from cardiopulmonary bypass, all arterial and venous cannulae are removed, and arterial and venous punctures are closed. The patient is then recovered from anesthesia.
- A further understanding of the nature and advantages of the invention will become apparent from the following detailed description taken in conjunction with the drawings.
- FIG. 1 is an anterior view of a patient's chest schematically illustrating an endovascular system for inducing cardioplegic arrest and establishing cardiopulmonary bypass according to the invention.
- FIG. 2 is a close-up view of a patient's heart and aorta showing the placement of an endoaortic catheter in the system of FIG. 1.
- FIG. 3 is an anterior view of a patient's chest schematically illustrating a first embodiment of a thoracoscopic system for inducing cardioplegic arrest and establishing cardiopulmonary bypass according to the invention.
- FIG. 3A is an anterior view of a patient's chest schematically illustrating a technique of gaining access to the aorta according to the invention.
- FIG. 4 is a close-up view of a patient's heart and aorta illustrating the placement of a thoracoscopic balloon cannula in the system of FIG. 3.
- FIG. 5 is an anterior view of a patient's chest schematically illustrating a second embodiment of a thoracoscopic system for inducing cardioplegic arrest and establishing cardiopulmonary bypass according to the invention.
- FIG. 6 is a close-up view of a patient's heart and aorta illustrating the placement of a thoracoscopic clamp in the system of FIG. 5.
- FIG. 7 is an anterior view of a patient's chest schematically illustrating a third embodiment of a thoracoscopic system for inducing cardioplegic arrest and establishing cardiopulmonary bypass according to the invention.
- FIG. 8 is a close-up view of a patient's heart and aorta illustrating the placement of a detachable thoracoscopic clamp and applicator in the system of FIG. 7.
- FIG. 9 is an anterior view of a patient's chest schematically illustrating the formation of an aortotomy in the ascending aorta according to the invention.
- FIG. 10 is a close-up view of a patient's heart and aorta illustrating the formation of an aortotomy in the ascending aorta according to the invention.
- FIG. 11 is an anterior view of a patient's chest schematically illustrating retraction of the aortotomy according to the invention.
- FIG. 12 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the placement of sutures for retraction of the aortotomy according to the invention.
- FIG. 13 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the removal of the aortic valve leaflets according to the invention.
- FIG. 14 is a close-up partial cross-section of the left ventricle of the heart and the aorta showing a catcher placed in the left ventricle to catch pieces of valve leaflet and debris removed from the native valve annulus according to the invention.
- FIG. 15 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the removal of calcific and fibrous material from the native valve annulus according to the invention.
- FIG. 16 is a transverse cross-sectional view of a portion of the patient's chest and heart illustrating the use of a valve sizing device for sizing the native valve annulus according to the invention.
- FIG. 17 is a transverse cross-sectional view of a portion of the patient's chest and heart illustrating the placement of sutures in the native valve annulus according to the invention.
- FIG. 18 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the placement of sutures in the native valve annulus according to the invention.
- FIG. 19 right lateral elevational view of the patient's chest illustrating the placement of sutures through a prosthetic valve according to the invention.
- FIG. 20 is a transverse cross-sectional view of a portion of the patient's chest and heart illustrating the positioning of a prosthetic valve into the chest through an access port according to the invention.
- FIG. 21 is a right lateral elevational view of the patient's chest with a portion of the chest cut-away illustrating the placement of the prosthetic valve at the native valve position in the heart.
- FIG. 22 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the tying and trimming of sutures to secure a prosthetic valve in the heart according to the invention.
- FIG. 23 is a view of the aortotomy and the aortic valve through an oval-shaped access port placed in an intercostal space in the patient's chest, illustrating the closure of the aortotomy according to the invention.
- FIG. 24 is a perspective view of an alternative embodiment of a delivery handle according to the invention holding an element schematically representing a valve sizing disk or prosthetic valve.
- FIG. 25 is a perspective view of the delivery handle of FIG. 24 illustrating the element pivoted into an orientation suitable for positioning through an intercostal access port.
- FIG. 26 is a side cross-sectional view of the delivery handle of FIGS. 24 and 25.
- FIG. 27 is a perspective view of an additional embodiment of an access port through which a prosthetic valve may be positioned into the chest according to the invention.
- FIG. 28 is a perspective view of the access port of FIG. 27 showing deployment of a retention element for retaining the access port in the chest wall.
- FIG. 29 is a perspective assembly view of the access port of FIGS.27-28.
- FIG. 30 is a perspective view of an obturator for use in conjunction with the access port of FIGS.27-29.
- FIGS.31A-31B are side cross-sectional views of the obturator of FIG. 30 illustrating the actuation a means for retracting the retention means of the access port of FIGS. 27-29.
- FIG. 32 is a perspective view of the delivery handle of FIGS.24-26 including an alternative embodiment of a valve holder according to the invention.
- FIG. 33A is a side assembly view of a distal portion of the delivery handle and valve holder of FIG. 32.
- FIG. 33B is an end view of the valve holder of FIG. 32.
- FIG. 34 is a perspective view of a bileaflet mechanical heart valve useful in conjunction with the devices and methods of the invention.
- FIG. 35 is a perspective view of a further embodiment of a valve holder according to the invention holding the bileaflet mechanical heart valve of FIG. 34.
- FIGS.36A-36C are side, bottom, and proximal end views, respectively of the valve holder of FIG. 35.
- FIG. 37 is a perspective view of an access port and illumination device constructed in accordance with the principles of the invention.
- FIGS.38-40 are cross-sections taken along the lines 38-38, 39-39 and 40-40, respectively, of FIG. 37.
- FIG. 41 is a transverse cross-section of an alternative embodiment of an access port and illumination device according to the invention.
- FIG. 42A is a front view of an alternative embodiment of an access port having a channel through which an illumination or visualization device may be inserted.
- FIG. 42B is a transverse cross-section taken along
line 42B-42B of FIG. 42A. - Specific embodiments of the devices and methods of the invention will now be described in connection with aortic valve replacement procedures. However, it will be understood to those of ordinary skill in the art that a wide variety of procedures may be performed on a variety of body structures without departing from the scope of the invention. These include, in addition to surgery of the aortic valve via the aorta, interventions in the coronary arteries, left ventricle, mitral valve, left atrium, or pulmonary vein via the aorta, interventions in the right atrium, tricuspid valve, right ventricle, pulmonary valve or pulmonary artery via the superior vena cava or inferior vena cava, as well as interventions in various other organs via vessels in communication with those organs. The types of interventions which can be performed include not only aortic valve repair and replacement, but catheter interventions in the coronaries such as angioplasty, atherectomy, stent placement or endoarterectomy, electrophysiological interventions within the heart such as mapping and ablation, transmyocardial revascularization using a laser placed within the heart, repair of septal defects and patent ductus arteriosus using patch placement or other defect closure devices placed in the right or left chambers of the heart, repair or replacement of the mitral, tricuspid or pulmonary valve including placement of annuloplasty rings and prosthetic valves, reattachment of chordae tendonae, commissurotomy, and quadrangular resection, incision of the atrial or ventricular wall for the performance of a Cox maze procedure in the treatment of atrial fibrillation, and other procedures. The principles of the invention will apply to the performance of these procedures in much the same way as to the performance of aortic valve replacement, which is now described with reference to FIGS.1-36.
- The patient is first prepared for aortic valve surgery by putting the patient under general anesthesia, establishing cardiopulmonary bypass (CPB) and inducing cardioplegic arrest. General anesthesia is induced in a conventional manner. A preferred technique for accomplishing CPB and cardioplegic arrest which does not require a sternotomy, thoracotomy, or other opening in the patient's chest is illustrated in FIG. 1. Additional aspects of the systems and methods for inducing cardioplegic arrest described here may be found in patent application Ser. Nos. 08/1282,192, filed Jul. 28, 1994, now U.S. Pat. Nos. 5,584,803 and 08/486,216, filed Jun. 7, 1995, now U.S. Pat. No. 5,766,151, the complete disclosures of which are hereby incorporated herein by reference.
- A
cardiopulmonary bypass system 20 includes avenous cannula 22 which is placed in afemoral vein 24 in the groin area or in another peripheral vein such as an internal jugular vein or subclavian vein, located in the neck. While illustrated in a shorter configuration, the venous cannula may be long enough to extend from the femoral vein into the inferior vena cava, into the right atrium of the heart or through the right atrium into the superior vena cava. The system also includes anarterial return cannula 26 placed in afemoral artery 28 or in another peripheral artery such as the subclavian or brachial artery in the neck or armpit. Thearterial return cannula 26 is generally long enough so that it extends sufficiently into the femoral artery to avoid backing out of the artery but as short as possible to reduce damage to blood delivered through the arterial return cannula. Bothvenous cannula 22 andarterial return cannula 26 are configured to be placed into the femoral vein and femoral artery, respectively, either by surgical cut-down, or by a percutaneous technique such as the Seldinger technique. -
Venous cannula 22 andarterial return cannula 26 are connected to a CPB pump andoxygenator 30 of well-known construction. CPB pump andoxygenator 30 oxygenates the deoxygenated blood withdrawn from the patient's venous system throughvenous cannula 22, and pumps the oxygenated blood back into the patient's arterial system viaarterial return cannula 26. In this way, circulation and re-oxygenation of the patient's blood may be maintained while the heart is temporarily arrested. - Cardioplegic arrest may be induced using any of several techniques. One preferred technique is illustrated in FIGS. 1 and 2. In this technique, an
endoaortic catheter 32 is introduced by surgical cut-down or by a percutaneous technique into a peripheral artery, which may be thefemoral artery 34 as illustrated, or a brachial or subclavian artery.Endoaortic catheter 32 is configured to be advanced transluminally, usually over a guidewire (not shown), fromfemoral artery 34 into the aorta until itsdistal end 36 is positioned in the ascendingaorta 38 between the coronary ostia (not shown) just downstream of the aortic valve and thebrachiocephalic artery 40.Endoaortic catheter 32 has anexpandable member 42 mounted near itsdistal end 36 which, as shown in FIG. 2, is configured to expand into sealing engagement with the inner wall of the ascendingaorta 38 to block blood flow through the aorta without occluding eitherbrachiocephalic artery 40 or the coronary ostia. In a preferred embodiment,expandable member 42 is an elastomeric balloon in communication with aninflation lumen 43 extending throughendoaortic catheter 32 to a delivery device such assyringe 46 for delivering an inflation fluid such as saline or radio-opaque contrast solution to expandexpandable member 42 until completely occluding the aorta. The elastomeric balloon preferably is short in the axial direction, being disc-shaped (a short cylinder), donut-shaped (toroidal), ellipsoidal, or other shortened shape to minimize the amount of the ascending aorta which is occupied by the balloon so that the surgeon has the maximum room to work upstream of the balloon. In one embodiment,expandable member 42 has an axial length between its proximal and distal ends of about 1-40 mm, preferably about 1-20 mm, and an expanded outer diameter in the radial direction of about 10 to 60 mm, preferably about 30-40 mm. - In a particularly preferred embodiment,
arterial return cannula 26 includes an additional hemostatic port (not shown) at its proximal end that allowsendoaortic catheter 32 to be slidably positioned through the blood return lumen of the arterial return cannula. Arterial return cannulae having such a configuration are disclosed in copending application Ser. No. 08/282,192, filed Jul. 28, 1994, now U.S. Pat. No. 5,584,803, which is incorporated herein by reference. - With
expandable member 42 occluding the ascendingaorta 38, a cardioplegic fluid is delivered from acardioplegic fluid supply 48 through adelivery lumen 44 inendoaortic catheter 32 and aport 51 at itsdistal end 36 into the ascending aorta distal toexpandable member 42 so that the cardioplegic fluid flows into the coronary arteries to perfuse the myocardium. The cardioplegic fluid preferably includes a cardioplegic agent such as potassium chloride mixed with blood and cooled to a low temperature, e.g. 5-20° C. Upon perfusion of the myocardium with cardioplegic fluid, heart contractions will quickly cease. Circulation of oxygenated blood to organs and tissues other than the heart is maintained bycardiopulmonary bypass system 20.Expandable member 42 prevents the oxygenated blood delivered byarterial return cannula 26 from reaching the coronary arteries, which would allow the blood to perfuse the myocardium and revive the heart. - Periodically, it may be necessary to remove fluids from the ascending
aorta 38 during the procedure. Such fluids may be withdrawn throughdelivery lumen 44 ofendoaortic catheter 32 and diverted through avalve 47 to a filter andrecovery system 49, which removes impurities from the blood and directs the blood tocardiopulmonary bypass system 20 where it is delivered back into the arterial system. Alternatively, a separate cardiotomy suction probe may be introduced through an access port and through the aortic wall to remove such fluids.Endoaortic catheter 32 preferably also includes apressure port 53 near itsdistal end 36 in communication with a pressure lumen extending to the proximal end of the catheter where it may be connected to apressure measurement device 50, allowing pressures in the ascending aorta distal toexpandable member 42 to be monitored during the procedure. - In addition to delivery of cardioplegic fluid in the “antegrade” manner via
endoaortic catheter 32 as just described, it is usually desirable to deliver cardioplegic fluid in a “retrograde” manner through the coronary sinus during the aortic valve replacement procedure. For this purpose, acoronary sinus catheter 52 is placed into aperipheral vein 54, preferably the internal jugular vein or subclavian vein in the neck, and advanced through the superior vena cava into the right atrium, where it is maneuvered into the coronary sinus (not illustrated).Coronary sinus catheter 52 has a balloon or otherexpandable member 58 near its distal end 60 which may be expanded by means of asyringe 62 to occlude the coronary sinus during fluid delivery. A delivery lumen (not pictured) extends through thecoronary sinus catheter 52 to a port at its distal end 60 to allow delivery of a cardioplegic fluid, which will usually be similar to that described above used in antegrade delivery.Coronary sinus catheter 52 may also include a pressure port near distal end 60 and a pressure lumen extending to its proximal end for monitoring pressure distal toexpandable member 58. Other aspects of coronary sinus catheters and retrograde cardioplegia techniques useful in connection with the present invention are disclosed in copending application Ser. No. 08/372,741, filed Jan. 12, 1995, now U.S. Pat. No. 5,558,644, which is hereby incorporated herein by reference. - In a preferred technique, after an initial infusion of cardioplegic fluid through
endoaortic catheter 32 to induce cardioplegic arrest, most subsequent infusions are performed retrograde throughcoronary sinus catheter 52. To maintain cardioplegic arrest, cardioplegic fluid is preferably delivered in periodic infusions at, for example, 600 ml volumes delivered in about 120 to 180 seconds at 15 minute intervals. Between infusions,expandable member 58 ofcoronary sinus catheter 52 is preferably deflated to allow fluid to drain from the coronary sinus. - In an alternative technique for inducing cardioplegic arrest, devices are introduced thoracoscopically through access ports between the ribs to occlude the ascending aorta and, optionally, to deliver cardioplegic fluid into the ascending aorta upstream of the occluded area. In these thoracoscopic techniques, the pericardium is first opened to expose the ascending aorta. As illustrated in FIG. 3A,
several access ports 71, such as trocar sleeves or other tubular cannulae, are placed in intercostal spaces I between ribs R. A thoracoscope 73 of conventional construction and having avideo camera 75 mounted to its proximal end may be placed through one ofaccess ports 71 for visualizing the procedure, or the surgeon may look directly into the chest through one ofaccess ports 71.Thoracoscopic scissors 77 andgraspers 79 are introduced throughaccess ports 71 and used to create anincision 81 approximately 4-10 cm in length in the anterior side of thepericardium 83 overlying theaorta 85 so that the ascendingaorta 87 and upper anterior side of theheart 89 are exposed.Thoracoscopic scissors 77 andgraspers 79 may have any of various well-known constructions, including those described in copending application Ser. No. 08/194,946, filed Feb. 14, 1994, now U.S. Pat. No. 5,501,698, which is hereby incorporated herein by reference. - In a first embodiment of a thoracoscopic technique for arresting the heart, illustrated in FIGS.3-4, an
expandable member 64 such as an elastomeric balloon is positioned in the ascendingaorta 66 through a penetration in a wall of the aorta.Expandable member 64 will be shaped and dimensioned to allow complete occlusion of ascendingaorta 66 without blocking blood flow into thebrachiocephalic artery 78 or the coronary ostia. Additionally,expandable member 64 will be as short as possible in the axial direction (along the central axis of the aortic lumen) to minimize its space requirements in the ascending aorta, preferably having a short cylindrical, discoid, ellipsoid, donut or toroidal shape with an axial length of about 1-40 mm, preferably about 1-20 mm.Expandable member 64 is attached to adistal end 68 of ashaft 70, which may be a rigid or flexible biocompatible metal or polymer.Shaft 70 extends through the penetration in the aortic wall and out of the chest through anaccess port 72 between theribs R. Shaft 72 is at least about 6 cm, preferably about 10-20 cm, in length so that itsproximal end 76 is outside of the chest whenexpandable member 64 is in the ascendingaorta 66 between thebrachiocephalic artery 78 and the coronary ostia (not shown). -
Access port 72, as with other access ports referred to in this application, is illustrated as a tubular cannula Or trocar sleeve, but may alternatively comprise a wound retractor with rigid blades or flexible adhesive strips for retracting tissue to create a small opening between the ribs. Instruments may alternatively be positioned directly through a puncture or incision between the ribs without a retractor, cannula or trocar, but usually some means of retracting tissue is desirable to prevent tissue damage and to facilitate introduction and manipulation of instruments. In some cases, it may be necessary to cut or remove one or more of the costal cartilages that connect the ribs to the sternum, to allow a slightly greater degree of rib retraction. However, in most cases, the access ports will be configured to facilitate introduction of surgical instruments, visualization devices, valve prostheses, and other devices used in the various procedures of the invention without removing the ribs R or sternum S, and preferably without retracting or cutting the ribs R significantly. Thus, the access ports will have a transverse profile suitable for positioning within an intercostal space I between two adjacent ribs R, which typically has a width (the distance between adjacent ribs R) of about 10-25 mm in normal adult patients, without cutting or removing the ribs, and without retracting the ribs more than about 1-2 cm from their natural, undeflected positions. In many cases, the access ports may be circular in cross-section with an outer diameter of less than about 12 mm so as to be easily positionable within an intercostal space I. In other cases the access ports may have a cross-sectional shape other than circular and may have a slightly larger transverse dimension to accommodate specialized instruments or prostheses, as described below. - As shown in FIG. 4,
shaft 70 includes adelivery lumen 80 extending from afirst connector 82 atproximal end 76 to adelivery port 84 atdistal end 68, through which cardioplegic fluid may be delivered into ascendingaorta 66. Ifexpandable member 64 is a balloon,shaft 70 also has aninflation lumen 86 extending from a second connector 88 to the interior ofexpandable member 64, through which an inflation fluid such as saline or contrast solution may be delivered into the balloon. In addition,shaft 70 may optionally include anarterial return lumen 90 extending from athird connector 92 atproximal end 76 to anarterial return port 94 atdistal end 68, through which oxygenated blood may be delivered into the aorta downstream ofexpandable member 64.Third connector 92 may be connected with tubing to the outlet ofcardiopulmonary bypass system 20, allowingarterial return lumen 90 to be used in place of or as a supplement to the use of separatearterial return cannula 26 of FIG. 1.Shaft 70 may also include a pressure lumen (not shown) extending fromproximal end 76 to a pressure port (not shown) atdistal end 68 to allow pressure monitoring in ascendingaorta 66 upstream ofexpandable member 64. -
Shaft 70 is dimensioned so as to pass easily throughaccess port 72 between ribs R, while having sufficient cross-section thatlumens shaft 70 will have an outer diameter of less than about 12 mm, preferably less than about 10 mm.Delivery lumen 80 must be large enough in cross-section to allow cardioplegic fluid to be delivered at a sufficient flow rate to induce and maintain cardioplegic arrest, preferably allowing cooled cardioplegic fluid containing blood, usually having a viscosity of about 1-4 centipoise, to be delivered at a flow rate of at least about 200 ml/min at a pressure no more than about 300 mmHg. Thus,delivery lumen 80 has a cross-sectional area of about 0.5-8 mm2, preferably about 0.5-2.0 mm2.Arterial return lumen 90 is preferably large enough to allow blood to be delivered at flow rates adequate to maintain full cardiopulmonary bypass with the heart arrested (preferably without the use a separate arterial return cannula), having a cross-sectional area of about 12-75 mm2, and preferably about 25-50 mm2. In addition,inflation lumen 86 must be large enough to allow saline or other inflation fluid to be delivered at flow rates sufficient to inflateexpandable member 64 in less than about 30 seconds, preferably less than about 10 seconds, having a cross-sectional area of about 0.1-5 mm2, preferably about 1-3 mm. - A second embodiment of a thoracoscopic technique for inducing cardioplegic arrest is illustrated in FIGS.5-6. In this technique, an
external clamp 98 is placed around the ascendingaorta 100 to occlude theaortic lumen 102 just upstream of thebrachiocephalic artery 104.Clamp 98 is attached to adistal end 106 of ashaft 108 which is long enough to extend out of the chest through anaccess port 110 between ribs R, having a length of at least about 10 cm, preferably 20-30 cm. Anactuator 112 is attached toproximal end 114 ofshaft 108 to allowclamp 98 to be opened and closed from outside of the chest.Actuator 112 includes a pair ofmovable handles 116 withfinger loops 118, and alocking mechanism 120 which may comprise a pair of overlappingfingers 122 with transverse teeth (not shown) which interlock with one another.Clamp 98 includes afirst jaw 124 fixed toshaft 108, and asecond jaw 126 fixed to an inner shaft (not shown) extending through the interior ofshaft 108 and rotatable relative toshaft 108. One ofhandles 116 is fixed to the proximal end ofshaft 108, while a second ofhandles 116 is fixed to a proximal end of the inner shaft, so that by pivotinghandles 116 relative to one another, the inner shaft rotates relative toshaft 108, opening or closingjaws - In order to deliver cardioplegic fluid into the ascending aorta, several alternative techniques may be used. In one technique, illustrated in FIGS.5-6, a
delivery cannula 130 may be positioned through an inner lumen ofshaft 108 so that aneedle 132 at the distal end of the delivery cannula extends distally ofdistal end 106 ofshaft 108, generally parallel to and spaced apart fromjaws 124.Jaws 124 may be curved or angled away fromshaft 108 so that the portions of the jaws that extend around the aorta are offset fromneedle 132 to allowneedle 132 to be placed throughshaft 108 and penetrate the aortic wall upstream fromjaws 124.Delivery cannula 130 has an inner lumen extending from its distal end to its proximal end which may be connected to a cardioplegic fluid source. In one embodiment, aconnector 134 is provided near the proximal end ofdelivery cannula 130 which connects to a connector on the proximal end ofshaft 108 to fix the delivery cannula in position relative to clamp 98. In this way, afterclamp 98 has been closed on ascendingaorta 100 to occlude theaortic lumen 102,delivery cannula 130 may be positioned throughshaft 108 to penetrate the aortic wall withneedle 132, allowing cardioplegic fluid to be delivered upstream ofclamp 98. The inner lumen ofdelivery cannula 130 will be configured to facilitate delivering cardioplegic fluid containing blood at a rate of at least about 200 ml/min and a pressure of no more than about 300 mmHg, having a cross-sectional area of at least about 0.5 mm2, and preferably 0.5-2.0 mm2.Delivery cannula 130 may alternatively be independent ofclamp 98 andshaft 108, and placed through a separate access port rather than being placed throughshaft 108. - Alternative techniques of delivering cardioplegic fluid are described in U.S. Pat. No. 5,425,705, which has been incorporated herein by reference. In one such technique, not illustrated here, an endovascular delivery catheter may be placed through a peripheral artery such as a femoral artery until its distal end is in the ascending
aortic lumen 102 upstream of thebrachiocephalic artery 104.Clamp 98 may then be actuated to close on the aorta around the endovascular delivery catheter, which may be reinforced in its distal extremity to prevent collapsing. In this way, cardioplegic fluid may be delivered upstream of theexternal clamp 98 without requiring a puncture through the aortic wall. Such an endovascular delivery catheter may also include a pressure port and pressure lumen for monitoring pressure in the ascending aorta during the procedure. - In a further embodiment of a thoracoscopic aortic occlusion technique, illustrated in FIGS.7-8, an
external clamp 136 is placed around the ascendingaorta 138 by athoracoscopic clamp applier 140, closed onaorta 138 to block blood flow through the aortic lumen. then released fromclamp applier 140, which may then be removed from the chest.Clamp 136 comprises a pair ofmovable jaws pin 152.Jaws proximal extremities locking mechanism 148 is mounted, which may comprise a pair of deflectable overlappingfingers 150 havingtransverse teeth 152 which interlock with one another to maintainclamp 136 in a closed position. A pair ofdetents 158 are disposed at the proximal ends ofjaws distal tips 160 of clampapplier jaws 162.Clamp 136 is configured to be positionable through anaccess port 146 or incision between ribsR. Access port 146 has a transverse cross-sectional width to fit between the ribs without requiring significant deflection or removal of the ribs, but may have a longer transverse cross-sectional dimension parallel to the ribs to allowclamp 136 to be positioned through the access port when held byclamp applier 140. -
Clamp applier 140 has, as shown in FIG. 7, anactuator 164 at its proximal end which comprises one or moremovable leaves 166 pivotably mounted to ashaft 168.Leaves 166 are linked to clampapplier jaws 162 by alinkage 170, best seen in FIG. 8, which may be a rod or wire slidably disposed in alumen 171 withinshaft 168, linked to ascissors mechanism 172 coupled tojaws 162. In this way, movingleaves 166 towardshaft 168 causesjaws 162 to move between an open position for releasingclamp 136 to a closed position for grasping andclosing clamp 136.Clamp 136 is preferably biased into an open configuration by a torsion spring (not shown) aroundpin 152 or a compression spring (not shown) betweenproximal extremities jaws mechanism 148 is released by deflectingfingers 150 away from each other, clamp 136 will be urged open as clampapplier jaws 162 are opened. Other aspects and alternative configurations ofclamp 136 and clampapplier 140 are disclosed in commonly-assigned copending application Ser. No. 08/567,996, filed Dec. 4, 1995, now U.S. Pat. No. 5,618,307, which is hereby incorporated herein by reference. - With
clamp 136 closed on the aorta to occlude blood flow through the aortic lumen, cardioplegic fluid may be delivered into the ascending aorta by means of adelivery cannula 176 placed into the chest through anaccess port 178 and having aneedle 180 at its distal end for penetrating the aortic wall. Usually, a purse-string suture 182 will be placed in the aorticwall surrounding needle 180 using thoracoscopic needle drivers positioned through an intercostal access port. The purse-string suture 182 is cinched up arounddelivery cannula 176 to maintain hemostasis around the cannula. Alternatively, as discussed above, an endovascular delivery catheter (not illustrated) may be used which extends into the ascending aortic lumen transluminally from a peripheral artery such as the femoral, brachial, or subclavian artery.Clamp 136 is clamped around the aorta after the endovascular delivery catheter has been positioned so that the inner wall of the aorta seals against the outer wall of the delivery catheter. The delivery catheter may be reinforced in its distal extremity to resist collapsing under the force ofclamp 136. The delivery catheter may alternatively have an expandable member such as a balloon near its distal end which may be expended in the ascending aorta likeendoaortic catheter 32 of FIGS. 1-2.Clamp 136 may then be applied to the ascending aorta directly around the expandable member to achieve complete occlusion without excessive crushing or collapsing of theaortal Clamp 136 may also be placed distally or proximally of the expandable member, or a clamp may be placed in either side, to prevent migration of the expandable member as well as blocking blood flow. - In addition, retrograde delivery of cardioplegic fluid via the coronary sinus by means of an endovascular catheter introduced through a peripheral vein (described above) may be used instead of or in combination with antegrade delivery through a thoracoscopic or endovascular delivery catheter placed in the aorta.
- It should be noted that, in some cases, it may be appropriate not to induce cardioplegic arrest, but instead to place the heart in a state of fibrillation. While this is usually not desirable because it is generally thought to provide inadequate protection of the myocardium, it may be induced using the devices and methods of the present invention. The patient is placed on cardiopulmonary bypass as described above (without occluding the ascending aorta so as to arrest the heart), and the oxygenated blood returned to the arterial system is cooled to a sufficiently low temperature to induce fibrillation. An endovascular or thoracoscopic catheter may be placed in the ascending aorta as described above, and, without occluding the ascending aorta, drugs or blood may be delivered to the coronary arteries, and fluids may be removed to vent the heart and aorta. Alternatively, one of the above-described aortic occlusion devices may be used to periodically induce fibrillation during the procedure by occluding the aorta temporarily without delivering the cardioplegic fluids that induce cardioplegic arrest, with intermittent periods of no occlusion so as to avoid ischemia.
- While the remainder of the aortic valve replacement procedure is described with reference to the use of
clamp 136 anddelivery cannula 176 for inducing cardioplegic arrest, it should be understood that any of the devices and techniques described above, as well as various other techniques not specifically described here, may be used for inducing cardioplegic arrest without departing from the scope of the invention. - Once cardioplegic arrest is induced, the patient is supported on cardiopulmonary bypass, and the pericardium has been opened as described above, an incision, or aortotomy,184 is formed in the wall of ascending
aorta 186 as shown in FIGS. 9-10. At this point. at least one, and usually at least three, access ports should be placed in intercostal spaces I between ribs R on the right anterior side of the chest. One or twoaccess ports 188 with outer diameter less than about 12 mm are placed in the first, second, or third intercostal space through whichdelivery cannula 176 and thoracoscope 73 (if utilized) are positioned. Anotheraccess port 190 with outer diameter less than about 12 mm is placed in the third, fourth or fifth intercostal space through which various instruments used in the procedure may be positioned. Anadditional access port 192, which is specially-configured for positioning a replacement valve through its central lumen as described more fully below, is placed in the first, second, third or fourth intercostal space, depending upon patient size and anatomy. As described above,access ports access ports - It should be noted that, in the absence of a large thoracic incision for access into the chest, some means of illuminating the chest cavity is usually necessary. A thoracoscopic light wand or a commercially-available thoracoscope or endoscope having a fiber-optic channel which emits light from the distal end of the device may be placed through an access port for illumination. Alternatively, one or more access ports may have an illumination device mounted to it, as described below in connection with FIGS.37-40.
-
Aortotomy 184 is created using thoracoscopic angledscissors 194 or a knife (not shown) positioned throughaccess port 192, assisted by means ofthoracoscopic forceps 196 positioned throughaccess port 190.Angled scissors 194 andforceps 196 may be commercially-available thoracoscopic instruments or may be constructed as described in copending applications Ser. No. 08/194,946, now U.S. Pat. No. 5,501,698, and Ser. No. 08/281,962, now abandoned, which have been incorporated herein by reference.Aortotomy 184 is approximately 6-8 cm in length, extending distally and slightly posteriorly along the anterior side of the aorta from a point at least about 10 mm, and preferably about 15 mm, downstream of the right coronary ostium. -
Aortotomy 184 is then retracted open as illustrated in FIGS. 11-12. In an exemplary embodiment, sutures 200 are placed in the aortic wall along the edges ofaortotomy 184, preferably with a suture near each end ofaortotomy 184 on each side of the incision. Each ofsutures 200 has aneedle 202 attached to an end thereof which is driven throughaortic wall 204 usingthoracoscopic needle drivers 206 introduced through eitheraccess port 190 oraccess port 192.Needle drivers 206 may be commercially-available thoracoscopic instruments or may be constructed as described in the aforementioned patent applications, Ser. Nos. 08/194,946, or 08/281,962, now abandoned.Sutures 200 preferably have a length of at least about 20 cm so that they may be withdrawn from the chest cavity by passingneedles 202 through the chest wall between ribs R or by snaring the sutures with a hook introduced through an intercostal space.Sutures 200 are tensioned in opposing directions to retractaortotomy 184 open and are then secured outside the chest withhemostats 208 or other suitable clamping device of conventional construction. Alternatively, sutures 200 may be secured to tissue within the chest cavity by passingneedles 202 through such tissue and tying the sutures off, or by attaching the suture ends to a clip, clamp, hook or staple which can be fastened to tissue in the chest. Withaortotomy 184 retracted open, theaortic valve 210 is fully exposed and visible through theinner lumen 212 ofaccess port 192, as illustrated in FIG. 12. - The
leaflets 214 of the nativeaortic valve 210 are then removed using thoracoscopic curved orangled scissors 194 or knife (not illustrated), andforceps 196 positioned throughaccess ports Leaflets 214 are grasped byforceps 196, retracted away from thevalve annulus 216, and cut closely to the inner edge ofvalve annulus 216 without cutting into the valve annulus or the aortic wall. - During this process, it may be advantageous to provide a mechanism for catching any bits of valve leaflet, calcium or other debris that may fall into the left ventricle as the leaflets are excised. As illustrated in FIG. 14, a
catcher 220 may be placed throughaortic valve 210 into theleft ventricle 222 and positioned so as to catch any debris released in the leaflet removal or debridement process.Catcher 220 may comprise a flexible, porous mesh, foam, gauze, or screen constructed as a bag or pouch with anopening 222 on atop end 224 thereof.Top end 224 is configured to be positioned in the left ventricle just below the aortic valve, with the sides ofcatcher 220 engaging theventricular wall 226. Preferablycatcher 220 is collapsible into a smaller shape suitable for positioning throughaccess port 190 oraccess port 192, throughaortotomy 184, and throughaortic valve 210, and at leasttop end 224 is resiliently biased to return to an expanded configuration in which the outer sides oftop end 224 engageventricular wall 226. A flexible and resilient metal orelastomeric ring 228 may be mounted tocatcher 220 around opening 222 which may be radially collapsed during positioning, then released to allow the ring to expand outwardly to engage the ventricular wall. To facilitate positioning,catcher 220 may be collapsed and placed in a tubular sleeve or catheter (not shown) during positioning through the aortic valve, then ejected from the sleeve within the left ventricle. Alternatively, thoracoscopic forceps or graspers positionable through an intercostal access port may be used to grasp and collapsecatcher 220 and position it into the left ventricle. A suture or otherflexible tether 230 is preferably attached tocatcher 220 and extends out of the chest through an access port to allowcatcher 220 to be retrieved after use. The aforementioned tubular sleeve may be guided overtether 230 back into the left ventricle andcatcher 220 then collapsed and retracted into the sleeve to facilitate removing the device from the chest. - Following removal of the aortic valve leaflets, any calcific deposits and any remaining leaflet tissue around the inner surface of
valve annulus 216 are removed usingthoracoscopic rongeurs 232.Rongeurs 232 have a split-shaft construction, wherein twoindependent shaft members jaw 238 is disposed at the end ofshaft member 234, and amovable jaw 240 is pivotably mounted to the distal end ofshaft member 236 by afirst pin 242 and pivotably attached toshaft member 234 by asecond pin 244. In this way, longitudinal translation ofshaft member 236 relative toshaft member 234 by means of an actuator (not shown) at the proximal end of the device pivotsmovable jaw 240 relative to fixedjaw 238. Fixed jaw238 andmovable jaw 240 have hollow or concave inner sides facing each other, and cuttingedges edges valve annulus 216 to excise any remaining leaflet material or calcific deposits along the valve annulus. Any material removed is collected within the concave inner sides ofjaws rongeurs 232 include a suction lumen through which a vacuum may be applied from the proximal end of the device to evacuate tissue and debris as it is cut fromvalve annulus 216. In the split shaft design of FIG. 15, for example, at least one ofshaft members jaws edges - In addition, an irrigation lumen may be provided in one of
shaft members jaws shaft member 234 and an irrigation lumen is provided in theother shaft member 236 to provide both irrigation and suction in the space betweenjaws - As an alternative to the use of
thoracoscopic rongeurs 232, various other devices may be used for removal of calcific and fibrous material at the native valve position, including high-speed rotating cutters or grinders like those used in atherectomy and arthroscopy devices, lasers, and ultrasonic scalpels, any of which may be equipped with irrigation or suction lumens. - The valve annulus is then sized to determine the appropriate size for a replacement valve. As illustrated in FIG. 16, a
valve sizing device 250 is introduced throughaccess port 192 into the ascendingaorta 186 throughaortotomy 184. Sizingdevice 250 includes ashaft 252 having a pivotingtongue 254 at its distal end and ahandle 256 at its proximal end. Asizing disk 258 is releasably attached totongue 254. Anactuator button 260 is slidably mounted to handle 256 and is connected totongue 254 by a linkage (not shown) such as a slidable rod extending through a passage inshaft 252. In this way, slidingactuator button 260 alonghandle 256pivots tongue 254 from a first orientation in which the tongue is generally parallel toshaft 252 to a second orientation in which the tongue is perpendicular toshaft 252. Thus, for a generally cylindrical sizing disk having a central axis, sizingdisk 258 is positionable in an orientation in which the central axis is perpendicular to the longitudinal axis ofshaft 252, providing a minimum profile to allow the sizing disk to be introduced throughlumen 212 ofaccess port 192. Once inside the chest, sizingdisk 258 may be re-oriented usingactuator button 260 so that the sizing disk is in an appropriate orientation for sizingvalve annulus 216, usually with its axis about parallel to the longitudinal axis ofshaft 252 as shown in FIG. 16. Abutton lock 262 may also be provided onactuator button 260 to allowsizing disk 258 to be releasably locked in a suitable orientation for sizingvalve annulus 216. Other aspects of valve sizing devices suitable for use in the method of the invention are described in copending applications Ser. No. 08/485,600 and Ser. No. 08/281,962, which have been incorporated herein by reference. - Once positioned inside ascending aorta.186 through
aortotomy 184 and oriented in an orientation suitable for sizingvalve annulus 216, sizingdisk 258 is positioned withinvalve annulus 216 to allow a comparison of the outer diameter of sizingdisk 258 to the inner diameter ofvalve annulus 216. To see the sizing procedure, the surgeon may look directly atvalve annulus 216 throughlumen 212 ofaccess port 192 or a thoracoscope may be used for video imaging of the valve annulus. If the sizing disk is either larger or smaller than the valve annulus, sizingdevice 250 is removed from the chest and sizingdisk 258 is removed fromtongue 254 and replaced with another sizing disk of a different diameter. The process is repeated until the surgeon has identified the appropriate size of replacement valve to be implanted. It should be understood that other techniques may be used for determining the annulus size, including endoscopic video imaging, transesophageal echocardiography, or thoracoscopic ultrasonic imaging, as well as using an adjustable valve sizer that may be placed within the valve annulus and adjusted in diameter until the appropriate size is determined. - When the size of the valve annulus has been determined, the appropriate replacement valve is then identified. A variety of replacement valves may be used in the method of the invention, including many of the more widely-accepted valves used in conventional open-chest aortic valve replacement procedures. These include mechanical valves such as the St. Jude Medical Mechanical Heart Valve (St. Jude Medical, Inc., St. Paul, Minn.), the Carbomedics Prosthetic Heart Valve (Carbomedics, Inc., Austin, Tex.), and the Sorin Monostrut Heart Valve or Sorin Bicarbon Valve (Sorin Biomedical, Inc., Irvine, Calif.), as well as bioprosthetic or tissue valves, such as the Carpentier-Edwards Pericardial Bioprosthesis or Carpentier-Edwards Model 2625 Porcine Bioprosthesis (Baxter, Inc., Edwards CVS Division, Irvine, Calif.), or Medtronic Hancock Mo. Bioprosthesis or Medtronic Hall valve (Medtronic, Anaheim, Calif.). In addition, the method of the invention may be used to replace a diseased aortic valve with an autologous graft such as the pulmonary valve from the same patient, which may be removed thoracoscopically from the patient's pulmonary artery using thoracoscopic instruments and visualization devices positioned through access ports between the ribs. Allografts, such as an aortic valve removed from another donor patient's heart, may also be implanted using the methods of the invention. While the aortic valve replacement procedure of the invention will be described with reference to a mechanical bileaflet valve such as the St. Jude Medical Mechanical Valve, it should be understood that the methods described are equally applicable to other types of mechanical valves, as well as to bioprosthetic valves, autografts and allografts.
- In order to implant most mechanical valve prostheses, a plurality of
sutures 264 are placed in the native valve annulus to form mattress stitches or inverted mattress stitches. As shown in FIGS. 17-18,sutures 264 are double-armed witharcuate needles 266 on both ends, and are placed invalve annulus 216 using a specializedrotational needle driver 268, described in detail in copending application Ser. No. 08/594,869, entitled “Endoscopic Suturing Devices and Methods”, which is hereby incorporated herein by reference.Rotational needle driver 268 has ashaft 270 with arotatable carriage 272 at its distal end ahandle 274 at its proximal end. One ofneedles 266 is releasably held incarriage 272 such that the needle'ssharp point 274 is exposed outside of the carriage.Carriage 272 is rotatable about apin 276 inshaft 270. Anactuator button 278 is slidably mounted to handle 274 and is coupled tocarriage 272 by a linkage (not shown) such as a slidable rod within a passage inshaft 270. In this way, sliding actuator button alonghandle 274 rotatescarriage 272 aboutpin 276.Carriage 272 may be configured to drivesharp point 275 ofneedle 266 in either a distal or proximal direction, depending upon whether it is desired to drive the needle from the ventricle toward the aorta, or from the aorta toward the ventricle. In the embodiment illustrated,rotational needle driver 268 is set up to driveneedle 266 from theleft ventricle 222 towardaorta 186.Carriage 272 holdingneedle 266 is positioned throughaccess port 192, throughaortotomy 184 and throughvalve annulus 216.Sharp point 275 ofneedle 266 is then positioned so as to penetrate the valve annulus a distance of about 1-5 mm from the inner edge of the annulus, as visualized by looking throughaccess port 192 or under thoracoscopic visualization. When the needle is properly positioned,actuator button 278 is moved alonghandle 274 to translateneedle 266 throughvalve annulus 216. Oncesharp point 275 emerges from the annulus within the aorta, the needle may be picked up withthoracoscopic needle drivers 206 positioned through access port 192 (or through a separate access port). In an alternative embodiment, a needle pick-up mechanism (not shown) is provided onneedle driver 268 to allowneedle 266 to be picked up without the use of a separate instrument, as described in the above-mentioned patent application Ser. No. 08/594,869, entitled “Endoscopic Suturing Devices and Methods”. Whenneedle 266 is picked up, it is drawn throughvalve annulus 216 and withdrawn from the chest throughlumen 212 ofaccess port 192. A total of 10-20 sutures are placed invalve annulus 216 in this way. - Because of the large number of sutures that are placed in
valve annulus 216, a suture organizing device is provided outside the chest to keep the sutures orderly and free of tangles. In a preferred embodiment, a suture organizer 279 is disposed on the proximal end ofaccess port 192 itself, the suture organizer including a plurality ofradial slits 280, usually 12-24 pairs, arranged around the circumference of arim 282 onaccess port 192.Slits 280 are configured to frictionally engagesutures 264 placed into the slits, allowing eachsuture 264 to be placed invalve annulus 216, drawn out of the chest and placed in one ofslits 280 until all of the sutures have been placed Other aspects of suture organizer 279 are described in copending application Ser. No. 08/485,600, which has been incorporated herein by reference. - In the case of certain bioprosthetic valves and other types of replacement valves, techniques may be used for securing the valve to the heart which do not require a plurality of sutures to be placed in
valve annulus 216. For example, some tissue valves are secured using a single continuous length of suture to make a running stitch around the sewing ring of the replacement valve. In other cases, staples, clips or other fastening devices may be used to secure the replacement valve to the native annulus or adjacent tissue. In such cases, it may be unnecessary to place sutures or other fasteners invalve annulus 216 until after the replacement valve has been introduced into the chest and positioned at the aortic valve position. - With all of
sutures 264 placed invalve annulus 216 and the ends ofsutures 264 organized outside of the chest, each suture is placed throughsewing ring 286 ofprosthetic valve 288, which is held by adelivery handle 290. Delivery handle 290 has an elongatedshaft 291 and ahandle 293 at its proximal end, and may be the same handle used invalve sizing device 250 described above in reference to FIG. 16, with sizingdisk 258 removed fromtongue 254.Prosthetic valve 288 is releasably held on aholder 292 which includes a slot or aperture (not shown) configured to receive a tongue ondelivery handle 290 similar totongue 254 onvalve sizing device 250. Various other details concerning the construction ofdelivery handle 290,prosthetic valve 288, andholder 292 are described in copending application Ser. No. 08/281,962 and application Ser. No. 08/485,600, which have been incorporated herein by reference. A needle driver of conventional construction is used to grasp each ofneedles 266 and drive it throughsewing ring 286. After each needle is driven through the sewing ring, it is secured by means of ahemostat 294 or by placement in a suture organizer positioned on or near the patient's chest. -
Delivery handle 290 is configured to allowprosthetic valve 288, mounted toholder 292, to be delivered through an intercostal access port with minimal retraction of the ribs. If theannular sewing ring 286 has a central axis extending through it (generally defining the direction of blood flow through the valve), delivery handle 290 preferably holdsprosthetic valve 288 in an orientation in which the central axis ofsewing ring 286 is generally perpendicular to the longitudinal axis ofshaft 291, wherein the prosthetic valve, holder, and delivery handle have a minimum profile in a direction perpendicular to the longitudinal axis ofshaft 291. This will allowprosthetic valve 288 to be delivered through an intercostal space without removing or cutting the ribs or the sternum, and, in most patients, without retracting the ribs. Certain types of prosthetic valves, particularly tissue valves, may have a larger profile. due to the height of the valve commissures. However, even for these prosthetic valves, delivery handle 290 is adapted to hold the prosthetic valve in an orientation of minimum profile, allowing the prosthetic valve to be positioned into the chest with minimal retraction of the ribs, usually with less than about 10 mm of retraction of each rib from its natural, undetected position, and preferably less than about 5 mm from the rib's natural, undeflected position. - To facilitate positioning
prosthetic valve 288 through an intercostal space without interference with the ribs or tissue of the chest wall, the prosthetic valve is placed throughinner lumen 212 ofaccess port 192, as illustrated in FIG. 20.Inner lumen 212 is specially adapted to allowprosthetic valve 288 to pass through it in an edge-first orientation. Preferably, the prosthetic valve is positioned throughlumen 212 such that the central axis ofsewing ring 286 is generally perpendicular to the longitudinal axis ofinner lumen 212. At the same time, the overall profile ofaccess port 192 is minimized so as to require an incision in the chest wall of minimum size. In a preferred embodiment, the cross-section ofinner lumen 212 in a direction perpendicular to its longitudinal axis has a cross-sectional length which is substantially greater than its cross-sectional width, with an oval, rectangular, racetrack, elliptical, or other shape suitable for passage ofprosthetic valve 288 in the edge-first orientation illustrated. The cross-sectional length will be just larger than the outer diameter ofsewing ring 286, usually 17-35 mm, and the cross-sectional width will be just larger than the height of the valve parallel to the central axis ofsewing ring 286, ranging from about 5-25 mm for mechanical valves, to about 15-30 mm for tissue valves. - Of course, a variety of other devices may be used to retract the chest wall tissue to allow
prosthetic valve 288 to be introduced into the chest, including a soft tissue retractor designed to atraumatically retract tissue adjacent to an intercostal incision to create an opening in the chest without retracting the ribs. Alternatively, a conventional retractor with a pair of movable parallel rigid blades may be positioned in an intercostal incision parallel to the ribs, the distance between the blades being adjustable to create an opening in the intercostal space of a desired width. Such an adjustable retractor may be desirable where the height and outer diameter of the prosthetic valve are both larger than the distance between the ribs in the intercostal space through which the prosthetic valve is to be positioned, as may be the case with certain types of tissue valves. In this way, the ribs may be slightly retracted temporarily to allow the prosthetic valve to be positioned into the chest, and the retractor then re-adjusted to allow the ribs to return to their natural, undeflected positions for the remainder of the procedure, thus minimizing the trauma associated with such retraction. - As
prosthetic valve 288 is advanced into the chest, tension is maintained onsutures 264 by means ofhemostats 294 or an assistant's hands so thatsewing ring 286 slides alongsutures 264 towardaortic valve annulus 216. Delivery handle 290 has a length sufficient to allowprosthetic valve 288 to be positioned at the native aortic valve position in the heart withhandle 293 remaining outside the chest,shaft 291 preferably having a length of at least about 15 cm. Once inside the chest,prosthetic valve 288 may be reoriented into an orientation suitable for securing the valve tovalve annulus 216, i.e., an orientation in whichsewing ring 286 may be positioned parallel to and axially-aligned with valve annulus 216 (illustrated in FIG. 21). Such reorientation may be accomplished by simply removingprosthetic valve 288 fromdelivery handle 290, but is preferably accomplished by pivotingprosthetic valve 288 relative toshaft 291 by sliding anactuator button 296 onhandle 293. This pivots a tongue at the distal end ofshaft 291 to whichholder 292 andprosthetic valve 288 are attached, in a manner like that described above with reference tovalve sizing device 250 of FIG. 16 (and described in copending application Ser. No. 08/485,600, which has been incorporated herein by reference). Usually,prosthetic valve 288 is reoriented such that the central axis ofsewing ring 286 is generally parallel to the longitudinal axis ofshaft 291 plus or minus about 30°, although the exact angular orientation may vary according to the location ofaccess port 192 and patient anatomy. -
Prosthetic valve 288 is positioned adjacent to thevalve annulus 216 and then released fromdelivery handle 290, which may then be removed from the chest, as illustrated in FIG. 21.Prosthetic valve 288 is preferably released by cutting a suture (not shown) on bolder 292 as frequently provided on conventional prosthetic valve holders. This allows a movable portion ofholder 292 to pivot away fromsewing ring 286, releasing the prosthetic valve from the holder, as described in greater detail in copending application Ser. No. 08/281,962, which has been incorporated herein by reference. - Referring now to FIG. 22,
knots 300 are formed in each ofsutures 264 outside of the chest, and athoracoscopic knot pusher 302 is used to pushknots 300 alongsutures 264 throughlumen 212 ofaccess port 192, throughaortotomy 184 and againstsewing ring 286 ofprosthetic valve 288.Knot pusher 302 preferably has an elongatedshaft 303 to which is attached ahead 304 with a convex curvature on itsdistal end 306 and a pair ofaxial channels 308, 310 along its lateral sides, as described in copending application Ser. No. 08/288,674, filed Aug. 10, 1994, which is hereby incorporated herein by reference. One end of each suture is threaded throughchannel 308, aknot 300 is formed in the suture distally ofhead 304, and the other end of the suture is positioned in channel 310. While holding the ends ofsuture 264 in tension,knot pusher 302 is advanced towardprosthetic valve 288, engagingknot 300 withdistal end 306 and sliding the knot alongsuture 264 until it is againstsewing ring 286. Several knots are formed in each suture in this manner. The ends ofsutures 264, along withneedles 266, are then trimmed off aboveknots 300, using thoracoscopic angledscissors 194 or other suitable cutting device. - With
prosthetic valve 288 successfully secured in the aortic valve position, themovable leaflets 312 may be tested for proper action by inserting a probe (not shown) through an access port and exerting a gentle force against the outer edges of the leaflets. The probe may comprise an elongated shaft with an atraumatic tip of a soft elastomer suitable for contacting the valve leaflets, like that described in copending application Ser. No. 08/485,600, which has been incorporated herein by reference. Alternatively, the probe may include an inner lumen extending to a port at its distal end, the inner lumen being adapted for connection to a source of suction outside the chest, whereby suction may be applied to the valve leaflets to test for proper opening and closing. - If
leaflets 312 are functioning properly,aortotomy 184 may be closed. This may be accomplished, as illustrated in FIG. 23, by suturing the opposing edges of the aortic incision together using a conventional running stitch applied by means ofthoracoscopic needle drivers 206 positioned throughaccess ports aortotomy 184. - While
aortotomy 184 is being closed, it will usually be desirable to remove any air from within the left ventricle and ascendingaorta 186 upstream ofaortic clamp 136. This is accomplished by first reducing venous drainage of the heart viavenous cannula 22 to allow blood to flow from the right side of the heart into the left ventricle, thereby filling the left ventricle with blood. This forces air out of the left ventricle into the ascending aorta. Preferably, the patient will be positioned so that the superior or anterior aspect of the aortic arch is upward so that any air collects at a point where it can be suctioned out throughdelivery cannula 176. An irrigation fluid such as saline may also be delivered throughdelivery cannula 176 into the ascending aorta and left ventricle to assist in displacing air to the upper part of the ascending aorta neardelivery cannula 176. Additionally, thoracoscopic instruments may be positioned through intercostal access ports to depress and collapse the heart, forcing out any air in the left ventricle. Heart manipulation devices may also be positioned through an access port to lift and/or rotate the heart so that any air tends to flow through the aortic valve into the ascending aorta, where it may be suctioned out. Further, small needles may be used to aspirate air from the left ventricle and/or aorta. - In an alternative technique of keeping air out of the heart during the procedure, the chest cavity may be flooded with a gas such as carbon dioxide at the outset6 fthe procedure to prevent any air from entering the chest through the access ports. A gas delivery tube may be introduced through an intercostal access port, or a gas delivery lumen may be provided in a wall of the one of the access ports themselves through which the gas is delivered. To facilitate maintaining the gas within the chest, the access ports may be provided with gaseous seals such as those commonly used in laparoscopic trocar sleeves which provide a gas-tight seal both when an instrument is introduced through the port, as well as when the instrument is removed. These and other techniques for removing air from the heart and aorta are disclosed in copending application Ser. No. 08/585,871, filed Jan. 12, 1996, entitled “Methods and Apparatus for Preventing Air Embolism When Performing A Procedure On A Patient's Cardiovascular System,” which is incorporated herein by reference.
- With de-airing complete, cardiac function may be allowed to resume. The patient's head is temporarily tilted head-down to prevent emboli from entering the cerebral circulation. Aortic clamp136 (or other aortic occlusion device) is removed from ascending
aorta 186 to allow oxygenated blood delivered viaarterial return cannula 26 to flow into the ascending aorta and into the coronary arteries. To removeclamp 136, clamp applier 140 (FIGS. 7-8) is reintroduced into the chest viaaccess port 192, andproximal extremities applier jaws 162 and actuated so as to releaselocking mechanism 148, allowingjaws Clamp 136 is then withdrawn from the chest cavity. Oxygenated blood is then permitted to flow through the coronary arteries to perfuse the myocardium, whereupon cardiac contractions will quickly resume. In the event that cardiac function does not return spontaneously, electrical defibrillation may be utilized to restore normal heart beat. Defibrillation electrodes may be placed on the heart via intercostal access ports, or external paddles of conventional construction may be used on the surface of the chest, and an electrical charge may then be delivered to stimulate the heart. - When cardiac contractions have resumed, it may still be desirable to maintain suction through
delivery cannula 176 so as to remove any air or other emboli which may be present in the aorta or left ventricle. When it is believed that such emboli are no longer present,delivery cannula 176 is removed from ascendingaorta 186 and purse-string suture 182 (FIG. 8) is tightened securely and knotted to close the puncture in the aortaThoracoscopic needle drivers 206 may be used for this purpose. Thoracoscopic scissors are then used to trim the ends of purse-string suture 182. - The patient is then weaned from cardiopulmonary bypass in the conventional manner, and
venous cannula 22,arterial return cannula 24,coronary sinus catheter 52, any other catheters utilized in the procedure, andaccess port - While the invention has been described in the context of aortic valve replacement, various other procedures may be performed using the methods of the invention, including repair or replacement of the mitral, pulmonary or tricuspid valves; repair of atrial and ventricular septal defects and patent ductus arteriosus by means of stapling, suturing or patch-applying instrument positioned into the heart; transmyocardial revascularization by means of a laser introduced into the heart; electrophysiological mapping and ablation by means of a mapping and ablation catheter positioned into the heart; performance of a Cox maze procedure by means of a cutting or ablation device positioned in the heart for transecting the atrial wall to correct atrial fibrillation; and pulmonary embolectomy by positioning a embolus-removal device into the pulmonary artery. Advantageously, in each such procedure, all instruments may be introduced into the heart either through intercostal access ports or via blood vessels with the surgeon's hands outside the chest, eliminating the need for a median sternotomy or other form of gross thoracotomy.
- Another exemplary embodiment of a delivery handle for positioning either a sizing disk or a replacement valve through an intercostal access port and into the native valve position is illustrated in FIGS.24-26. In this embodiment, delivery handle 320 comprises a
shaft 322 having adistal end 324 and aproximal end 326. A sizing disk or a holder for releasably holding a replacement valve, represented schematically bycylindrical element 328, is pivotably mounted todistal end 324 by atransverse pin 330. (A pair of finger grips 332 are fixed toshaft 322 nearproximal end 326, and anend cap 334 is slidably received overproximal end 326. - As shown in FIG. 26, a
rod 336 extends through aninner lumen 338 inshaft 322.Rod 336 has aproximal end 340 fixed to endcap 334, and adistal end 342 rotatably pinned toelement 328 at a point laterally offset fromtransverse pin 330. Aspring 344 is disposed within abore 346 withinend cap 334 and engages the proximal end ofshaft 322 to biasend cap 334 androd 336 in the proximal direction. In this way,element 328 may be pivoted relative toshaft 322 by pushingend cap 334 distally with the thumb while the fingers are placed against finger grips 332.Element 328 is usually rotatable through an angle of at least about 45°, and preferably at least about 90°, relative toshaft 322. In a preferred embodiment, delivery handle 320 is configured to positionelement 328 in an orientation suitable for introduction through an intercostal access port without removing, cutting, or significantly retracting the ribs. As illustrated in FIG. 25,element 328 is preferably movable into an orientation in which the central axis AA extending axially throughcylindrical element 328 is generally perpendicular +/−20° relative to the longitudinal axis LA ofshaft 322. In this way, the profile of delivery handle 320 together withelement 328 as seen from the distal end of the device is minimized.Element 328—whether a sizing disk or replacement valve—may be introduced through an intercostal access port (such asaccess port 192 of FIGS. 7-24) in the orientation of FIG. 25 by maintaining pressure againstend cap 334. Once inside the chest,end cap 334 may be released, allowingelement 328 to return to the orientation of FIG. 24, wherein the element is in a suitable orientation for alignment with the native valve annulus for either sizing the annulus or implanting the replacement valve. Usually,element 328 will be oriented such that central axis AA is at an angle of between −45° and 45°, and preferably about 0°+/−20°, relative to the longitudinal axis LA ofshaft 322. - FIGS.27-29 illustrate an additional embodiment of an access port for retraction of tissue within an intercostal space so as to provide an open passageway through which a replacement valve may be positioned into the chest.
Access port 350 comprises atubular body 352 having anaxial passage 354 configured to allow a replacement valve to be positioned through it without contacting the inner walls of the axial passage.Tubular body 352 is a metal or biocompatible polymer with sufficient rigidity to retract intercostal tissue and to retain a shape suitable for positioning a replacement valve through the axial passage into the chest.Axial passage 354 preferably has a cross-sectional shape suitable for introducing a replacement valve or sizing disk through it in the edge-first orientation illustrated in FIG. 25, such as oval, elliptical, racetrack, rectangular, trapezoidal, or other suitable shape.Axial passage 354 will have a cross-sectional width orthogonal to a central axis AX of less than about 30 mm, usually about 10 mm-25 mm, and preferably about 15 mm-20 mm. The cross-sectional length ofaxial passage 354 orthogonal to central axis AX will be larger than the outer diameter of the replacement valve utilized, and usually substantially larger than the cross-sectional width of the axial passage, usually being about 15 mm-50 mm, and preferably being about 25 mm-40 mm.Tubular body 352 has an exterior shape and dimensions suitable forpositioning access port 350 in an intercostal space without cutting or removing the ribs, and preferably without significant retraction of the ribs from their natural, undeflected positions (e.g. less than about 10 mm of retraction). In an exemplary configuration, the outer surface oftubular body 352 has a shape corresponding to that ofaxial passage 354 with a wall thickness therebetween of about 0.25-2 mm, preferably 0.75-1.25 mm. Of course, the exact size and shape oftubular body 352 will be determined by the size and shape of the replacement valve to be utilized in the procedure. -
Access port 350 may further include aflange 356 on its proximal end which engages the outer surface of the patient's chest. A suture organizer 358 is preferably mounted toflange 356, and includes anannular wall 360 with a plurality ofradial slits 362 in spaced-apart locations around its circumference. Eachslit 362 is configured to receive a suture thread and frictionally retain it as described above in connection with FIGS. 18-19. -
Access port 350 additionally includes aretention mechanism 364 mounted to a distal extremity oftubular body 352 for retaining the access port in the chest wall. As illustrated in FIG. 28,retention mechanism 364 comprises asleeve 366 slidably mounted ontubular body 352 and coupled toflange 356 by a pair of tension springs 368, which may be elastomeric bands or cords. Aretention element 370 is mounted near the distal end ofsleeve 366 and is collapsible for introduction through an intercostal space in the chest wall, and then expandable into a configuration in which the retention element engages the inner wall of the chest. In the exemplary configuration illustrated in the figures,retention element 370 comprises a continuousflexible band 372 which extends through two pairs ofslots 374 on opposing sidewalls ofsleeve 366 forming twoinner loops 376 in the interior ofsleeve 366 and twoouter loops 378 exterior tosleeve 366.Band 372 is preferably a resilient, flexible metal, plastic or elastomer which is biased into a fully expanded oval or circular ring shape. By compressingouter loops 378 radially inward towardsleeve 366, a portion ofband 372 slides throughslots 374, enlarginginner loops 376 and collapsingouter loops 378 into the configuration illustrated in FIG. 28. To, expandouter loops 378, inner loops are pushed outwardly againstsleeve 366. - An assembly view of
access port 350 is illustrated in FIG. 29.Annular wall 360 has a plurality ofopenings 380 formed around its circumference. Aninsert assembly 382 has asupport ring 383 with a plurality ofelastomeric inserts 384 attached thereto and configured to fit intoopenings 380. A lower end of eachinsert 384 is configured to be received in one of a plurality of slots (not shown) inflange 356 aligned with eachopening 380. Eachinsert 384 has an enlargedlower end 386 which engages the lower surface offlange 356 to retain the insert withinopening 380. In this way, the adjacent surfaces ofinserts 384 andwall 360 withinopenings 380 form radial slits 362 (FIG. 27).Inserts 384 will preferably have sufficient compliance to deflect slightly as a suture thread is drawn intoslit 362, and sufficient resilience to maintain pressure against the thread to retain it in the slit. - Also attached to support
ring 383 are tension springs 368, which may comprise resilient elastomeric bands or cords, extending distally through a pair of appropriately aligned slots (not shown) inflange 383.Sleeve 366 has a pair ofears 388 at its proximal end with axial passages through which tension springs 368 may extend. Eachtension spring 368 has a flange orledge 390 at its distal end which retains the tension spring inear 388. - To facilitate expanding and collapsing
retention element 370, the invention provides a specialized obturator for use withaccess port 350, illustrated in FIGS. 30-31.Obturator 392 has ashaft 394 shaped to occludeaxial passage 354 ofaccess port 350. Adistal end 396 ofshaft 394 is tapered to facilitate introduction through a puncture or incision in the chest wall. Ahandle 398 is fixed to the proximal end ofshaft 394. A pair ofhooks 400 are movably coupled toshaft 394 neardistal end 396 and form a distally-openU-shaped channel 401 configured to receiveinner loops 376 ofband 372. As illustrated in FIGS. 31A-31B, hooks 400 are mounted to a pair ofactuators 402 pivotably mounted to handle 398 by apin 404 such thatactuators 402 move in a scissors-like manner.Actuators 402 each have an outwardly extendingbutton 406 which extends through anaperture 408 inhandle 398.Actuators 402 are biased outwardly by a torsion orU-shaped spring 410. In this way, pressingbuttons 406 inwardly moveshooks 400 from the outward position illustrated in FIG. 31A to the inward position illustrated in FIG. 31B. -
Obturator 392 further includes alocking mechanism 412 comprising apivotable locking button 414 mounted within anopening 416 inhandle 398. Lockingbutton 414 has afoot 418 extending from a distal surface thereof. Each ofactuators 402 has anotch 420 on a proximal surface thereof which is configured to receivefoot 418. Atorsion spring 422biases locking button 414 in a clockwise direction. When actuators 402 are pivoted inwardly,foot 418 slides along the proximal surfaces ofactuators 402 untilnotches 420 are aligned. This allowsfoot 418 to slide intonotches 420, lockingactuators 402 in the inward position, as shown in FIG. 31B. The locking mechanism is released by pushing on the proximal surface oflocking button 414 on the side opposite that offoot 418, pivotinglocking button 414 counterclockwise to removefoot 418 fromnotches 420. - In use,
obturator 392 is positioned inaxial passage 354 ofaccess port 350 such that hooks 400 extend aroundinner loops 376 ofband 372 to position the band inchannels 401.Buttons 406 are then pressed inwardly, drawinginner loops 376 inwardly and collapsingouter loops 378 against the outer surface ofsleeve 366.Access port 350 may then be positioned through an incision or puncture through the chest wall between two ribs. Whenband 372 is inside the chest cavity, lockingbutton 414 is released, allowingactuators 402 and hooks 400 to return to the outward position.Outer loops 378 are thereby deployed into their expanded configuration, andobturator 392 may be removed fromaxial passage 354. Tension springs 368pull sleeve 366 towardflange 356 ontubular body 352, compressing the chest wall betweenband 372 andflange 356.Access port 350 is thus firmly held in position during the procedure. To remove the access port from the chest,obturator 392 is reinserted intoaxial passage 354 such that hooks 400 engageinner loops 376,buttons 406 are pressed inwardly to collapseouter loops 378, andaccess port 350 is withdrawn from the intercostal incision. - Referring now to FIGS.32-33, a preferred embodiment of a holder for an aortic valve prosthesis according to the invention will be described. As shown in FIG. 32,
holder 430 is attached to the distal end of delivery handle 320 in place ofelement 328, described above in connection with FIGS. 24-26.Holder 430 is pivotable relative toshaft 322 from a first orientation of minimum profile suitable for introduction through an intercostal space, to a second orientation suitable for aligning the prosthetic valve with the native valve annulus so that it may be secured thereto. Preferably, as described above, in the first orientation,holder 430 is positioned such that the central axis of the prosthetic valve sewing ring is generally perpendicular to the longitudinal axis ofshaft 322, as shown in phantom in FIG. 32. In the second orientation,holder 430 is preferably positioned so that the central axis of the prosthetic valve sewing ring is generally parallel to the longitudinal axis ofshaft 322. - A configuration of
holder 430 will be described which is appropriate for use with a mechanical bileaflet aortic valve prosthesis such as the St. Jude Medical Mechanical Aortic Valve. However, it will be understood to those of ordinary skill in the art thatholder 430 may be configured to accommodate a wide variety of prosthetic valves without departing from the scope of the invention. As shown in FIGS. 33A-33B,holder 430 is configured to holdprosthetic valve 432 from its downstream side withmovable valve leaflets 434 in their closed position. In this position,valve leaflets 434 form a V-shaped space within the interior of the valve surrounded byannular valve body 436 andsewing ring 438.Holder 430 therefore has a peaked or wedge-shapeddistal surface 440 with angled faces 441A, 441B forming an angle a of between about 90° and 150°, which fits within the V-shaped spaceadjacent valve leaflets 434. An annular rim orflange 442 is configured to abutannular sewing ring 438 ofprosthetic valve 432. Ahandle coupling 444 is attached to theproximal surface 446 ofholder 430 and is configured to be attached todelivery handle 320. Handle coupling 444 has atransverse channel 448 as shown in FIG. 33B configured to receive the distal end ofshaft 322. A pair ofholes handle coupling 444 acrosschannel 448 and may be aligned withholes rod 336,holder 430 pivots relative toshaft 320. -
Prosthetic valve 432 may be removably attached toholder 430 in various ways. In a preferred embodiment, sutures are placed throughsewing ring 438 and through bolder 430 and tied in order to secure the prosthetic valve to the holder. For this purpose,holder 430 may include holes, loops, eyelets or the like proximal torim 442 through which sutures may be placed. Alternatively,holder 430 may be made of a soft elastomeric material through which a suture needle may be driven to secure the suture to the holder. When it is desired to remove the prosthetic valve fromholder 430, the sutures are cut with scissors or a knife. - Certain prosthetic valves are designed to allow the valve body and valve leaflets to be rotated relative to the sewing ring of the prosthesis after the sewing ring has been secured to the heart. Advantageously, once
holder 430 has been removed fromprosthetic valve 432 and the prosthetic valve secured in the heart,holder 430 may be used to rotatevalve body 436 along withleaflets 434 byrepositioning holder 430 within the V-shaped space formed byleaflets 434 androtating handle 320 about its longitudinal axis. A flat 458 is provided along the two sides ofholder 430 which are positioned adjacent to side supports 459 ofprosthetic valve 432, allowing torque to be transmitted tovalve body 436 rather than to thefragile valve leaflets 434. - FIGS.34-36 illustrate an alternative embodiment of a holder according to the invention. In this embodiment ,
holder 460 is configured to hold a bi-leaflet mechanical valve from its upstream side for replacement of a diseased cardiac valve from the upstream side of the native valve, e.g., for replacement of the mitral valve via an incision in the left atrium as described in copending application Ser. No. 08/281,962 and Ser. No. 08/485,600, which have been incorporated herein by reference. As shown in FIG. 34,mechanical bileaflet valve 462 has a pair ofleaflets 464 movably attached to a pair of upwardly extending side supports 465 on anannular valve body 466. Asewing ring 468 is attached tovalve body 466.Leaflets 464 are pivotable between an open position wherein the leaflets are nearly parallel, to a closed position wherein the inner edges ofleaflets 464 abut one another and the curved outer edges of the leaflets abut the inner surface ofannular valve body 466. As shown in FIGS. 35-36,holder 460 is configured to be positioned on the upstream side ofvalve 462 withleaflets 464 in the open position.Holder 460 has adistal end 470 having a pair of crescent-shapedfeet 472 for positioning between the outer (upstream) surface of eachleaflet 464 and the inner surface ofvalve body 466. Anarcuate channel 474 extends acrossdistal end 470 betweenfeet 472 which accommodates side supports 465 and the inner ends ofleaflets 464. Arim 476 extends around the perimeter ofdistal end 470 which abutssewing ring 468 and/orvalve body 466.Holder 460 is adapted for attachment to delivery handle 320 by ahandle coupling 480 extending laterally from a proximal end of the holder. Handle coupling 480 has a pair ofholes -
Prosthetic valve 462 may be releasably attached toholder 460 in various ways. In a preferred technique,holder 460 is constructed of a soft elastomer which allows a suture needle to be driven through it. In this way, one or more sutures may be placed throughsewing ring 468 and throughholder 460 and tied to secure the valve to the holder. Alternatively,holder 460 may be a more rigid material and holes, eyelets, or loops may be mounted to the holder to which sutures may be secured. Whenvalve 462 is to be released, the sutures are simply cut. - An additional embodiment of an access port according to the invention is illustrated in FIGS. 3740. In this embodiment,
access port 490 comprises atubular cannula 492 having adistal end 494, aproximal end 496, and alumen 498 through which any of the replacement valves, valve holders and valve delivery devices described above may be positioned without interference. As described above in connection with FIGS. 27-29,lumen 498 is preferably oval-shaped, but the lumen may be any of a variety of shapes suitable for introducing a prosthetic valve into the chest with minimal retraction of the ribs.Cannula 492 has awall 500 constructed of a material having sufficient rigidity to retract intercostal tissue so as to provide an opening into the chest through which a replacement valve may be positioned. Arim 501 is provided atproximal end 496 which is adapted to engage the outer surface of the chest. An obturator (not shown) removably positionable withinlumen 498 may also be provided to facilitate introduction through the chest wall. - As best seen in FIGS.38-39, a
channel 502 extends axially throughwall 500 betweenproximal end 496 anddistal end 494. A plurality of axially-extendingoptical fibers 504 are distributed aroundchannel 502 so as to surroundlumen 498 and are potted, bonded or other wise fixed withinchannel 502 such that distal ends 506 of the optical fibers are disposed neardistal end 494 of the cannula and are pointing generally in the distal direction.Optical fibers 504 extend proximally throughchannel 502, through anannular space 508 withinrim 501, and into aflexible cable 510 attached torim 501 that has a protective,opaque jacket 511 surrounding the optical fibers. Anoptical coupling 512 is fixed to the free end ofcable 510 and is configured to be coupled to a conventional fiber optic light source of the type used for fiber optic lighting in endoscopes and the like, allowing light to be transmitted from the light source throughoptical fibers 504 and emitted from their distal ends 506. - In use,
cannula 492 is positioned within a small incision between two ribs such thatdistal end 494 is within the chest cavity. Coupling 512 is connected to a light source so that light is emitted fromoptical fibers 504 so as to illuminate the chest cavity. Various surgical procedures may then be performed within the chest using instruments positioned throughlumen 498 or through other access ports under the illumination provided byoptical fibers 504. For example, the various steps of an aortic valve replacement procedure as described above may be performed under illumination provided byaccess port 490. Advantageously,access port 490 may be positioned in alignment with the aortic valve to provide the optimum angle of illumination, while at the same time providing the optimum angle of approach to the valve for introduction of instruments, valve sizers, and the prosthetic valve itself throughlumen 498. The provision ofoptical fibers 504 onaccess port 490 may thereby eliminate the need for a separate light source within the body cavity for much of the procedure, reducing the number of access ports that are required. -
Optical fiber 504 may be mounted to accessport 490 in various ways. In addition to the annular arrangement of FIGS. 37-40,optical fibers 504′ may also be mounted along one side oflumen 498′, in a crescent-shapedchannel 516 extending throughcannula 492′, as shown in FIG. 41. Multiple channels (not shown) may extend along two or more sides oflumen 498 among whichoptical fibers 504 may be distributed. Alternatively, as shown in FIGS. 42A-42B, instead of mounting optical fibers to the access port, an openaxial channel 518 may extend throughcannula 492″ through which an endoscopic light wand or thoracoscope (not shown) having a light source mounted to it may be slidably inserted into the body cavity alongsidelumen 498″. - The access ports of FIGS.37-42 may also include any of the features of the access ports described above in connection with FIGS. 27-29, including having a suture organizer mounted to the proximal end of the access port for retaining sutures in an organized manner around
lumen 498, or having a selectively deployable retention device mounted near the distal end of the access port for engaging the inner wall of the chest (or other body cavity) to maintain the access port in position. - While the above is a complete description of the preferred embodiments of the invention, various alternatives, substitutions, modifications and improvements are possible without departing from the scope hereof, which is defined by the following claims.
Claims (20)
1. A method of accessing an internal chamber of the heart through a vessel having a lumen in fluid communication with the chamber, the heart and the vessel being within a patient's chest defined by a plurality of ribs connected to a sternum, the method comprising:
positioning an instrument into an inner lumen of the vessel through a penetration in a wall thereof, a proximal end of the instrument extending out of the patient's chest through a percutaneous access port between two adjacent ribs; and
manipulating the proximal end of the instrument to advance a distal end of the instrument through the vessel and into the internal chamber of the heart;
wherein all manipulations of the instrument are performed outside of the patient's chest.
2. The method of claim 1 wherein the vessel comprises an aorta and the internal chamber comprises a left ventricle, the step of manipulating comprising passing the distal end of the instrument through an aortic valve disposed in an aortic position between the aorta and the left ventricle.
3. The method of claim 2 further comprising attaching a valve prosthesis at the aortic position.
4. The method of claim 3 wherein the instrument comprises a suturing instrument, further comprising applying sutures to an annulus of the aortic valve using the suturing instrument.
5. The method of claim 3 wherein the step of attaching a valve prosthesis comprises positioning the valve prosthesis through a percutaneous access port between two adjacent ribs.
6. The method of claim 3 wherein the valve prosthesis is positioned at the aortic position using a delivery handle removably coupled to the valve prosthesis, the delivery handle being manipulated at a proximal end thereof which extends out of the patient's chest through a percutaneous access port between two adjacent ribs.
7. The method of claim 3 further comprising positioning the valve prosthesis through a percutaneous access port in a first orientation and re-orienting the valve prosthesis within the patient's chest into a second orientation before attachment at the aortic position.
8. The method of claim 7 wherein the step of re-orienting comprises manipulating from outside of the patient's chest an actuator on a delivery handle releasably coupled to the valve prosthesis.
9. The method of claim 7 wherein the second orientation is approximately perpendicular to the first orientation.
10. The method of claim 1 wherein all steps are performed without cutting or removing the ribs or sternum.
11. The method of claim 1 further comprising visualizing the vessel through a visualization device positioned in a percutaneous access port between two adjacent ribs.
12. The method of claim I further comprising forming an incision in the vessel using a cutting tool manipulated from outside of the patient's chest.
13. The method of claim 12 further comprising retracting the incision open before positioning the instrument in the vessel lumen.
14. The method of claim 2 wherein the percutaneous access port is positioned in an intercostal space selected from the first, second, third, or fourth intercostal space on an anterior side of the patient's chest.
15. The method of claim 1 wherein the percutaneous access port comprises a cannula having a proximal end outside of the patient's chest, a distal end within th patient's chest exterior to the vessel, and a passage therebetween through which the instrument is positioned.
16. In a valve replacement procedure, a method of positioning a replacement valve in a patient's heart within a patient's chest, the chest being defined by a plurality of ribs, the method comprising:
positioning an access device in the chest between two adjacent ribs, the access device defining an opening into the chest between the ribs and having and an illuminating device mounted adjacent to the opening;
illuminating the interior of the chest with the illuminating the device; and
introducing the replacement valve into the patient's chest through the opening.
17. In a valve replacement procedure, a method of positioning a replacement valve in a patient's heart within a patient's chest, the chest being defined by a plurality of ribs, the method comprising:
positioning the distal end of an illuminating device within the chest through a percutaneous access port between two adjacent ribs;
illuminating the interior of the chest with the illuminating the device; and
introducing the replacement valve into the patient's chest through a percutaneous access port between two adjacent ribs while illuminating the interior of the chest with the illuminating device.
18. An access device for providing a percutaneous passage into a chest cavity through which a replacement cardiac valve may be positioned, the access device comprising:
a device body having proximal and distal ends, the distal end being positionable between two adjacent ribs into the chest, the device body being configured to displace tissue between the ribs so as to define an opening into the chest through which the replacement valve may be positioned without interference; and
an illumination device mounted to the device body so as to illuminate the interior of the chest.
19. An access cannula for providing a percutaneous passage into a chest cavity through which a replacement cardiac valve may be positioned the access cannula comprising:
a cannula body having proximal and distal ends, the distal end being positionable between two adjacent ribs into the chest, and having a lumen between the proximal and distal ends through which the replacement valve may be positioned into the chest; and
a light-conducting element mounted to the cannula body and extending from outside the chest to the distal end of the cannula body for illuminating the interior of the chest.
20. In a valve replacement procedure, a method of positioning a replacement valve in an aortic position of a patient's heart within a patient's chest, the aortic position being disposed between a left ventricle of the heart and an aorta leading away from the heart, the chest being defined by a plurality of ribs connected to a sternum, the method comprising:
introducing the replacement valve into the patient's chest through a percutaneous access port between two adjacent ribs; and
positioning the replacement valve through a penetration in the aorta and into the aortic position by manipulating a valve-positioning instrument which engages the replacement valve, wherein all manipulation of the valve-engaging instrument is performed outside of the chest.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/662,727 US20040073301A1 (en) | 1993-02-22 | 2003-09-15 | Less-invasive devices and methods for cardiac valve surgery |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/023,778 US5452733A (en) | 1993-02-22 | 1993-02-22 | Methods for performing thoracoscopic coronary artery bypass |
US08/163,241 US5571215A (en) | 1993-02-22 | 1993-12-06 | Devices and methods for intracardiac procedures |
US28196294A | 1994-07-28 | 1994-07-28 | |
US48560095A | 1995-06-07 | 1995-06-07 | |
US08/486,941 US5799661A (en) | 1993-02-22 | 1995-06-07 | Devices and methods for port-access multivessel coronary artery bypass surgery |
US08/594,870 US6010531A (en) | 1993-02-22 | 1996-01-31 | Less-invasive devices and methods for cardiac valve surgery |
US09/416,492 US6651671B1 (en) | 1993-02-22 | 1999-10-12 | Lens-invasive devices and methods for cardiac valve surgery |
US10/662,727 US20040073301A1 (en) | 1993-02-22 | 2003-09-15 | Less-invasive devices and methods for cardiac valve surgery |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/486,941 Continuation-In-Part US5799661A (en) | 1993-02-22 | 1995-06-07 | Devices and methods for port-access multivessel coronary artery bypass surgery |
US09/416,492 Continuation US6651671B1 (en) | 1993-02-22 | 1999-10-12 | Lens-invasive devices and methods for cardiac valve surgery |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040073301A1 true US20040073301A1 (en) | 2004-04-15 |
Family
ID=24380760
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/594,870 Expired - Lifetime US6010531A (en) | 1993-02-22 | 1996-01-31 | Less-invasive devices and methods for cardiac valve surgery |
US09/416,492 Expired - Fee Related US6651671B1 (en) | 1993-02-22 | 1999-10-12 | Lens-invasive devices and methods for cardiac valve surgery |
US10/662,727 Abandoned US20040073301A1 (en) | 1993-02-22 | 2003-09-15 | Less-invasive devices and methods for cardiac valve surgery |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/594,870 Expired - Lifetime US6010531A (en) | 1993-02-22 | 1996-01-31 | Less-invasive devices and methods for cardiac valve surgery |
US09/416,492 Expired - Fee Related US6651671B1 (en) | 1993-02-22 | 1999-10-12 | Lens-invasive devices and methods for cardiac valve surgery |
Country Status (3)
Country | Link |
---|---|
US (3) | US6010531A (en) |
AU (1) | AU1582497A (en) |
WO (1) | WO1997027799A1 (en) |
Cited By (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030191479A1 (en) * | 2002-04-03 | 2003-10-09 | Thornton Sally C. | Body lumen closure |
US20040059411A1 (en) * | 2000-10-26 | 2004-03-25 | Strecker Ernst Peter | Implantable valve system |
US20040127848A1 (en) * | 2002-12-30 | 2004-07-01 | Toby Freyman | Valve treatment catheter and methods |
US20040230297A1 (en) * | 2002-04-03 | 2004-11-18 | Boston Scientific Corporation | Artificial valve |
US20050137676A1 (en) * | 2003-12-19 | 2005-06-23 | Scimed Life Systems, Inc. | Venous valve apparatus, system, and method |
US20050203614A1 (en) * | 2004-02-27 | 2005-09-15 | Cardiacmd, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US20060047338A1 (en) * | 2004-09-02 | 2006-03-02 | Scimed Life Systems, Inc. | Cardiac valve, system, and method |
US20060178550A1 (en) * | 2005-02-04 | 2006-08-10 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US20060247611A1 (en) * | 2005-04-29 | 2006-11-02 | Marwan Abboud | Wide area ablation of myocardial tissue |
US20070173861A1 (en) * | 2006-01-10 | 2007-07-26 | Mediguide Ltd. | System and method for positioning an artificial heart valve at the position of a malfunctioning valve of a heart through a percutaneous route |
US20070213582A1 (en) * | 2006-03-09 | 2007-09-13 | Zollinger Christopher J | Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ |
US20090099554A1 (en) * | 2006-06-20 | 2009-04-16 | Forster David C | Elongate Flexible Torque Instruments And Methods Of Use |
US20090259107A1 (en) * | 2008-04-11 | 2009-10-15 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US20090287060A1 (en) * | 2008-05-14 | 2009-11-19 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US20100161045A1 (en) * | 2008-12-23 | 2010-06-24 | Sorin Biomedica Cardio S.R.L. | Expandable prosthetic valve having anchoring appendages |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US20100256752A1 (en) * | 2006-09-06 | 2010-10-07 | Forster David C | Prosthetic heart valves, support structures and systems and methods for implanting the same, |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US20110024614A1 (en) * | 2006-10-19 | 2011-02-03 | Syft Technologies Limited | Sift-ms instrument |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US20110082539A1 (en) * | 2009-10-05 | 2011-04-07 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US7951189B2 (en) | 2005-09-21 | 2011-05-31 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US20110184400A1 (en) * | 2010-01-28 | 2011-07-28 | Medtronic Cryocath Lp | Triple balloon catheter |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
WO2011150222A1 (en) * | 2010-05-28 | 2011-12-01 | Salient Surgical Technologies, Inc. | Fluid- assisted electrosurgical devices, and methods of manufacture thereof |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US8163008B2 (en) | 2002-08-28 | 2012-04-24 | Heart Leaflet Technologies, Inc. | Leaflet valve |
WO2013036921A1 (en) * | 2011-09-08 | 2013-03-14 | Physcient, Inc. | Rib-protecting devices for thoracoscopic surgery, and related methods |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US8920492B2 (en) | 2005-02-10 | 2014-12-30 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US9049989B2 (en) | 2008-04-11 | 2015-06-09 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US9089423B2 (en) | 2010-05-10 | 2015-07-28 | Hlt, Inc. | Stentless support structure |
US9113911B2 (en) | 2012-09-06 | 2015-08-25 | Medtronic Ablation Frontiers Llc | Ablation device and method for electroporating tissue cells |
US9161836B2 (en) | 2011-02-14 | 2015-10-20 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9248017B2 (en) | 2010-05-21 | 2016-02-02 | Sorin Group Italia S.R.L. | Support device for valve prostheses and corresponding kit |
US9289289B2 (en) | 2011-02-14 | 2016-03-22 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9387031B2 (en) | 2011-07-29 | 2016-07-12 | Medtronic Ablation Frontiers Llc | Mesh-overlayed ablation and mapping device |
US9402610B2 (en) | 2009-04-13 | 2016-08-02 | Physcient, Inc. | Rib-protecting devices for thoracoscopic surgery, and related methods |
US9439760B2 (en) | 2005-05-27 | 2016-09-13 | Hlt, Inc. | Stentless support structure |
US9480565B2 (en) | 2015-02-02 | 2016-11-01 | On-X Life Technologies, Inc. | Rapid deployment artificial chordae tendinae system |
US9486314B2 (en) | 2013-03-15 | 2016-11-08 | Hlt, Inc. | Low-profile prosthetic valve structure |
US9622859B2 (en) | 2005-02-01 | 2017-04-18 | Boston Scientific Scimed, Inc. | Filter system and method |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US9867695B2 (en) | 2004-03-03 | 2018-01-16 | Sorin Group Italia S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US20200222184A1 (en) * | 2011-09-28 | 2020-07-16 | Medtronic CV Luxembourg S.a.r.l. | Distal tip assembly for a heart valve delivery catheter |
WO2021151028A1 (en) * | 2020-01-24 | 2021-07-29 | Children's Medical Center Corporation | Device for visualization of valve during surgery |
US11103350B2 (en) | 2016-06-01 | 2021-08-31 | On-X Life Technologies, Inc. | Pull-through chordae tendineae system |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
Families Citing this family (433)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6010531A (en) * | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
US5888247A (en) * | 1995-04-10 | 1999-03-30 | Cardiothoracic Systems, Inc | Method for coronary artery bypass |
US5894843A (en) | 1996-02-20 | 1999-04-20 | Cardiothoracic Systems, Inc. | Surgical method for stabilizing the beating heart during coronary artery bypass graft surgery |
CA2197614C (en) * | 1996-02-20 | 2002-07-02 | Charles S. Taylor | Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery |
US6290644B1 (en) | 1996-02-20 | 2001-09-18 | Cardiothoracic Systems, Inc. | Surgical instruments and procedures for stabilizing a localized portion of a beating heart |
US6852075B1 (en) * | 1996-02-20 | 2005-02-08 | Cardiothoracic Systems, Inc. | Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery |
US6183411B1 (en) | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US6077214A (en) | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6050936A (en) * | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6096037A (en) * | 1997-07-29 | 2000-08-01 | Medtronic, Inc. | Tissue sealing electrosurgery device and methods of sealing tissue |
US6390976B1 (en) * | 1997-09-17 | 2002-05-21 | Origin Medsystems, Inc. | System to permit offpump beating heart coronary bypass surgery |
US6889082B2 (en) * | 1997-10-09 | 2005-05-03 | Orqis Medical Corporation | Implantable heart assist system and method of applying same |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6033419A (en) * | 1998-05-15 | 2000-03-07 | Sulzer Carbomedics Inc. | Apparatus and method for cutting a heart valve annulus |
US6607541B1 (en) * | 1998-06-03 | 2003-08-19 | Coalescent Surgical, Inc. | Tissue connector apparatus and methods |
US6641593B1 (en) | 1998-06-03 | 2003-11-04 | Coalescent Surgical, Inc. | Tissue connector apparatus and methods |
US6613059B2 (en) | 1999-03-01 | 2003-09-02 | Coalescent Surgical, Inc. | Tissue connector apparatus and methods |
US6945980B2 (en) | 1998-06-03 | 2005-09-20 | Medtronic, Inc. | Multiple loop tissue connector apparatus and methods |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
DE69934318T2 (en) * | 1998-08-10 | 2007-07-05 | Coroneo Inc., Montreal | AS A RETRACTOR INSERTABLE SURGICAL SEAM WITH FASTENER |
US8118822B2 (en) * | 1999-03-01 | 2012-02-21 | Medtronic, Inc. | Bridge clip tissue connector apparatus and methods |
US6695859B1 (en) * | 1999-04-05 | 2004-02-24 | Coalescent Surgical, Inc. | Apparatus and methods for anastomosis |
US6231506B1 (en) | 1999-05-04 | 2001-05-15 | Cardiothoracic Systems, Inc. | Method and apparatus for creating a working opening through an incision |
AU5003100A (en) * | 1999-05-11 | 2000-11-21 | Craig Berky | Surgical clamp devices and methods especially useful in cardiac surgery |
US6488689B1 (en) | 1999-05-20 | 2002-12-03 | Aaron V. Kaplan | Methods and apparatus for transpericardial left atrial appendage closure |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US6511416B1 (en) | 1999-08-03 | 2003-01-28 | Cardiothoracic Systems, Inc. | Tissue stabilizer and methods of use |
US20030187461A1 (en) * | 1999-08-10 | 2003-10-02 | Chin Albert K. | Releasable guide and method for endoscopic cardiac lead placement |
US20030187460A1 (en) * | 1999-08-10 | 2003-10-02 | Chin Albert K. | Methods and apparatus for endoscopic cardiac surgery |
US6569082B1 (en) * | 1999-08-10 | 2003-05-27 | Origin Medsystems, Inc. | Apparatus and methods for cardiac restraint |
US7398781B1 (en) * | 1999-08-10 | 2008-07-15 | Maquet Cardiovascular, Llc | Method for subxiphoid endoscopic access |
US7264587B2 (en) * | 1999-08-10 | 2007-09-04 | Origin Medsystems, Inc. | Endoscopic subxiphoid surgical procedures |
US7597698B2 (en) * | 1999-08-10 | 2009-10-06 | Maquet Cardiovascular Llc | Apparatus and method for endoscopic encirclement of pulmonary veins for epicardial ablation |
US7526342B2 (en) * | 1999-08-10 | 2009-04-28 | Maquet Cardiovascular Llc | Apparatus for endoscopic cardiac mapping and lead placement |
US20040102804A1 (en) * | 1999-08-10 | 2004-05-27 | Chin Albert K. | Apparatus and methods for endoscopic surgical procedures |
US7288096B2 (en) * | 2003-01-17 | 2007-10-30 | Origin Medsystems, Inc. | Apparatus for placement of cardiac defibrillator and pacer |
US20060287574A1 (en) * | 1999-08-25 | 2006-12-21 | Chin Albert K | Longitudinal dilator |
US8529583B1 (en) | 1999-09-03 | 2013-09-10 | Medtronic, Inc. | Surgical clip removal apparatus |
US6506149B2 (en) | 1999-09-07 | 2003-01-14 | Origin Medsystems, Inc. | Organ manipulator having suction member supported with freedom to move relative to its support |
US6406424B1 (en) * | 1999-09-16 | 2002-06-18 | Williamson, Iv Warren P. | Tissue stabilizer having an articulating lift element |
US6626930B1 (en) * | 1999-10-21 | 2003-09-30 | Edwards Lifesciences Corporation | Minimally invasive mitral valve repair method and apparatus |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US6926730B1 (en) * | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
NL1014095C2 (en) * | 2000-01-17 | 2001-07-18 | Cornelis Hendrikus Anna Witten | Implant valve for implantation into a blood vessel. |
US6447443B1 (en) * | 2001-01-13 | 2002-09-10 | Medtronic, Inc. | Method for organ positioning and stabilization |
US6450951B2 (en) * | 2000-01-26 | 2002-09-17 | Genzyme Corporation | Suture organizing device for surgical retractor and methods related thereto |
US6872226B2 (en) * | 2001-01-29 | 2005-03-29 | 3F Therapeutics, Inc. | Method of cutting material for use in implantable medical device |
US7749245B2 (en) * | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US6719717B1 (en) * | 2000-03-17 | 2004-04-13 | Advanced Research & Technology Institute, Inc. | Thrombectomy treatment system and method |
US6551332B1 (en) * | 2000-03-31 | 2003-04-22 | Coalescent Surgical, Inc. | Multiple bias surgical fastener |
US20020107514A1 (en) * | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with parallel jaws |
US6546935B2 (en) | 2000-04-27 | 2003-04-15 | Atricure, Inc. | Method for transmural ablation |
US7083628B2 (en) * | 2002-09-03 | 2006-08-01 | Edwards Lifesciences Corporation | Single catheter mitral valve repair device and method for use |
US8366769B2 (en) | 2000-06-01 | 2013-02-05 | Edwards Lifesciences Corporation | Low-profile, pivotable heart valve sewing ring |
AU2001271667A1 (en) * | 2000-06-30 | 2002-01-14 | Viacor Incorporated | Method and apparatus for performing a procedure on a cardiac valve |
US6409758B2 (en) * | 2000-07-27 | 2002-06-25 | Edwards Lifesciences Corporation | Heart valve holder for constricting the valve commissures and methods of use |
SE0002878D0 (en) * | 2000-08-11 | 2000-08-11 | Kimblad Ola | Device and method of treatment of atrioventricular regurgitation |
US6776770B1 (en) | 2000-09-07 | 2004-08-17 | Advanced Research & Technology Institute | Thromboaspiration valve-filter device and methods |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6918917B1 (en) | 2000-10-10 | 2005-07-19 | Medtronic, Inc. | Minimally invasive annuloplasty procedure and apparatus |
US6974476B2 (en) * | 2003-05-05 | 2005-12-13 | Rex Medical, L.P. | Percutaneous aortic valve |
US7740623B2 (en) * | 2001-01-13 | 2010-06-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US7628780B2 (en) * | 2001-01-13 | 2009-12-08 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20040138621A1 (en) | 2003-01-14 | 2004-07-15 | Jahns Scott E. | Devices and methods for interstitial injection of biologic agents into tissue |
US6758808B2 (en) | 2001-01-24 | 2004-07-06 | Cardiothoracic System, Inc. | Surgical instruments for stabilizing a localized portion of a beating heart |
US20020107531A1 (en) * | 2001-02-06 | 2002-08-08 | Schreck Stefan G. | Method and system for tissue repair using dual catheters |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US7374571B2 (en) | 2001-03-23 | 2008-05-20 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of manufacture |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US20060293701A1 (en) * | 2001-05-02 | 2006-12-28 | Medtronic, Inc. | Self-closing surgical clip for tissue |
US7935145B2 (en) | 2001-05-17 | 2011-05-03 | Edwards Lifesciences Corporation | Annuloplasty ring for ischemic mitral valve insuffuciency |
ITMI20011012A1 (en) * | 2001-05-17 | 2002-11-17 | Ottavio Alfieri | ANNULAR PROSTHESIS FOR MITRAL VALVE |
US7846096B2 (en) | 2001-05-29 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Method for monitoring of medical treatment using pulse-echo ultrasound |
US20030032898A1 (en) * | 2001-05-29 | 2003-02-13 | Inder Raj. S. Makin | Method for aiming ultrasound for medical treatment |
WO2002098282A2 (en) * | 2001-06-04 | 2002-12-12 | Albert Einstein Healthcare Network | Cardiac stimulating apparatus having a blood clot filter and atrial pacer |
US8771302B2 (en) * | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
AU2002327219B2 (en) * | 2001-07-06 | 2009-04-23 | Syntach Ag | Anti-arrhythmia devices and methods of use |
US20030036698A1 (en) * | 2001-08-16 | 2003-02-20 | Robert Kohler | Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts |
US6908482B2 (en) | 2001-08-28 | 2005-06-21 | Edwards Lifesciences Corporation | Three-dimensional annuloplasty ring and template |
DK1423066T3 (en) | 2001-09-07 | 2008-11-17 | Mardil Inc | Method and apparatus for external cardiac stabilization |
US6616682B2 (en) * | 2001-09-19 | 2003-09-09 | Jomed Gmbh | Methods and apparatus for distal protection during a medical procedure |
US6942672B2 (en) | 2001-10-23 | 2005-09-13 | Vascor, Inc. | Method and apparatus for attaching a conduit to the heart or a blood vessel |
US20080249504A1 (en) | 2007-04-06 | 2008-10-09 | Lattouf Omar M | Instrument port |
US7201771B2 (en) | 2001-12-27 | 2007-04-10 | Arbor Surgical Technologies, Inc. | Bioprosthetic heart valve |
US8308797B2 (en) | 2002-01-04 | 2012-11-13 | Colibri Heart Valve, LLC | Percutaneously implantable replacement heart valve device and method of making same |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7967816B2 (en) | 2002-01-25 | 2011-06-28 | Medtronic, Inc. | Fluid-assisted electrosurgical instrument with shapeable electrode |
US7094244B2 (en) * | 2002-03-26 | 2006-08-22 | Edwards Lifesciences Corporation | Sequential heart valve leaflet repair device and method of use |
WO2003088809A2 (en) * | 2002-04-16 | 2003-10-30 | Viacor, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US20030199974A1 (en) * | 2002-04-18 | 2003-10-23 | Coalescent Surgical, Inc. | Annuloplasty apparatus and methods |
US7753858B2 (en) * | 2002-06-13 | 2010-07-13 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US8287555B2 (en) * | 2003-02-06 | 2012-10-16 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20060241656A1 (en) * | 2002-06-13 | 2006-10-26 | Starksen Niel F | Delivery devices and methods for heart valve repair |
US20050216078A1 (en) * | 2002-06-13 | 2005-09-29 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US8641727B2 (en) | 2002-06-13 | 2014-02-04 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20060122633A1 (en) * | 2002-06-13 | 2006-06-08 | John To | Methods and devices for termination |
EP1530441B1 (en) * | 2002-06-13 | 2017-08-02 | Ancora Heart, Inc. | Devices and methods for heart valve repair |
US7883538B2 (en) * | 2002-06-13 | 2011-02-08 | Guided Delivery Systems Inc. | Methods and devices for termination |
US7753922B2 (en) * | 2003-09-04 | 2010-07-13 | Guided Delivery Systems, Inc. | Devices and methods for cardiac annulus stabilization and treatment |
US20040243227A1 (en) * | 2002-06-13 | 2004-12-02 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7758637B2 (en) * | 2003-02-06 | 2010-07-20 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US9949829B2 (en) | 2002-06-13 | 2018-04-24 | Ancora Heart, Inc. | Delivery devices and methods for heart valve repair |
US7588582B2 (en) * | 2002-06-13 | 2009-09-15 | Guided Delivery Systems Inc. | Methods for remodeling cardiac tissue |
US9226825B2 (en) * | 2002-06-13 | 2016-01-05 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7666193B2 (en) * | 2002-06-13 | 2010-02-23 | Guided Delivery Sytems, Inc. | Delivery devices and methods for heart valve repair |
US7258694B1 (en) | 2002-06-17 | 2007-08-21 | Origin Medsystems, Inc. | Medical punch and surgical procedure |
US7241257B1 (en) * | 2002-06-28 | 2007-07-10 | Abbott Cardiovascular Systems, Inc. | Devices and methods to perform minimally invasive surgeries |
US7959674B2 (en) * | 2002-07-16 | 2011-06-14 | Medtronic, Inc. | Suture locking assembly and method of use |
US7155273B2 (en) * | 2002-07-29 | 2006-12-26 | Taylor Geoffrey L | Blanching response pressure sore detector apparatus and method |
US7297150B2 (en) | 2002-08-29 | 2007-11-20 | Mitralsolutions, Inc. | Implantable devices for controlling the internal circumference of an anatomic orifice or lumen |
US8758372B2 (en) * | 2002-08-29 | 2014-06-24 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
US8066724B2 (en) | 2002-09-12 | 2011-11-29 | Medtronic, Inc. | Anastomosis apparatus and methods |
US20040059413A1 (en) * | 2002-09-20 | 2004-03-25 | Claudio Argento | Suture template for facilitating implantation of a prosthetic heart valve |
US7217277B2 (en) * | 2002-09-30 | 2007-05-15 | Ethicon, Inc. | Device for providing intracardiac access in an open chest |
US7323004B2 (en) * | 2002-09-30 | 2008-01-29 | Ethicon, Inc. | Device for providing automatic stitching of an incision |
US20040092985A1 (en) * | 2002-09-30 | 2004-05-13 | Ethicon, Inc. | Device for providing thoracoscopic intracardiac access |
US8105345B2 (en) * | 2002-10-04 | 2012-01-31 | Medtronic, Inc. | Anastomosis apparatus and methods |
US7931590B2 (en) | 2002-10-29 | 2011-04-26 | Maquet Cardiovascular Llc | Tissue stabilizer and methods of using the same |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US20040102789A1 (en) * | 2002-11-22 | 2004-05-27 | Scimed Life Systems, Inc. | Selectively locking device |
US8551162B2 (en) * | 2002-12-20 | 2013-10-08 | Medtronic, Inc. | Biologically implantable prosthesis |
WO2004075789A2 (en) * | 2003-02-26 | 2004-09-10 | Cook Incorporated | PROTHESIS ADAPTED FOR PLACEDd UNDER EXTERNAL IMAGING |
WO2004078066A2 (en) | 2003-03-03 | 2004-09-16 | Sinus Rhythm Technologies, Inc. | Primary examiner |
EP1605866B1 (en) * | 2003-03-03 | 2016-07-06 | Syntach AG | Electrical conduction block implant device |
US20050015048A1 (en) * | 2003-03-12 | 2005-01-20 | Chiu Jessica G. | Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof |
US7250041B2 (en) * | 2003-03-12 | 2007-07-31 | Abbott Cardiovascular Systems Inc. | Retrograde pressure regulated infusion |
US7381210B2 (en) | 2003-03-14 | 2008-06-03 | Edwards Lifesciences Corporation | Mitral valve repair system and method for use |
US7399315B2 (en) | 2003-03-18 | 2008-07-15 | Edwards Lifescience Corporation | Minimally-invasive heart valve with cusp positioners |
US20050075659A1 (en) * | 2003-03-30 | 2005-04-07 | Fidel Realyvasquez | Apparatus and methods for minimally invasive valve surgery |
US7334064B2 (en) * | 2003-04-23 | 2008-02-19 | Dot Hill Systems Corporation | Application server blade for embedded storage appliance |
US7288092B2 (en) * | 2003-04-23 | 2007-10-30 | Atricure, Inc. | Method and apparatus for ablating cardiac tissue with guide facility |
DE602004018059D1 (en) | 2003-04-30 | 2009-01-15 | Medtronic Vascular Inc | Perivascular repair system for leaks |
EP1631233A2 (en) * | 2003-05-01 | 2006-03-08 | Sinus Rhythm Technologies, Inc. | Methods and devices for creating electrical block at specific targeted sites in cardia tissue |
US7704263B2 (en) * | 2003-07-02 | 2010-04-27 | Morris John K | Method and device for suture isolation |
US7993355B2 (en) * | 2003-07-02 | 2011-08-09 | Morris John K | Method and device for suture isolation |
US7479104B2 (en) | 2003-07-08 | 2009-01-20 | Maquet Cardiovascular, Llc | Organ manipulator apparatus |
US7182769B2 (en) * | 2003-07-25 | 2007-02-27 | Medtronic, Inc. | Sealing clip, delivery systems, and methods |
US8021421B2 (en) * | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US20050043749A1 (en) | 2003-08-22 | 2005-02-24 | Coalescent Surgical, Inc. | Eversion apparatus and methods |
US7534204B2 (en) * | 2003-09-03 | 2009-05-19 | Guided Delivery Systems, Inc. | Cardiac visualization devices and methods |
US7235042B2 (en) * | 2003-09-16 | 2007-06-26 | Acorn Cardiovascular, Inc. | Apparatus and method for applying cardiac support device |
US8394114B2 (en) * | 2003-09-26 | 2013-03-12 | Medtronic, Inc. | Surgical connection apparatus and methods |
US20050075713A1 (en) * | 2003-10-06 | 2005-04-07 | Brian Biancucci | Minimally invasive valve replacement system |
US7556647B2 (en) * | 2003-10-08 | 2009-07-07 | Arbor Surgical Technologies, Inc. | Attachment device and methods of using the same |
EP1682034B1 (en) * | 2003-10-09 | 2018-11-21 | Sentreheart, Inc. | Apparatus for the ligation of tissue |
WO2005039689A2 (en) * | 2003-10-24 | 2005-05-06 | Sinus Rhythm Technologies, Inc. | Methods and devices for creating cardiac electrical blocks |
US20060276684A1 (en) * | 2003-11-07 | 2006-12-07 | Giovanni Speziali | Device and method for treating congestive heart failure |
SE526861C2 (en) | 2003-11-17 | 2005-11-15 | Syntach Ag | Tissue lesion creation device and a set of devices for the treatment of cardiac arrhythmia disorders |
US7879047B2 (en) | 2003-12-10 | 2011-02-01 | Medtronic, Inc. | Surgical connection apparatus and methods |
US20050273138A1 (en) * | 2003-12-19 | 2005-12-08 | Guided Delivery Systems, Inc. | Devices and methods for anchoring tissue |
US7179224B2 (en) * | 2003-12-30 | 2007-02-20 | Cardiothoracic Systems, Inc. | Organ manipulator and positioner and methods of using the same |
US7871435B2 (en) | 2004-01-23 | 2011-01-18 | Edwards Lifesciences Corporation | Anatomically approximate prosthetic mitral heart valve |
US20050187545A1 (en) * | 2004-02-20 | 2005-08-25 | Hooven Michael D. | Magnetic catheter ablation device and method |
US9398967B2 (en) * | 2004-03-02 | 2016-07-26 | Syntach Ag | Electrical conduction block implant device |
US7976539B2 (en) | 2004-03-05 | 2011-07-12 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
US20050228494A1 (en) * | 2004-03-29 | 2005-10-13 | Salvador Marquez | Controlled separation heart valve frame |
US7530980B2 (en) * | 2004-04-14 | 2009-05-12 | Atricure, Inc | Bipolar transmural ablation method and apparatus |
US7473250B2 (en) * | 2004-05-21 | 2009-01-06 | Ethicon Endo-Surgery, Inc. | Ultrasound medical system and method |
EP1750608B1 (en) | 2004-06-02 | 2012-10-03 | Medtronic, Inc. | Ablation device with jaws |
US7806839B2 (en) * | 2004-06-14 | 2010-10-05 | Ethicon Endo-Surgery, Inc. | System and method for ultrasound therapy using grating lobes |
EP1809195A4 (en) * | 2004-10-08 | 2010-01-20 | Syntach Ag | Two-stage scar generation for treating atrial fibrillation |
US9387010B2 (en) | 2004-10-28 | 2016-07-12 | Nico Corporation | Surgical access assembly and method of using same |
US9186175B2 (en) | 2004-10-28 | 2015-11-17 | Nico Corporation | Surgical access assembly and method of using same |
US20070219630A1 (en) * | 2004-11-24 | 2007-09-20 | Xi Chu | Devices and Methods for Beating Heart Cardiac Surgeries |
US20060149121A1 (en) * | 2005-01-03 | 2006-07-06 | Hughett James D Sr | Instrument guide and method for use |
US8029528B2 (en) * | 2005-01-03 | 2011-10-04 | Atricure, Inc. | Instrument guide and method for use |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US8574257B2 (en) * | 2005-02-10 | 2013-11-05 | Edwards Lifesciences Corporation | System, device, and method for providing access in a cardiovascular environment |
US20060224110A1 (en) * | 2005-03-17 | 2006-10-05 | Scott Michael J | Methods for minimally invasive vascular access |
US8608797B2 (en) | 2005-03-17 | 2013-12-17 | Valtech Cardio Ltd. | Mitral valve treatment techniques |
EP1861045B1 (en) | 2005-03-25 | 2015-03-04 | St. Jude Medical, Cardiology Division, Inc. | Apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US8864823B2 (en) * | 2005-03-25 | 2014-10-21 | StJude Medical, Cardiology Division, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US7918865B2 (en) * | 2005-04-07 | 2011-04-05 | Sentreheart, Inc. | Apparatus and method for the ligation of tissue |
US7513909B2 (en) * | 2005-04-08 | 2009-04-07 | Arbor Surgical Technologies, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US7740627B2 (en) | 2005-04-29 | 2010-06-22 | Medtronic Cryocath Lp | Surgical method and apparatus for treating atrial fibrillation |
EP2901967B1 (en) | 2005-05-24 | 2019-10-02 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
US8083664B2 (en) | 2005-05-25 | 2011-12-27 | Maquet Cardiovascular Llc | Surgical stabilizers and methods for use in reduced-access surgical sites |
US20070088203A1 (en) * | 2005-05-25 | 2007-04-19 | Liming Lau | Surgical assemblies and methods for visualizing and performing surgical procedures in reduced-access surgical sites |
WO2006130505A2 (en) | 2005-05-27 | 2006-12-07 | Arbor Surgical Technologies, Inc. | Gasket with collar for prosthetic heart valves and methods for using them |
US8685083B2 (en) * | 2005-06-27 | 2014-04-01 | Edwards Lifesciences Corporation | Apparatus, system, and method for treatment of posterior leaflet prolapse |
US20070010780A1 (en) * | 2005-06-27 | 2007-01-11 | Venkataramana Vijay | Methods of implanting an aorto-coronary sinus shunt for myocardial revascularization |
EP1898840A1 (en) * | 2005-06-27 | 2008-03-19 | The Cleveland Clinic Foundation | Apparatus for placement in the annulus of a tricuspid valve |
US20070010781A1 (en) * | 2005-06-27 | 2007-01-11 | Venkataramana Vijay | Implantable aorto-coronary sinus shunt for myocardial revascularization |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US7776084B2 (en) * | 2005-07-13 | 2010-08-17 | Edwards Lifesciences Corporation | Prosthetic mitral heart valve having a contoured sewing ring |
US20070055206A1 (en) * | 2005-08-10 | 2007-03-08 | Guided Delivery Systems, Inc. | Methods and devices for deployment of tissue anchors |
US20070232941A1 (en) * | 2005-10-27 | 2007-10-04 | Stan Rabinovich | System, apparatus, and method for imaging and treating tissue |
US7874982B2 (en) * | 2005-11-02 | 2011-01-25 | Depuy Spine, Inc. | Illuminated surgical access system including a surgical access device and coupled light emitter |
US7632308B2 (en) * | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
WO2007100408A2 (en) | 2005-12-15 | 2007-09-07 | Georgia Tech Research Corporation | Papillary muscle position control devices, systems & methods |
CA2669195C (en) * | 2005-12-15 | 2013-06-25 | Georgia Tech Research Corporation | Systems and methods to control the dimension of a heart valve |
WO2007100410A2 (en) * | 2005-12-15 | 2007-09-07 | Georgia Tech Research Corporation | Systems and methods for enabling heart valve replacement |
US20070213813A1 (en) * | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US7967857B2 (en) | 2006-01-27 | 2011-06-28 | Medtronic, Inc. | Gasket with spring collar for prosthetic heart valves and methods for making and using them |
US7635386B1 (en) * | 2006-03-07 | 2009-12-22 | University Of Maryland, Baltimore | Methods and devices for performing cardiac valve repair |
EP1998719A1 (en) * | 2006-03-10 | 2008-12-10 | Arbor Surgical Technologies, Inc. | Valve introducers and methods for making and using them |
WO2007130881A2 (en) * | 2006-04-29 | 2007-11-15 | Arbor Surgical Technologies, Inc. | Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them |
US8021161B2 (en) * | 2006-05-01 | 2011-09-20 | Edwards Lifesciences Corporation | Simulated heart valve root for training and testing |
DE602007012691D1 (en) | 2006-05-15 | 2011-04-07 | Edwards Lifesciences Ag | SYSTEM FOR CHANGING THE GEOMETRY OF THE HEART |
CA2657442A1 (en) | 2006-06-20 | 2007-12-27 | Aortx, Inc. | Prosthetic heart valves, support structures and systems and methods for implanting the same |
US7815676B2 (en) * | 2006-07-07 | 2010-10-19 | The Cleveland Clinic Foundation | Apparatus and method for assisting in the removal of a cardiac valve |
US20080065156A1 (en) | 2006-09-08 | 2008-03-13 | Hauser David L | Expandable clip for tissue repair |
WO2010004546A1 (en) | 2008-06-16 | 2010-01-14 | Valtech Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
WO2008068756A2 (en) * | 2006-12-05 | 2008-06-12 | Valtech Cardio, Ltd. | Segmented ring placement |
US9974653B2 (en) | 2006-12-05 | 2018-05-22 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
US8070799B2 (en) | 2006-12-19 | 2011-12-06 | Sorin Biomedica Cardio S.R.L. | Instrument and method for in situ deployment of cardiac valve prostheses |
EP1935378B1 (en) | 2006-12-19 | 2014-09-17 | Sorin Group Italia S.r.l. | Instrument for in situ positioning of cardiac valve prostheses |
MX2009007289A (en) * | 2007-01-03 | 2009-09-09 | Mitralsolutions Inc | Implantable devices for controlling the size and shape of an anatomical structure or lumen. |
EP2120732A2 (en) * | 2007-01-05 | 2009-11-25 | Medtronic, Inc. | Anastomosis systems and methods |
US20080177380A1 (en) * | 2007-01-19 | 2008-07-24 | Starksen Niel F | Methods and devices for heart tissue repair |
WO2008097999A2 (en) | 2007-02-05 | 2008-08-14 | Mitralsolutions, Inc. | Minimally invasive system for delivering and securing an annular implant |
JP5604110B2 (en) * | 2007-02-05 | 2014-10-08 | ボストン サイエンティフィック リミテッド | System for delivering a valve |
CN101605511B (en) * | 2007-02-09 | 2013-03-13 | 爱德华兹生命科学公司 | Progressively sized annuloplasty rings |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
EP2574287B1 (en) | 2007-03-30 | 2015-04-22 | Sentreheart, Inc. | Devices for closing the left atrial appendage |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8753373B2 (en) * | 2007-05-08 | 2014-06-17 | Edwards Lifesciences Corporation | Suture-fastening clip |
US20100191261A1 (en) * | 2007-05-22 | 2010-07-29 | Sally Carter | Suture management port |
US8114154B2 (en) * | 2007-09-07 | 2012-02-14 | Sorin Biomedica Cardio S.R.L. | Fluid-filled delivery system for in situ deployment of cardiac valve prostheses |
US8377117B2 (en) | 2007-09-07 | 2013-02-19 | Edwards Lifesciences Corporation | Active holder for annuloplasty ring delivery |
EP2033581A1 (en) | 2007-09-07 | 2009-03-11 | Sorin Biomedica Cardio S.R.L. | Prosthetic valve delivery system including retrograde/antegrade approch |
US8808367B2 (en) | 2007-09-07 | 2014-08-19 | Sorin Group Italia S.R.L. | Prosthetic valve delivery system including retrograde/antegrade approach |
EP2214563B1 (en) | 2007-09-20 | 2017-04-19 | Sentreheart, Inc. | Devices and methods for remote suture management |
CA2702615C (en) | 2007-10-19 | 2017-06-06 | Guided Delivery Systems, Inc. | Systems and methods for cardiac remodeling |
US20090171456A1 (en) * | 2007-12-28 | 2009-07-02 | Kveen Graig L | Percutaneous heart valve, system, and method |
US8617145B2 (en) | 2008-01-25 | 2013-12-31 | Intrepid Medical, Inc. | Methods of treating a cardiac arrhythmia by thoracoscopic production of a Cox maze III lesion set |
WO2009100242A2 (en) * | 2008-02-06 | 2009-08-13 | Guided Delivery Systems, Inc. | Multi-window guide tunnel |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US8177836B2 (en) * | 2008-03-10 | 2012-05-15 | Medtronic, Inc. | Apparatus and methods for minimally invasive valve repair |
US8252013B2 (en) * | 2008-04-30 | 2012-08-28 | Kyphon Sarl | Expandable surgical access device and methods of use |
CA2723810C (en) | 2008-05-07 | 2015-06-30 | Guided Delivery Systems, Inc. | Deflectable guide |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US20100121349A1 (en) | 2008-10-10 | 2010-05-13 | Meier Stephen C | Termination devices and related methods |
EP2349020B1 (en) | 2008-10-10 | 2020-06-03 | Ancora Heart, Inc. | Tether tensioning device |
US8449625B2 (en) * | 2009-10-27 | 2013-05-28 | Edwards Lifesciences Corporation | Methods of measuring heart valve annuluses for valve replacement |
CA2743719C (en) | 2008-11-25 | 2019-03-19 | Edwards Lifesciences Corporation | Apparatus and method for in situ expansion of prosthetic device |
US8308798B2 (en) | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
US8926697B2 (en) | 2011-06-23 | 2015-01-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US8940044B2 (en) | 2011-06-23 | 2015-01-27 | Valtech Cardio, Ltd. | Closure element for use with an annuloplasty structure |
US8147542B2 (en) | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US8808368B2 (en) | 2008-12-22 | 2014-08-19 | Valtech Cardio, Ltd. | Implantation of repair chords in the heart |
CN102341063B (en) | 2008-12-22 | 2015-11-25 | 瓦尔泰克卡迪欧有限公司 | Adjustable annuloplasty device and governor motion thereof |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US20110011917A1 (en) * | 2008-12-31 | 2011-01-20 | Hansen Medical, Inc. | Methods, devices, and kits for treating valve prolapse |
WO2010085456A1 (en) | 2009-01-20 | 2010-07-29 | Guided Delivery Systems Inc. | Anchor deployment devices and related methods |
EP2389121B1 (en) * | 2009-01-22 | 2020-10-07 | St. Jude Medical, Cardiology Division, Inc. | Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring |
US20100191065A1 (en) * | 2009-01-29 | 2010-07-29 | Tyco Healthcare Group Lp | Suture management system for surgical portal apparatus including springs |
US20100198019A1 (en) * | 2009-01-30 | 2010-08-05 | Tyco Healthcare Group Lp | Suture management apparatus for surgical portal apparatus including interlocking cap |
US20100198018A1 (en) * | 2009-01-30 | 2010-08-05 | Tyco Healthcare Group Lp | Suture management system for surgical portal apparatus including internal tubes |
US20100210912A1 (en) * | 2009-02-17 | 2010-08-19 | Tyco Healthcare Group Lp | Access port with suture management system including flapper with inserts |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US20100211084A1 (en) * | 2009-02-18 | 2010-08-19 | Tyco Healthcare Group Lp | Suture management system for surgical portal apparatus including numbered clips |
US20100249810A1 (en) * | 2009-03-24 | 2010-09-30 | Tyco Healthcare Group Lp | Suture management system for surgical portal apparatus including slotted ring |
US9980818B2 (en) | 2009-03-31 | 2018-05-29 | Edwards Lifesciences Corporation | Prosthetic heart valve system with positioning markers |
US9198664B2 (en) | 2009-04-01 | 2015-12-01 | Sentreheart, Inc. | Tissue ligation devices and controls therefor |
US8518060B2 (en) | 2009-04-09 | 2013-08-27 | Medtronic, Inc. | Medical clip with radial tines, system and method of using same |
US8668704B2 (en) | 2009-04-24 | 2014-03-11 | Medtronic, Inc. | Medical clip with tines, system and method of using same |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
US8523881B2 (en) | 2010-07-26 | 2013-09-03 | Valtech Cardio, Ltd. | Multiple anchor delivery tool |
US8353953B2 (en) * | 2009-05-13 | 2013-01-15 | Sorin Biomedica Cardio, S.R.L. | Device for the in situ delivery of heart valves |
US9168105B2 (en) * | 2009-05-13 | 2015-10-27 | Sorin Group Italia S.R.L. | Device for surgical interventions |
US8403982B2 (en) * | 2009-05-13 | 2013-03-26 | Sorin Group Italia S.R.L. | Device for the in situ delivery of heart valves |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
US20110022165A1 (en) * | 2009-07-23 | 2011-01-27 | Edwards Lifesciences Corporation | Introducer for prosthetic heart valve |
US20110022064A1 (en) * | 2009-07-27 | 2011-01-27 | Tyco Healthcare Group Lp | Access apparatus including hinged suture traps |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US8940042B2 (en) | 2009-10-29 | 2015-01-27 | Valtech Cardio, Ltd. | Apparatus for guide-wire based advancement of a rotation assembly |
US8277502B2 (en) | 2009-10-29 | 2012-10-02 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
EP2506777B1 (en) | 2009-12-02 | 2020-11-25 | Valtech Cardio, Ltd. | Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
SG186837A1 (en) | 2010-03-01 | 2013-02-28 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve and methods associated therewith |
EP2558014A4 (en) | 2010-04-13 | 2017-11-29 | Sentreheart, Inc. | Methods and devices for treating atrial fibrillation |
CN102883684B (en) | 2010-05-10 | 2015-04-08 | 爱德华兹生命科学公司 | Prosthetic heart valve |
US9554901B2 (en) | 2010-05-12 | 2017-01-31 | Edwards Lifesciences Corporation | Low gradient prosthetic heart valve |
US8790394B2 (en) | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
WO2011159733A1 (en) | 2010-06-14 | 2011-12-22 | Maquet Cardiovascular Llc | Surgical instruments, systems and methods of use |
AU2011276503B2 (en) | 2010-06-28 | 2015-09-17 | Colibri Heart Value LLC | Method and apparatus for the endoluminal delivery of intravascular devices |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
CN103179920B (en) | 2010-08-24 | 2015-11-25 | 爱德华兹生命科学公司 | There is the flexible valve forming ring selecting control point |
US9861350B2 (en) | 2010-09-03 | 2018-01-09 | Ancora Heart, Inc. | Devices and methods for anchoring tissue |
US8641757B2 (en) | 2010-09-10 | 2014-02-04 | Edwards Lifesciences Corporation | Systems for rapidly deploying surgical heart valves |
US9125741B2 (en) | 2010-09-10 | 2015-09-08 | Edwards Lifesciences Corporation | Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves |
US9370418B2 (en) | 2010-09-10 | 2016-06-21 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
US8845720B2 (en) | 2010-09-27 | 2014-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve frame with flexible commissures |
US8932350B2 (en) | 2010-11-30 | 2015-01-13 | Edwards Lifesciences Corporation | Reduced dehiscence annuloplasty ring |
SG10201601962WA (en) | 2010-12-14 | 2016-04-28 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
US10709449B2 (en) | 2011-02-18 | 2020-07-14 | Ancora Heart, Inc. | Systems and methods for variable stiffness tethers |
US10111663B2 (en) | 2011-02-18 | 2018-10-30 | Ancora Heart, Inc. | Implant retrieval device |
US8945209B2 (en) | 2011-05-20 | 2015-02-03 | Edwards Lifesciences Corporation | Encapsulated heart valve |
US20120303048A1 (en) | 2011-05-24 | 2012-11-29 | Sorin Biomedica Cardio S.R.I. | Transapical valve replacement |
CN106974692B (en) | 2011-06-08 | 2021-06-01 | 森特里心脏股份有限公司 | Tissue ligation device and tensioning device therefor |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
EP3395298A1 (en) | 2011-06-27 | 2018-10-31 | University of Maryland, Baltimore | Transapical mitral valve repair device |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
EP3970627B1 (en) | 2011-11-08 | 2023-12-20 | Edwards Lifesciences Innovation (Israel) Ltd. | Controlled steering functionality for implant-delivery tool |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
CN102614001B (en) * | 2012-04-27 | 2014-01-15 | 陈文胜 | Thread managing apparatus for operation |
JP2015531630A (en) * | 2012-08-23 | 2015-11-05 | ミニマリー・インヴェイシヴ・サージカル・アクセス・リミテッド | Direct aortic access system for transcatheter aortic valve surgery |
EP2900150B1 (en) | 2012-09-29 | 2018-04-18 | Mitralign, Inc. | Plication lock delivery system |
US9949828B2 (en) | 2012-10-23 | 2018-04-24 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US20150289860A1 (en) * | 2012-11-03 | 2015-10-15 | Novogate Medical Ltd. | Intercostal delivery system and methods thereof |
US9730793B2 (en) | 2012-12-06 | 2017-08-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
EP2948103B1 (en) | 2013-01-24 | 2022-12-07 | Cardiovalve Ltd | Ventricularly-anchored prosthetic valves |
AU2014214700B2 (en) | 2013-02-11 | 2018-01-18 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
CA2902064C (en) | 2013-03-12 | 2021-06-01 | Sentreheart, Inc. | Tissue ligation devices and methods therefor |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
US9687346B2 (en) | 2013-03-14 | 2017-06-27 | Edwards Lifesciences Corporation | Multi-stranded heat set annuloplasty rings |
US11007058B2 (en) | 2013-03-15 | 2021-05-18 | Edwards Lifesciences Corporation | Valved aortic conduits |
EP2968847B1 (en) | 2013-03-15 | 2023-03-08 | Edwards Lifesciences Corporation | Translation catheter systems |
SG11201506352SA (en) | 2013-03-15 | 2015-09-29 | Edwards Lifesciences Corp | Valved aortic conduits |
US9510820B2 (en) * | 2013-04-24 | 2016-12-06 | Medos International Sárl | Devices, systems, and methods for suture management |
US9468527B2 (en) | 2013-06-12 | 2016-10-18 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
US9895219B2 (en) | 2013-07-31 | 2018-02-20 | Medtronic Vascular Galway | Mitral valve prosthesis for transcatheter valve implantation |
EP3030159A1 (en) * | 2013-08-06 | 2016-06-15 | Minimally Invasive Surgical Access Limited | Intra-thoracic access device without thoracotomy, and related methods |
US9919137B2 (en) | 2013-08-28 | 2018-03-20 | Edwards Lifesciences Corporation | Integrated balloon catheter inflation system |
CN105491978A (en) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
SG11201508895RA (en) | 2013-09-20 | 2015-11-27 | Edwards Lifesciences Corp | Heart valves with increased effective orifice area |
WO2015059699A2 (en) | 2013-10-23 | 2015-04-30 | Valtech Cardio, Ltd. | Anchor magazine |
WO2015066549A1 (en) | 2013-10-31 | 2015-05-07 | Sentreheart, Inc. | Devices and methods for left atrial appendage closure |
US20150122687A1 (en) | 2013-11-06 | 2015-05-07 | Edwards Lifesciences Corporation | Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage |
WO2015095806A2 (en) | 2013-12-20 | 2015-06-25 | Microvention, Inc. | Device delivery system |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US9681864B1 (en) | 2014-01-03 | 2017-06-20 | Harpoon Medical, Inc. | Method and apparatus for transapical procedures on a mitral valve |
US9549816B2 (en) | 2014-04-03 | 2017-01-24 | Edwards Lifesciences Corporation | Method for manufacturing high durability heart valve |
US9585752B2 (en) | 2014-04-30 | 2017-03-07 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
USD867594S1 (en) | 2015-06-19 | 2019-11-19 | Edwards Lifesciences Corporation | Prosthetic heart valve |
CA2914094C (en) | 2014-06-20 | 2021-01-05 | Edwards Lifesciences Corporation | Surgical heart valves identifiable post-implant |
EP3206629B1 (en) | 2014-10-14 | 2021-07-14 | Valtech Cardio, Ltd. | Apparatus for heart valve leaflet restraining |
WO2016090308A1 (en) | 2014-12-04 | 2016-06-09 | Edwards Lifesciences Corporation | Percutaneous clip for repairing a heart valve |
EP3253333B1 (en) | 2015-02-05 | 2024-04-03 | Cardiovalve Ltd | Prosthetic valve with axially-sliding frames |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
CA2978599C (en) | 2015-03-05 | 2022-09-06 | Ancora Heart, Inc. | Devices and methods of visualizing and determining depth of penetration in cardiac tissue |
EP4282371A3 (en) | 2015-03-24 | 2024-03-06 | AtriCure, Inc. | Devices for left atrial appendage closure |
US10130369B2 (en) | 2015-03-24 | 2018-11-20 | Sentreheart, Inc. | Tissue ligation devices and methods therefor |
CN114515173A (en) | 2015-04-30 | 2022-05-20 | 瓦尔泰克卡迪欧有限公司 | Valvuloplasty techniques |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US10980973B2 (en) | 2015-05-12 | 2021-04-20 | Ancora Heart, Inc. | Device and method for releasing catheters from cardiac structures |
EP3294219B1 (en) | 2015-05-14 | 2020-05-13 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US10314707B2 (en) | 2015-06-09 | 2019-06-11 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
WO2017004369A1 (en) | 2015-07-02 | 2017-01-05 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
CR20170597A (en) | 2015-07-02 | 2018-04-20 | Edwards Lifesciences Corp | INTEGRATED HYBRID HEART VALVES |
EP3344158B1 (en) | 2015-09-02 | 2023-03-01 | Edwards Lifesciences Corporation | Spacer for securing a transcatheter valve to a bioprosthetic cardiac structure |
US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
EP3753498B1 (en) | 2015-10-02 | 2023-12-06 | Harpoon Medical, Inc. | Distal anchor apparatus for mitral valve repair |
WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
EP3419531B1 (en) | 2016-02-26 | 2024-04-03 | AtriCure, Inc. | Devices for left atrial appendage closure |
US10849688B2 (en) | 2016-03-02 | 2020-12-01 | Truinject Corp. | Sensory enhanced environments for injection aid and social training |
US10667904B2 (en) | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
US11219746B2 (en) | 2016-03-21 | 2022-01-11 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10799677B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10835714B2 (en) | 2016-03-21 | 2020-11-17 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10799676B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10799675B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Cam controlled multi-direction steerable handles |
US10624743B2 (en) | 2016-04-22 | 2020-04-21 | Edwards Lifesciences Corporation | Beating-heart mitral valve chordae replacement |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
US10456245B2 (en) | 2016-05-16 | 2019-10-29 | Edwards Lifesciences Corporation | System and method for applying material to a stent |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
US10893861B2 (en) * | 2016-06-17 | 2021-01-19 | Lsi Solutions, Inc. | Surgical port for stay sutures |
US10973638B2 (en) | 2016-07-07 | 2021-04-13 | Edwards Lifesciences Corporation | Device and method for treating vascular insufficiency |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
CN114587712A (en) | 2016-08-10 | 2022-06-07 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
US10653862B2 (en) | 2016-11-07 | 2020-05-19 | Edwards Lifesciences Corporation | Apparatus for the introduction and manipulation of multiple telescoping catheters |
US10667914B2 (en) | 2016-11-18 | 2020-06-02 | Ancora Heart, Inc. | Myocardial implant load sharing device and methods to promote LV function |
BR102016027541A2 (en) * | 2016-11-23 | 2018-06-12 | César Santos De Abreu Mário | SURGICAL TREATMENT SYSTEM FOR HEART VALVES TO EASILY THE OPERATING ACT ORGANIZING SURGICAL WIRE, EASYING THE SURGICAL PRESENTATION OF THE HEART STRUCTURES TO BE TREATED |
USD846122S1 (en) | 2016-12-16 | 2019-04-16 | Edwards Lifesciences Corporation | Heart valve sizer |
US10905554B2 (en) | 2017-01-05 | 2021-02-02 | Edwards Lifesciences Corporation | Heart valve coaptation device |
EP3596721B1 (en) * | 2017-01-23 | 2023-09-06 | Truinject Corp. | Syringe dose and position measuring apparatus |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
US10463485B2 (en) | 2017-04-06 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
US10765515B2 (en) | 2017-04-06 | 2020-09-08 | University Of Maryland, Baltimore | Distal anchor apparatus and methods for mitral valve repair |
US11224511B2 (en) | 2017-04-18 | 2022-01-18 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
IL269799B2 (en) | 2017-04-18 | 2023-10-01 | Edwards Lifesciences Corp | Heart valve sealing devices and delivery devices therefor |
CA3060663C (en) | 2017-04-28 | 2024-03-26 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
US10799312B2 (en) | 2017-04-28 | 2020-10-13 | Edwards Lifesciences Corporation | Medical device stabilizing apparatus and method of use |
US10959846B2 (en) | 2017-05-10 | 2021-03-30 | Edwards Lifesciences Corporation | Mitral valve spacer device |
EP3641699B1 (en) | 2017-06-19 | 2023-08-30 | Harpoon Medical, Inc. | Apparatus for cardiac procedures |
CN110831547B (en) | 2017-06-21 | 2022-07-15 | 爱德华兹生命科学公司 | Double-wire limited expansion heart valve |
US11051940B2 (en) | 2017-09-07 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic spacer device for heart valve |
US11065117B2 (en) | 2017-09-08 | 2021-07-20 | Edwards Lifesciences Corporation | Axisymmetric adjustable device for treating mitral regurgitation |
WO2019051476A1 (en) | 2017-09-11 | 2019-03-14 | Incubar, LLC | Conduit vascular implant sealing device for reducing endoleak |
US11040174B2 (en) | 2017-09-19 | 2021-06-22 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
EP3700434A1 (en) | 2017-10-24 | 2020-09-02 | University of Maryland, Baltimore | Method and apparatus for cardiac procedures |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
CN111655198A (en) | 2018-01-09 | 2020-09-11 | 爱德华兹生命科学公司 | Native valve repair devices and procedures |
US10111751B1 (en) | 2018-01-09 | 2018-10-30 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10973639B2 (en) | 2018-01-09 | 2021-04-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10245144B1 (en) | 2018-01-09 | 2019-04-02 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10136993B1 (en) | 2018-01-09 | 2018-11-27 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10231837B1 (en) | 2018-01-09 | 2019-03-19 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10123873B1 (en) | 2018-01-09 | 2018-11-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10507109B2 (en) | 2018-01-09 | 2019-12-17 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10238493B1 (en) | 2018-01-09 | 2019-03-26 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10159570B1 (en) | 2018-01-09 | 2018-12-25 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10130475B1 (en) | 2018-01-09 | 2018-11-20 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10076415B1 (en) | 2018-01-09 | 2018-09-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10105222B1 (en) | 2018-01-09 | 2018-10-23 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
CN111565678B (en) | 2018-01-23 | 2023-07-07 | 爱德华兹生命科学公司 | Prosthetic valve holders, systems, and methods |
WO2019145947A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
US11389297B2 (en) | 2018-04-12 | 2022-07-19 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US11207181B2 (en) | 2018-04-18 | 2021-12-28 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11517435B2 (en) | 2018-05-04 | 2022-12-06 | Edwards Lifesciences Corporation | Ring-based prosthetic cardiac valve |
US11064990B2 (en) * | 2018-05-08 | 2021-07-20 | Lsi Solutions, Inc. | Cardiac retractor |
USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
AU2019301967A1 (en) | 2018-07-12 | 2021-01-21 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty systems and locking tools therefor |
EP3829490A1 (en) | 2018-07-30 | 2021-06-09 | Edwards Lifesciences Corporation | Minimally-invasive low strain annuloplasty ring |
US10945844B2 (en) | 2018-10-10 | 2021-03-16 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
CR20210427A (en) | 2019-02-14 | 2022-03-30 | Edwards Lifesciences Corp | Heart valve sealing devices and delivery devices therefor |
WO2021011659A1 (en) | 2019-07-15 | 2021-01-21 | Ancora Heart, Inc. | Devices and methods for tether cutting |
CR20210640A (en) | 2019-10-29 | 2022-05-30 | Valtech Cardio Ltd | Annuloplasty and tissue anchor technologies |
WO2021126778A1 (en) | 2019-12-16 | 2021-06-24 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
CN113967043B (en) * | 2021-10-27 | 2024-01-12 | 邹承伟 | Suture-free auxiliary implantation device for artificial mitral valve |
Citations (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1127325A (en) * | 1915-02-02 | Baldwin Locomotive Works | Joint. | |
US3409013A (en) * | 1965-08-23 | 1968-11-05 | Berry Henry | Instrument for inserting artificial heart valves |
US3587115A (en) * | 1966-05-04 | 1971-06-28 | Donald P Shiley | Prosthetic sutureless heart valves and implant tools therefor |
US3890969A (en) * | 1974-01-21 | 1975-06-24 | Baxter Laboratories Inc | Cardiopulmonary bypass system |
US4056854A (en) * | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
US4065816A (en) * | 1975-05-22 | 1978-01-03 | Philip Nicholas Sawyer | Surgical method of using a sterile packaged prosthesis |
US4173981A (en) * | 1977-05-23 | 1979-11-13 | University Of Utah | Cannula for arterial and venous bypass cannulation |
US4185636A (en) * | 1977-12-29 | 1980-01-29 | Albert Einstein College Of Medicine Of Yeshiva University | Suture organizer, prosthetic device holder, and related surgical procedures |
US4529397A (en) * | 1982-02-09 | 1985-07-16 | Sartorius Gmbh | Cardioplegic controlling and regulating system |
US4562832A (en) * | 1984-01-21 | 1986-01-07 | Wilder Joseph R | Medical instrument and light pipe illumination assembly |
US4585453A (en) * | 1983-02-22 | 1986-04-29 | Shiley, Incorporated | Disposable holder for prosthetic heart valve |
US4602911A (en) * | 1982-08-19 | 1986-07-29 | General Resorts S.A. | Adjustable ringprosthesis |
US4656218A (en) * | 1985-02-08 | 1987-04-07 | Sanyo Kokusaku Pulp Co., Ltd. | Adhesive copolymer microspheres-containing aqueous suspension and method for producing the same |
US4679556A (en) * | 1986-04-16 | 1987-07-14 | Shiley Inc. | Releasable holder and method of use |
US4702250A (en) * | 1983-09-02 | 1987-10-27 | Galil Advanced Technologies Ltd. | Surgical implement particularly useful for suturing prosthetic valves |
US4808163A (en) * | 1987-07-29 | 1989-02-28 | Laub Glenn W | Percutaneous venous cannula for cardiopulmonary bypass |
US4877016A (en) * | 1988-07-29 | 1989-10-31 | Kantor Edward A | Video endoscopic microscope |
US4972827A (en) * | 1989-02-06 | 1990-11-27 | Fuji Photo Optical Co., Ltd. | Guide device for percutaneous insertion of endoscope |
US5011481A (en) * | 1989-07-17 | 1991-04-30 | Medtronic, Inc. | Holder for annuloplasty ring |
US5032128A (en) * | 1988-07-07 | 1991-07-16 | Medtronic, Inc. | Heart valve prosthesis |
US5041130A (en) * | 1989-07-31 | 1991-08-20 | Baxter International Inc. | Flexible annuloplasty ring and holder |
US5104407A (en) * | 1989-02-13 | 1992-04-14 | Baxter International Inc. | Selectively flexible annuloplasty ring |
US5109859A (en) * | 1989-10-04 | 1992-05-05 | Beth Israel Hospital Association | Ultrasound guided laser angioplasty |
US5122122A (en) * | 1989-11-22 | 1992-06-16 | Dexide, Incorporated | Locking trocar sleeve |
US5147316A (en) * | 1990-11-19 | 1992-09-15 | Castillenti Thomas A | Laparoscopic trocar with self-locking port sleeve |
US5188619A (en) * | 1991-04-24 | 1993-02-23 | Gene E. Myers Enterprises, Inc. | Internal thoractic artery catheter |
US5197979A (en) * | 1990-09-07 | 1993-03-30 | Baxter International Inc. | Stentless heart valve and holder |
US5203776A (en) * | 1992-10-09 | 1993-04-20 | Durfee Paul J | Catheter |
US5209747A (en) * | 1990-12-13 | 1993-05-11 | Knoepfler Dennis J | Adjustable angle medical forceps |
US5213093A (en) * | 1991-05-29 | 1993-05-25 | Applied Vascular Devices, Inc. | Endoscope with non-circular probe and method of making same |
US5236450A (en) * | 1992-06-04 | 1993-08-17 | Carbon Implants, Inc. | Heart valve holder-rotator |
US5250038A (en) * | 1992-10-09 | 1993-10-05 | Cook Incorporated | Multiple lumen vascular access introducer sheath |
US5306234A (en) * | 1993-03-23 | 1994-04-26 | Johnson W Dudley | Method for closing an atrial appendage |
US5308320A (en) * | 1990-12-28 | 1994-05-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method |
US5332402A (en) * | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5383888A (en) * | 1992-02-12 | 1995-01-24 | United States Surgical Corporation | Articulating endoscopic surgical apparatus |
US5391156A (en) * | 1992-06-30 | 1995-02-21 | Ethicon, Inc. | Flexible encoscopic surgical port |
US5423887A (en) * | 1991-01-24 | 1995-06-13 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
US5433700A (en) * | 1992-12-03 | 1995-07-18 | Stanford Surgical Technologies, Inc. | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US5443446A (en) * | 1991-04-04 | 1995-08-22 | Shturman Cardiology Systems, Inc. | Method and apparatus for in vivo heart valve decalcification |
US5452733A (en) * | 1993-02-22 | 1995-09-26 | Stanford Surgical Technologies, Inc. | Methods for performing thoracoscopic coronary artery bypass |
US5458574A (en) * | 1994-03-16 | 1995-10-17 | Heartport, Inc. | System for performing a cardiac procedure |
US5478309A (en) * | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US5536251A (en) * | 1993-02-22 | 1996-07-16 | Heartport, Inc. | Thoracoscopic devices and methods for arresting the heart |
US5545214A (en) * | 1991-07-16 | 1996-08-13 | Heartport, Inc. | Endovascular aortic valve replacement |
US5556412A (en) * | 1991-12-17 | 1996-09-17 | Hill; John D. | Blood vessel occlusion trocar |
US5560487A (en) * | 1994-07-29 | 1996-10-01 | Carbomedics, Inc. | Holder and packaging for bioprosthetic heart valve |
US5578076A (en) * | 1995-05-24 | 1996-11-26 | St. Jude Medical, Inc. | Low profile holder for heart valve prosthesis |
US5613937A (en) * | 1993-02-22 | 1997-03-25 | Heartport, Inc. | Method of retracting heart tissue in closed-chest heart surgery using endo-scopic retraction |
US5626607A (en) * | 1995-04-03 | 1997-05-06 | Heartport, Inc. | Clamp assembly and method of use |
US5682906A (en) * | 1993-02-22 | 1997-11-04 | Heartport, Inc. | Methods of performing intracardiac procedures on an arrested heart |
US5702368A (en) * | 1991-07-16 | 1997-12-30 | Heartport, Inc. | System for cardiac procedures |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US35352A (en) * | 1862-05-20 | Improved hay-rigging | ||
US2646045A (en) | 1951-05-01 | 1953-07-21 | Bruno S Priestley | Mechanical suturing device |
US3626471A (en) | 1969-10-13 | 1971-12-07 | Robert E Florin | Illuminated suction brain retractor |
US3983863A (en) | 1975-06-02 | 1976-10-05 | American Hospital Supply Corporation | Heart support for coronary artery surgery |
US4049000A (en) | 1975-08-01 | 1977-09-20 | Williams Robert W | Suction retraction instrument |
US4111209A (en) | 1977-04-18 | 1978-09-05 | Datascope Corporation | Topical hypothermia apparatus and method for treating the human body and the like |
US4154245A (en) | 1977-07-11 | 1979-05-15 | Daily Pat O | Apparatus for local hypothermia |
US4259961A (en) | 1979-01-24 | 1981-04-07 | Hood Iii Andrew G | Cooling pad |
US4416281A (en) | 1981-03-05 | 1983-11-22 | Guardline Disposables Limited | Surgical cushion for cooling an organ |
US4423730A (en) | 1982-03-01 | 1984-01-03 | Shelhigh Inc. | Atriotomy button and implantation device |
US5067957A (en) | 1983-10-14 | 1991-11-26 | Raychem Corporation | Method of inserting medical devices incorporating SIM alloy elements |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4605006A (en) | 1984-02-28 | 1986-08-12 | Minnesota Mining And Manufacturing Company | Hypothermic protection pad |
US4553543A (en) | 1984-03-05 | 1985-11-19 | Amarasinghe Disamodha C | Suturing assembly and method |
US4592340A (en) | 1984-05-02 | 1986-06-03 | Boyles Paul W | Artificial catheter means |
NL8502382A (en) * | 1985-08-30 | 1987-03-16 | Martinus Jacobus Antonius Joha | CATHETER SUITABLE FOR MULTIPLE PURPOSES. |
US4637377A (en) | 1985-09-20 | 1987-01-20 | Loop Floyd D | Pillow or support member for surgical use |
GB2181057B (en) * | 1985-10-23 | 1989-09-27 | Blagoveshchensk G Med Inst | Prosthetic valve holder |
IL78177A0 (en) * | 1986-03-17 | 1986-07-31 | Yoel Ovil | Prosthetic heart valve and instrument for attaching and/or removing same |
US4822345A (en) | 1986-08-14 | 1989-04-18 | Danforth John W | Controllable flexibility catheter |
US4803984A (en) | 1987-07-06 | 1989-02-14 | Montefiore Hospital Association Of Western Pennsylvania | Method for performing small vessel anastomosis |
US4781682A (en) | 1987-08-13 | 1988-11-01 | Patel Piyush V | Catheter having support flaps and method of inserting catheter |
US5374261A (en) | 1990-07-24 | 1994-12-20 | Yoon; Inbae | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor |
US5011469A (en) * | 1988-08-29 | 1991-04-30 | Shiley, Inc. | Peripheral cardiopulmonary bypass and coronary reperfusion system |
US5014695A (en) | 1988-10-04 | 1991-05-14 | Benak Arnold M | Kidney cooling jacket |
US4943277A (en) | 1989-03-24 | 1990-07-24 | Bolling Steven F | Retrograde coronary sinus cardioplegia cannula and method for using same in heart surgery |
SU1690738A1 (en) * | 1989-04-11 | 1991-11-15 | Предприятие П/Я Р-6525 | Holder of artificial cardiac valve |
US5135492A (en) | 1989-06-26 | 1992-08-04 | University Of Florida | Arterial/venous fluid transfer system |
US4971056A (en) | 1989-08-07 | 1990-11-20 | Daily Medical Products Incorporated | Arcuate shaped cooling jacket |
US5104393A (en) * | 1989-08-30 | 1992-04-14 | Angelase, Inc. | Catheter |
US4973300A (en) | 1989-09-22 | 1990-11-27 | Pioneering Technologies, Inc. | Cardiac sling for circumflex coronary artery surgery |
US5002528A (en) | 1989-12-15 | 1991-03-26 | Aubrey Palestrant | Percutaneous irrigation and drainage system |
US5271385A (en) | 1990-03-29 | 1993-12-21 | United States Surgical Corporation | Abdominal cavity organ retractor |
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5370647A (en) | 1991-01-23 | 1994-12-06 | Surgical Innovations, Inc. | Tissue and organ extractor |
AR245376A1 (en) | 1991-02-25 | 1994-01-31 | Liliana Rosa Grinfeld Y Robert | Arterial profusion nozzle, for extra-corporal circulation and other uses. |
EP0533897B1 (en) | 1991-03-29 | 1996-03-13 | Laboratoire Perouse Implant | Surgical stapler |
US5117822A (en) | 1991-04-05 | 1992-06-02 | Laghi Aldo A | Silicone heart spoon |
US5370134A (en) | 1991-05-29 | 1994-12-06 | Orgin Medsystems, Inc. | Method and apparatus for body structure manipulation and dissection |
US5361752A (en) | 1991-05-29 | 1994-11-08 | Origin Medsystems, Inc. | Retraction apparatus and methods for endoscopic surgery |
US5203786A (en) | 1991-06-19 | 1993-04-20 | Thomas Jefferson University | Hepatic resection clamp |
US5304220A (en) | 1991-07-03 | 1994-04-19 | Maginot Thomas J | Method and apparatus for implanting a graft prosthesis in the body of a patient |
US5211683A (en) | 1991-07-03 | 1993-05-18 | Maginot Thomas J | Method of implanting a graft prosthesis in the body of a patient |
US5183033A (en) | 1991-07-15 | 1993-02-02 | Wilk Peter J | Surgical instrument assembly and apparatus and surgical method |
US5558644A (en) | 1991-07-16 | 1996-09-24 | Heartport, Inc. | Retrograde delivery catheter and method for inducing cardioplegic arrest |
US5571215A (en) * | 1993-02-22 | 1996-11-05 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5150706A (en) | 1991-08-15 | 1992-09-29 | Cox James L | Cooling net for cardiac or transplant surgery |
GB9118670D0 (en) | 1991-08-30 | 1991-10-16 | Mcnicholas Thomas A | Surgical devices and uses thereof |
IL103445A (en) | 1991-10-18 | 1997-04-15 | Ethicon Inc | Endoscopic tissue manipulator |
US5395349A (en) | 1991-12-13 | 1995-03-07 | Endovascular Technologies, Inc. | Dual valve reinforced sheath and method |
WO1993020741A1 (en) * | 1992-04-08 | 1993-10-28 | Jako Geza J | Percutaneous surgical endoscopy |
US5318013A (en) | 1992-11-06 | 1994-06-07 | Wilk Peter J | Surgical clamping assembly and associated method |
US5279575A (en) | 1992-08-13 | 1994-01-18 | Brigham & Women's Hospital | Locking pivotal surgical orifice |
US5339800A (en) | 1992-09-10 | 1994-08-23 | Devmed Group Inc. | Lens cleaning means for invasive viewing medical instruments with anti-contamination means |
US5325848A (en) | 1992-09-10 | 1994-07-05 | Ethicon, Inc. | Endoscopic tissue manipulator with expandable frame |
US5362294A (en) | 1992-09-25 | 1994-11-08 | Seitzinger Michael R | Sling for positioning internal organ during laparoscopic surgery and method of use |
US5522834A (en) | 1992-10-15 | 1996-06-04 | Applied Medical Resources Corporation | Internal mammary artery catheter and method |
US5304184A (en) | 1992-10-19 | 1994-04-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
DE4303274C2 (en) | 1993-02-05 | 1997-02-06 | Wolf Gmbh Richard | Endoscopic instrument |
US5370109A (en) | 1993-02-19 | 1994-12-06 | United States Surgical Corporation | Deformable endoscopic surgical retractor |
US5569274A (en) | 1993-02-22 | 1996-10-29 | Heartport, Inc. | Endoscopic vascular clamping system and method |
US5799661A (en) * | 1993-02-22 | 1998-09-01 | Heartport, Inc. | Devices and methods for port-access multivessel coronary artery bypass surgery |
US6010531A (en) * | 1993-02-22 | 2000-01-04 | Heartport, Inc. | Less-invasive devices and methods for cardiac valve surgery |
DE9302650U1 (en) | 1993-02-24 | 1993-04-15 | Karl Storz Gmbh & Co, 7200 Tuttlingen, De | |
US5339803A (en) | 1993-04-13 | 1994-08-23 | Ilya Mayzels | Self-hinging disposable retractor instrument for endoscopic surgery |
US5441494A (en) | 1993-07-29 | 1995-08-15 | Ethicon, Inc. | Manipulable hand for laparoscopy |
US5376094A (en) | 1993-08-19 | 1994-12-27 | Boston Scientific Corporation | Improved actuating handle with pulley system for providing mechanical advantage to a surgical working element |
US5588949A (en) | 1993-10-08 | 1996-12-31 | Heartport, Inc. | Stereoscopic percutaneous visualization system |
AU1041795A (en) | 1993-10-25 | 1995-05-22 | Children's Medical Center Corporation | Retractable suture needle with self-contained driver |
JP2580836Y2 (en) | 1993-12-16 | 1998-09-17 | 繁 風間 | Heart conversion device |
US5501698A (en) * | 1994-02-14 | 1996-03-26 | Heartport, Inc. | Endoscopic microsurgical instruments and methods |
US5601576A (en) | 1994-08-10 | 1997-02-11 | Heartport Inc. | Surgical knot pusher and method of use |
US5888247A (en) * | 1995-04-10 | 1999-03-30 | Cardiothoracic Systems, Inc | Method for coronary artery bypass |
-
1996
- 1996-01-31 US US08/594,870 patent/US6010531A/en not_active Expired - Lifetime
-
1997
- 1997-01-23 WO PCT/US1997/001018 patent/WO1997027799A1/en active Application Filing
- 1997-01-23 AU AU15824/97A patent/AU1582497A/en not_active Abandoned
-
1999
- 1999-10-12 US US09/416,492 patent/US6651671B1/en not_active Expired - Fee Related
-
2003
- 2003-09-15 US US10/662,727 patent/US20040073301A1/en not_active Abandoned
Patent Citations (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1127325A (en) * | 1915-02-02 | Baldwin Locomotive Works | Joint. | |
US3409013A (en) * | 1965-08-23 | 1968-11-05 | Berry Henry | Instrument for inserting artificial heart valves |
US3587115A (en) * | 1966-05-04 | 1971-06-28 | Donald P Shiley | Prosthetic sutureless heart valves and implant tools therefor |
US3890969A (en) * | 1974-01-21 | 1975-06-24 | Baxter Laboratories Inc | Cardiopulmonary bypass system |
US4065816A (en) * | 1975-05-22 | 1978-01-03 | Philip Nicholas Sawyer | Surgical method of using a sterile packaged prosthesis |
US4056854A (en) * | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
US4173981A (en) * | 1977-05-23 | 1979-11-13 | University Of Utah | Cannula for arterial and venous bypass cannulation |
US4185636A (en) * | 1977-12-29 | 1980-01-29 | Albert Einstein College Of Medicine Of Yeshiva University | Suture organizer, prosthetic device holder, and related surgical procedures |
US4529397A (en) * | 1982-02-09 | 1985-07-16 | Sartorius Gmbh | Cardioplegic controlling and regulating system |
US4602911A (en) * | 1982-08-19 | 1986-07-29 | General Resorts S.A. | Adjustable ringprosthesis |
US4585453A (en) * | 1983-02-22 | 1986-04-29 | Shiley, Incorporated | Disposable holder for prosthetic heart valve |
US4702250A (en) * | 1983-09-02 | 1987-10-27 | Galil Advanced Technologies Ltd. | Surgical implement particularly useful for suturing prosthetic valves |
US4562832A (en) * | 1984-01-21 | 1986-01-07 | Wilder Joseph R | Medical instrument and light pipe illumination assembly |
US4656218A (en) * | 1985-02-08 | 1987-04-07 | Sanyo Kokusaku Pulp Co., Ltd. | Adhesive copolymer microspheres-containing aqueous suspension and method for producing the same |
US4679556A (en) * | 1986-04-16 | 1987-07-14 | Shiley Inc. | Releasable holder and method of use |
US4808163A (en) * | 1987-07-29 | 1989-02-28 | Laub Glenn W | Percutaneous venous cannula for cardiopulmonary bypass |
US5032128A (en) * | 1988-07-07 | 1991-07-16 | Medtronic, Inc. | Heart valve prosthesis |
US4877016A (en) * | 1988-07-29 | 1989-10-31 | Kantor Edward A | Video endoscopic microscope |
US4972827A (en) * | 1989-02-06 | 1990-11-27 | Fuji Photo Optical Co., Ltd. | Guide device for percutaneous insertion of endoscope |
US5104407B1 (en) * | 1989-02-13 | 1999-09-21 | Baxter Int | Selectively flexible annuloplasty ring |
US5104407A (en) * | 1989-02-13 | 1992-04-14 | Baxter International Inc. | Selectively flexible annuloplasty ring |
US5011481A (en) * | 1989-07-17 | 1991-04-30 | Medtronic, Inc. | Holder for annuloplasty ring |
US5041130A (en) * | 1989-07-31 | 1991-08-20 | Baxter International Inc. | Flexible annuloplasty ring and holder |
US5109859A (en) * | 1989-10-04 | 1992-05-05 | Beth Israel Hospital Association | Ultrasound guided laser angioplasty |
US5122122A (en) * | 1989-11-22 | 1992-06-16 | Dexide, Incorporated | Locking trocar sleeve |
US5197979A (en) * | 1990-09-07 | 1993-03-30 | Baxter International Inc. | Stentless heart valve and holder |
US5147316A (en) * | 1990-11-19 | 1992-09-15 | Castillenti Thomas A | Laparoscopic trocar with self-locking port sleeve |
US5209747A (en) * | 1990-12-13 | 1993-05-11 | Knoepfler Dennis J | Adjustable angle medical forceps |
US5308320A (en) * | 1990-12-28 | 1994-05-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method |
US5423887A (en) * | 1991-01-24 | 1995-06-13 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
US5443446A (en) * | 1991-04-04 | 1995-08-22 | Shturman Cardiology Systems, Inc. | Method and apparatus for in vivo heart valve decalcification |
US5188619A (en) * | 1991-04-24 | 1993-02-23 | Gene E. Myers Enterprises, Inc. | Internal thoractic artery catheter |
US5213093A (en) * | 1991-05-29 | 1993-05-25 | Applied Vascular Devices, Inc. | Endoscope with non-circular probe and method of making same |
US5545214A (en) * | 1991-07-16 | 1996-08-13 | Heartport, Inc. | Endovascular aortic valve replacement |
US5702368A (en) * | 1991-07-16 | 1997-12-30 | Heartport, Inc. | System for cardiac procedures |
US5556412A (en) * | 1991-12-17 | 1996-09-17 | Hill; John D. | Blood vessel occlusion trocar |
US5383888A (en) * | 1992-02-12 | 1995-01-24 | United States Surgical Corporation | Articulating endoscopic surgical apparatus |
US5332402A (en) * | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5236450A (en) * | 1992-06-04 | 1993-08-17 | Carbon Implants, Inc. | Heart valve holder-rotator |
US5391156A (en) * | 1992-06-30 | 1995-02-21 | Ethicon, Inc. | Flexible encoscopic surgical port |
US5250038A (en) * | 1992-10-09 | 1993-10-05 | Cook Incorporated | Multiple lumen vascular access introducer sheath |
US5203776A (en) * | 1992-10-09 | 1993-04-20 | Durfee Paul J | Catheter |
USRE35352E (en) * | 1992-12-03 | 1996-10-15 | Heartport, Inc. | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US5433700A (en) * | 1992-12-03 | 1995-07-18 | Stanford Surgical Technologies, Inc. | Method for intraluminally inducing cardioplegic arrest and catheter for use therein |
US5536251A (en) * | 1993-02-22 | 1996-07-16 | Heartport, Inc. | Thoracoscopic devices and methods for arresting the heart |
US5613937A (en) * | 1993-02-22 | 1997-03-25 | Heartport, Inc. | Method of retracting heart tissue in closed-chest heart surgery using endo-scopic retraction |
US5682906A (en) * | 1993-02-22 | 1997-11-04 | Heartport, Inc. | Methods of performing intracardiac procedures on an arrested heart |
US5452733A (en) * | 1993-02-22 | 1995-09-26 | Stanford Surgical Technologies, Inc. | Methods for performing thoracoscopic coronary artery bypass |
US5306234A (en) * | 1993-03-23 | 1994-04-26 | Johnson W Dudley | Method for closing an atrial appendage |
US5458574A (en) * | 1994-03-16 | 1995-10-17 | Heartport, Inc. | System for performing a cardiac procedure |
US5478309A (en) * | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US5560487A (en) * | 1994-07-29 | 1996-10-01 | Carbomedics, Inc. | Holder and packaging for bioprosthetic heart valve |
US5626607A (en) * | 1995-04-03 | 1997-05-06 | Heartport, Inc. | Clamp assembly and method of use |
US5578076A (en) * | 1995-05-24 | 1996-11-26 | St. Jude Medical, Inc. | Low profile holder for heart valve prosthesis |
Cited By (122)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776053B2 (en) | 2000-10-26 | 2010-08-17 | Boston Scientific Scimed, Inc. | Implantable valve system |
US20040059411A1 (en) * | 2000-10-26 | 2004-03-25 | Strecker Ernst Peter | Implantable valve system |
US20040230297A1 (en) * | 2002-04-03 | 2004-11-18 | Boston Scientific Corporation | Artificial valve |
US20030191479A1 (en) * | 2002-04-03 | 2003-10-09 | Thornton Sally C. | Body lumen closure |
US7682385B2 (en) | 2002-04-03 | 2010-03-23 | Boston Scientific Corporation | Artificial valve |
US8163008B2 (en) | 2002-08-28 | 2012-04-24 | Heart Leaflet Technologies, Inc. | Leaflet valve |
US7780627B2 (en) | 2002-12-30 | 2010-08-24 | Boston Scientific Scimed, Inc. | Valve treatment catheter and methods |
US20040127848A1 (en) * | 2002-12-30 | 2004-07-01 | Toby Freyman | Valve treatment catheter and methods |
US10869764B2 (en) | 2003-12-19 | 2020-12-22 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US20050137676A1 (en) * | 2003-12-19 | 2005-06-23 | Scimed Life Systems, Inc. | Venous valve apparatus, system, and method |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US8721717B2 (en) | 2003-12-19 | 2014-05-13 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US9301843B2 (en) | 2003-12-19 | 2016-04-05 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7785341B2 (en) * | 2004-02-27 | 2010-08-31 | Aortx, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US8728156B2 (en) | 2004-02-27 | 2014-05-20 | Cardiac MD, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US20050203614A1 (en) * | 2004-02-27 | 2005-09-15 | Cardiacmd, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US8608770B2 (en) | 2004-02-27 | 2013-12-17 | Cardiacmd, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US8430925B2 (en) | 2004-02-27 | 2013-04-30 | Cardiacmd, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
US9867695B2 (en) | 2004-03-03 | 2018-01-16 | Sorin Group Italia S.R.L. | Minimally-invasive cardiac-valve prosthesis |
US20060047338A1 (en) * | 2004-09-02 | 2006-03-02 | Scimed Life Systems, Inc. | Cardiac valve, system, and method |
US9918834B2 (en) | 2004-09-02 | 2018-03-20 | Boston Scientific Scimed, Inc. | Cardiac valve, system and method |
US8932349B2 (en) | 2004-09-02 | 2015-01-13 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US8002824B2 (en) | 2004-09-02 | 2011-08-23 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US9622859B2 (en) | 2005-02-01 | 2017-04-18 | Boston Scientific Scimed, Inc. | Filter system and method |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US20060178550A1 (en) * | 2005-02-04 | 2006-08-10 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US9486313B2 (en) | 2005-02-10 | 2016-11-08 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US9895223B2 (en) | 2005-02-10 | 2018-02-20 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US8920492B2 (en) | 2005-02-10 | 2014-12-30 | Sorin Group Italia S.R.L. | Cardiac valve prosthesis |
US9808341B2 (en) | 2005-02-23 | 2017-11-07 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US9370419B2 (en) | 2005-02-23 | 2016-06-21 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US9861473B2 (en) | 2005-04-15 | 2018-01-09 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US8512399B2 (en) | 2005-04-15 | 2013-08-20 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US8512324B2 (en) | 2005-04-29 | 2013-08-20 | Medtronic Cryocath Lp | Wide area ablation of myocardial tissue |
US20080215043A1 (en) * | 2005-04-29 | 2008-09-04 | Cryocath Technologies Inc. | Wide area ablation of myocardial tissue |
US20060247611A1 (en) * | 2005-04-29 | 2006-11-02 | Marwan Abboud | Wide area ablation of myocardial tissue |
US8679104B2 (en) | 2005-04-29 | 2014-03-25 | Medtronic Cryocath Lp | Wide area ablation of myocardial tissue |
US7794455B2 (en) | 2005-04-29 | 2010-09-14 | Medtronic Cryocath Lp | Wide area ablation of myocardial tissue |
US20080091180A1 (en) * | 2005-04-29 | 2008-04-17 | Cryocath Technologies Inc. | Wide area ablation of myocardial tissue |
US20080103493A1 (en) * | 2005-04-29 | 2008-05-01 | Cryocath Technologies Inc. | Wide area ablation of myocardial tissue |
US8475440B2 (en) | 2005-04-29 | 2013-07-02 | Medtronic Cryocath Lp | Wide area ablation of myocardial tissue |
US9814575B2 (en) | 2005-05-27 | 2017-11-14 | Hlt, Inc. | Stentless support structure |
US10646337B2 (en) | 2005-05-27 | 2020-05-12 | Hlt, Inc. | Stentless support structure |
US9827095B2 (en) | 2005-05-27 | 2017-11-28 | Hlt, Inc. | Stentless support structure |
US10080655B2 (en) | 2005-05-27 | 2018-09-25 | Hlt, Inc. | Stentless support structure |
US9439760B2 (en) | 2005-05-27 | 2016-09-13 | Hlt, Inc. | Stentless support structure |
US11026784B2 (en) | 2005-05-27 | 2021-06-08 | Hlt, Inc. | Stentless support structure |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US11337812B2 (en) | 2005-06-10 | 2022-05-24 | Boston Scientific Scimed, Inc. | Venous valve, system and method |
US9028542B2 (en) | 2005-06-10 | 2015-05-12 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US8460365B2 (en) | 2005-09-21 | 2013-06-11 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US10548734B2 (en) | 2005-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US9474609B2 (en) | 2005-09-21 | 2016-10-25 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US8672997B2 (en) | 2005-09-21 | 2014-03-18 | Boston Scientific Scimed, Inc. | Valve with sinus |
US7951189B2 (en) | 2005-09-21 | 2011-05-31 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US9717468B2 (en) | 2006-01-10 | 2017-08-01 | Mediguide Ltd. | System and method for positioning an artificial heart valve at the position of a malfunctioning valve of a heart through a percutaneous route |
US20070173861A1 (en) * | 2006-01-10 | 2007-07-26 | Mediguide Ltd. | System and method for positioning an artificial heart valve at the position of a malfunctioning valve of a heart through a percutaneous route |
WO2007080569A3 (en) * | 2006-01-10 | 2009-04-16 | Mediguide Ltd | System and method for positioning an artificial heart valve |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US7431692B2 (en) | 2006-03-09 | 2008-10-07 | Edwards Lifesciences Corporation | Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ |
US20090043153A1 (en) * | 2006-03-09 | 2009-02-12 | Edwards Lifesciences Corporation | Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ |
US7871368B2 (en) | 2006-03-09 | 2011-01-18 | Edwards Lifesciences Corporation | Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ |
US20070213582A1 (en) * | 2006-03-09 | 2007-09-13 | Zollinger Christopher J | Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ |
US20090099554A1 (en) * | 2006-06-20 | 2009-04-16 | Forster David C | Elongate Flexible Torque Instruments And Methods Of Use |
US20100256752A1 (en) * | 2006-09-06 | 2010-10-07 | Forster David C | Prosthetic heart valves, support structures and systems and methods for implanting the same, |
US20110024614A1 (en) * | 2006-10-19 | 2011-02-03 | Syft Technologies Limited | Sift-ms instrument |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US8348999B2 (en) | 2007-01-08 | 2013-01-08 | California Institute Of Technology | In-situ formation of a valve |
US10226344B2 (en) | 2007-02-05 | 2019-03-12 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US11504239B2 (en) | 2007-02-05 | 2022-11-22 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US9421083B2 (en) | 2007-02-05 | 2016-08-23 | Boston Scientific Scimed Inc. | Percutaneous valve, system and method |
US8470023B2 (en) | 2007-02-05 | 2013-06-25 | Boston Scientific Scimed, Inc. | Percutaneous valve, system, and method |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US10966823B2 (en) | 2007-10-12 | 2021-04-06 | Sorin Group Italia S.R.L. | Expandable valve prosthesis with sealing mechanism |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8414641B2 (en) | 2007-12-21 | 2013-04-09 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US8137394B2 (en) | 2007-12-21 | 2012-03-20 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US8845527B2 (en) | 2008-04-11 | 2014-09-30 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US20090259107A1 (en) * | 2008-04-11 | 2009-10-15 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US9049989B2 (en) | 2008-04-11 | 2015-06-09 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US20090287060A1 (en) * | 2008-05-14 | 2009-11-19 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US8915845B2 (en) | 2008-05-14 | 2014-12-23 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
US10098733B2 (en) | 2008-12-23 | 2018-10-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US20100161045A1 (en) * | 2008-12-23 | 2010-06-24 | Sorin Biomedica Cardio S.R.L. | Expandable prosthetic valve having anchoring appendages |
US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
US9402610B2 (en) | 2009-04-13 | 2016-08-02 | Physcient, Inc. | Rib-protecting devices for thoracoscopic surgery, and related methods |
US10368854B2 (en) | 2009-04-13 | 2019-08-06 | Physcient, Inc. | Methods and devices to decrease tissue trauma during surgery |
US20110082539A1 (en) * | 2009-10-05 | 2011-04-07 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US8808369B2 (en) * | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US9743973B2 (en) | 2010-01-28 | 2017-08-29 | Medtronic Cryocath Lp | Triple balloon catheter |
US20110184400A1 (en) * | 2010-01-28 | 2011-07-28 | Medtronic Cryocath Lp | Triple balloon catheter |
US8926602B2 (en) | 2010-01-28 | 2015-01-06 | Medtronic Cryocath Lp | Triple balloon catheter |
US9089423B2 (en) | 2010-05-10 | 2015-07-28 | Hlt, Inc. | Stentless support structure |
US10022221B2 (en) | 2010-05-10 | 2018-07-17 | Hlt, Inc. | Stentless support structure |
US9248017B2 (en) | 2010-05-21 | 2016-02-02 | Sorin Group Italia S.R.L. | Support device for valve prostheses and corresponding kit |
WO2011150222A1 (en) * | 2010-05-28 | 2011-12-01 | Salient Surgical Technologies, Inc. | Fluid- assisted electrosurgical devices, and methods of manufacture thereof |
US9161836B2 (en) | 2011-02-14 | 2015-10-20 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9289289B2 (en) | 2011-02-14 | 2016-03-22 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
US9387031B2 (en) | 2011-07-29 | 2016-07-12 | Medtronic Ablation Frontiers Llc | Mesh-overlayed ablation and mapping device |
US10285755B2 (en) | 2011-07-29 | 2019-05-14 | Medtronic Ablation Frontiers Llc | Mesh-overlayed ablation and mapping device |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
WO2013036921A1 (en) * | 2011-09-08 | 2013-03-14 | Physcient, Inc. | Rib-protecting devices for thoracoscopic surgery, and related methods |
US20200222184A1 (en) * | 2011-09-28 | 2020-07-16 | Medtronic CV Luxembourg S.a.r.l. | Distal tip assembly for a heart valve delivery catheter |
US11497604B2 (en) * | 2011-09-28 | 2022-11-15 | Medtronic CV Luxembourg S.a.r.l. | Distal tip assembly for a heart valve delivery catheter |
US9113911B2 (en) | 2012-09-06 | 2015-08-25 | Medtronic Ablation Frontiers Llc | Ablation device and method for electroporating tissue cells |
US9486314B2 (en) | 2013-03-15 | 2016-11-08 | Hlt, Inc. | Low-profile prosthetic valve structure |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US9931205B2 (en) | 2013-03-15 | 2018-04-03 | Hlt, Inc. | Low-profile prosthetic valve structure |
US10213303B2 (en) | 2015-02-02 | 2019-02-26 | On-X Life Technologies, Inc. | Rapid deployment artificial chordae Tendinae system |
US9480565B2 (en) | 2015-02-02 | 2016-11-01 | On-X Life Technologies, Inc. | Rapid deployment artificial chordae tendinae system |
US11103350B2 (en) | 2016-06-01 | 2021-08-31 | On-X Life Technologies, Inc. | Pull-through chordae tendineae system |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
WO2021151028A1 (en) * | 2020-01-24 | 2021-07-29 | Children's Medical Center Corporation | Device for visualization of valve during surgery |
Also Published As
Publication number | Publication date |
---|---|
AU1582497A (en) | 1997-08-22 |
US6010531A (en) | 2000-01-04 |
WO1997027799A1 (en) | 1997-08-07 |
US6651671B1 (en) | 2003-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6651671B1 (en) | Lens-invasive devices and methods for cardiac valve surgery | |
JP3717929B2 (en) | Prosthetic assembly for non-thoracotomy replacement of heart valves | |
AU687232B2 (en) | Endoscopic retraction system and method | |
US6899704B2 (en) | Devices and methods for intracardiac procedures | |
US5814097A (en) | Devices and methods for intracardiac procedures | |
US5713951A (en) | Thoracoscopic valve prosthesis delivery device | |
US5718725A (en) | Devices and methods for intracardiac procedures | |
US6564805B2 (en) | Less-invasive devices and methods for treatment of cardiac valves | |
US6802319B2 (en) | Minimally-invasive devices and methods for treatment of congestive heart failure | |
JP3759497B2 (en) | Minimally invasive annuloplasty repair segment delivery template system | |
US5980455A (en) | Method for manipulating a tissue structure within a thoracic cavity | |
US7213601B2 (en) | Minimally-invasive devices and methods for treatment of congestive heart failure | |
US20020029783A1 (en) | Minimally-invasive devices and methods for treatment of congestive heart failure | |
AU5951996A (en) | Less invasive devices and methods for treatment of cardiac valves | |
CA2177490C (en) | Devices and methods for intracardiac procedures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |